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1Abbreviations 
Ar     Aromatic 
nBuLi     n-Butylithium 
DEPT Distortionless Enhancement by Polarisation 
Transfer 
EI     Electronic Impact 
ESI     Electrospray Ionization 
EtOAc     Ethylacetate 
HRMS     High Resolution Mass Spectroscopy 
IR     Infrared Spectroscopy 
LDA     Lithium Diisopropylamide 
MS     Mass Spectrometry 
Ph     Phenyl 
NEt3     Triethylamine 
NMR     Nuclear Magnetic Resonance 
HMQC    Heteronuclear Multiple Quantum Coherence 
HMBC    Heteronuclear Multiple Bond Correlation 
COSY     Correlated Spectroscopy 
NOESY    Nuclear Overhauser and Exchange Spectroscopy 
Me3SiOTf    Trimethylsilyl-trifluoromethanesulfonate 
Me3SiCl    Trimethylsilylchloride 
mp.     Melting Point 
TFA     Trifluoroacetic Acid 
Tf2O     Trifluoromethanesulfonic Anhydride 
THF     Tetrahydrofurane 
TLC     Thin Layer Chromatography 
TMS     Trimethylsilane
UV     Ultraviolet Spectroscopy
TfOH     Trifluoromethanesulfonic Acid 
2Summary 
A significant part of this dissertation has recently been published (see list of publications 
at the end). The work in this dissertation is mainly concerned with Synthesis of 
functionalized biaryls, benzophenones, phenols, fluorenones, fluoroarenes, and 
chloroarenes based on formal [3+3] cyclocondensations of 1,3-bis(silyloxy)-1,3-
butadienes and 1,3,5-tris(silyloxy)-1,3,5-hexatrienes. 
1. This Chapter contains the synthesis of Highly functionalized polyketide-type 
phenols (5a-j) and (6a-j) which were prepared by domino Michael / retro-Michael / 
aldol reactions of 3-formylchromones (4a-j) with 1-ethoxy-1,3,5-tris(trimethylsilyloxy)-
1,3,5-hexatriene (2) and its synthetic precursor, ethyl 3,5-bis(trimethylsilyloxy)-2,4-
hexadienoate (3). 
2. This cahapter includes the synthesis of Sterically encumbered biaryls (11a-e) and 
(13a-j) which were regioselectively prepared based on formal [3+3] cyclocondensations 
of novel 4-aryl-1,3-bis(trimethylsilyloxy)-1,3-dienes. 
3. This chapter contains the synthesis of Functionalized fluorenones (24) which were 
efficiently prepared in four steps. 1-hydroxyfluorenones (24) were prepared by [3+3] 
cyclization of 3-aryl-3-(silyloxy)-2-en-1-ones with 1,3-bis(silyloxy)buta-1,3-dienes and 
subsequent intramolecular Friedel–Crafts acylation of the 6-arylsalicylates (23).  
4. This chapter contains the reactions of first fluorine containing 1,3-bis(silyl enol 
ether) 27, the reactions of 27 with epichlohydrin, 2,3butenoxide, cyanochromones and 
phathaloyl dichloride resulted in several novel fluorinated compounds 28, 32, 33 and 
35a-e which are not readily available by other methods. 
5. This chapter is concerned with reactions of 2-chloro-1,3-bis(trimethylsilyloxy)-
1,3-butadienes (38) with epibromo and epichlorohydrin, 2,3butenoxide, cyanochromones 
and DMAD allow a convenient synthesis of chlorinated molecules such as 47, 48, 51a-d, 
and 52 which are not readily available by other methods. 
36. This chapter includes the synthesis of chlorinated biaryls (62a-f), azaxanthones 
(60a-d), benzotropones (66), and isobenzofurans which were prepared by one-pot 
cyclizations 1-alkoxy-4-chloro-1,3-bis(trimethylsilyloxy)-1,3-butadienes (55a-b) with 
various dielectrophiles.   
7. Acetal-protected (2,4-dioxocyclohex-1-yl)-acetic acids (73a,b) were prepared by 
allylation of dilithiated 1,3-cyclohexane-1,3-diones (67a,b), protection of the carbonyl 
groups and oxidation of the alkene moiety. Their reaction with amines afforded the 
corresponding amides (76a-v) which were transformed, by acid-catalyzed cyclization, 
into various 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles (77a-v). The reaction of the 
corresponding amides (76a-v) with triflic acid resulted in the formation of novel 5,8,9,10-
tetrahydro-6H-indolo [2,1-a]isoquinolin-9-ones (80a-c). 
41. Synthesis of Polyketide-Type Phenols by Domino Michael / 
Retro-Michael / Aldol Reactions of 3-Formylchromones with Silyl Enol 
Ethers derived from Ethyl 3,5-Dioxohexanoate. 
1.1 Introduction 
In recent years, several one-pot cyclization reactions of 1,3-bis(silyloxy)-1,3-butadienes, 
such as A,1 have been reported (Scheme 1). This includes, for example, cyclizations with 
oxalyl chloride to give butenolides,2 formal [3+3] cyclocondensations to give salicylates,3
syntheses of 2-alkylidenetetrahydrofurans,4 reactions with iminium salts,5 and domino 
reactions with benzopyrylium triflates.6 In contrast, reactions of 1,3,5-tris(silyloxy)-1,3,5-
hexatrienes, such as B, have only scarcely been reported to date. Trienes B contain three 
rather than only two masked carbonyl groups. Chan and coworkers studied their reaction 
with acid chlorides to give polyketides which spontaneously underwent an intramolecular 
aldol reaction to give hydroxylated arenes.7 The cyclization of B with oxalyl chloride has 
also been reported.8 Recently, we developed a new synthesis of 4-(2-
hydroxybenzoyl)phenols by domino reaction of 1,3-bis(silyloxy)-1,3-butadienes with 3-
formylchromones.9 Herein, we report for the first time the application of this 
methodology to 1-ethoxy-1,3,5-tris(trimethylsilyloxy)-1,3,5-hexatriene and its synthetic 
precursor, ethyl 3,5-bis(trimethylsilyloxy)-2,4-hexadienoate. The domino reactions 
reported herein provide a convenient access to highly functionalized polyketide-type 
phenols which are not readily available by other methods.  
OSiMe3
OMeMe3SiO
OSiMe3Me3SiO
OSiMe3MeOA B
Scheme 1:  Structure of 1,3-bis(silyloxy)-1,3-butadiene A and of 1,3,5-tris(silyloxy)-
1,3,5-hexatriene B.
1.2 Results and Discussion 
1,3,5-Tris(silyloxy)-1,3,5-hexatriene 3 was prepared, following the procedure reported 
for the synthesis of the methoxy derivative,7 in two steps (Scheme 1). The silylation of 
5ethyl 3,5-dioxohexanoate (1) gave ethyl 3,5-bis(trimethylsilyloxy)-2,4-hexadienoate (2). 
Deprotonation of the latter with LDA and subsequent addition of Me3SiCl gave 3 in 80% 
overall yield. The reaction of 1,3-bis(trimethylsilyloxy)-1,3-butadiene 2 with 3-
formylchromones 4a-j afforded the functionalized 4-(2-hydroxybenzoyl)phenols 5a-j
(Scheme 3, Table 1). The formation of the products can be explained by a domino 
Michael / retro-Michael / aldol reaction: the reaction of 4a-j with Me3SiOTf gave 
pyrylium triflate A. The conjugate addition of the diene onto A afforded intermediate B
which underwent a retro-Michael reaction to give intermediate C. An aldol reaction of 
the latter gave intermediate D which underwent an elimination of silanolate and 
aromatization (before or during the aqueous work-up) to give the final product. The best 
yields were obtained for products 5a, b, h-j which are derived from the chlorinated and 
fluorinated chromones 4h-j, from parent formylchromone 4a and from 4b. 
O O O
OEt
Me3SiO O
OEt
OSiMe3
i
Me3SiO OSiMe3
OEt
OSiMe3
ii
1
2 (82%)
3 (80%)
Scheme 2. Synthesis of 3; i: Me3SiCl (3.6 equiv.), NEt3 (3 equiv.), C6H6, 20 °C, 72 h; ii:
1) LDA (1.5 equiv.), THF, –78 °C, 1 h; 2) Me3SiCl (2.5 equiv.), 20 °C, –78  20 °C. 
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Scheme 3. Synthesis of 5a-j. Reagents and conditions: i, 1) 4a-j (1.0 equiv.), Me3SiOTf 
(0.3 equiv), 20 °C, 10 min; 2) 2 (1.3 equiv), CH2Cl2, 020 °C, 12 h; 3) HCl (10%). 
7        Table 1. Synthesis of 5a-j 
5 R1 R2 Yield 
(%) a
δ (O-H) b
a H H 79 11.67, 12.62 
b Me H 88 11.47, 12.62 
c Et H 63 11.48, 12.64 
d iPr H 52 11.47, 12.65 
e NO2 H 43 12.28, 12.70 
f Br H 54 11.55, 12.66 
g Br Br 56 12.10, 12.68 
h Cl H 76 11.54, 12.65 
i Cl Cl 80c 11.93, 12.67 
j F H 79 11.36, 12.63 
a Yields of isolated products 
b 1H NMR shifts of OH protons.  
c Synthesized by Muhammad Nawaz 
The structures of all products were established by spectroscopic methods. The structures 
of 5e, 5h and 5j were independently confirmed by X-ray crystal structure analyses 
(Figures 1 and 2).10 All products possess two low field signals (1H NMR, CDCl3) for the 
protons involved in intramolecular hydrogen bonds O−H⋅⋅⋅O. The chemical shifts of the 
hydroxyl proton derived from the chromone moiety are found in the range of  δ = 11.36-
12.10 ppm and strongly depend on the substitution pattern (Table 1). The most extreme 
downfield shift is observed for derivative 5e (δ = 12.28), due to the electron-withdrawing 
effect of the nitro group. Extreme low field shifts are observed also for compounds 5g
and 5i containing two halogen atoms.  
The signals of the hydroxyl protons of the second phenol moiety (which is derived from 
the diene 2) are located in a rather narrow chemical shift range (δ = 12.62-12.70 ppm). 
This can be explained by the fact that the substitution pattern of this phenol moiety is the 
same for all derivatives 5a-j. The chemical shifts of the hydroxyl protons appear in the 
same range as earlier reported9 for derivatives 5k and 5l (Scheme 4). It is worth to be 
noted that the hydroxyl proton may participate in a hydrogen bond either to the acetyl or 
the ester oxygen atom. In the solid state structures of 5e, 5h and 5j, the hydrogen bonds 
involve the ester group. However, the solution structures might be different. The 
comparison of the chemical shifts of the low field signals of 5a-j with those of 
8derivatives 5k and 5l, containing an acetyl and an ester group, do not allow to clearly 
distinguish the solution structure. However, the ester group is expected to be a better 
hydrogen bond acceptor than the keto group which is in accordance with the structures 
observed in the solid state.
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OEtO
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Scheme 4. Chemical shifts (1H NMR) of OH protons of 5a, 5k and 5l 
                             
Figure 1. Ortep plot of 5e 
9                     
Figure 2. Ortep plot of 5h 
Figure 3. Ortep plot of 5j 
The cyclization of 3-formylchromones 4a-j with 1,3,5-tris(silyloxy)-1,3,5-hexatriene 3
afforded the 4-(2-hydroxybenzoyl)phenols 6a-j which represent regioisomers of 5a-j
(Scheme 5, Table 2). The cyclizations involve, as expected, the terminal carbon atom of 
the triene. Phenols 6a-j can be regarded as masked polyketides. All products exist in their 
keto tautomeric form. The yields of 6a-j are generally lower than the yields of 5a-j. This 
can be explained by the unstable nature of triene 3 which results in some decomposition 
and hydrolysis under the reaction conditions. In fact, a small amount of 3,5-dioxoester 1
10
was isolated as side-product in all reactions. Similar to products 5a and 5i, relatively 
good yields are obtained for 6a and 6i which are derived from parent formylchromone 4a
and from dichlorinated formylchromone 4i, respectively. Besides, the trends of the yields 
of products 5 and 6 are quite different from each other.  
                    
Me3SiO
OEt
OSiMe3
+ O
O
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O
O
i
O
OEt
H
H
Scheme 5. Synthesis of 6a-j. Reagents and conditions: i, 1) 4a-j (1.0 equiv.), Me3SiOTf 
(0.3 equiv), 20 °C, 10 min; 2) 3 (1.1 equiv.), CH2Cl2, 020 °C, 12 h; 3) HCl (10%). 
Table 2. Synthesis of 6a-j 
6 R1 R2 Yield 
(%) a
δ (O-H) b
a H H 43c 11.63, 12.14 
b Me H 36 11.60, 12.29 
c Et H 45 11.60, 12.30 
d iPr H 47 11.59, 12.30 
e NO2 H 30 12.30  
f Br H 31 11.56, 12.24 
g Br Br 33 12.13, 12.27 
h Cl H 37 11.63, 12.33 
i Cl Cl 59c 12.13, 12.27 
j F H 34 11.39, 12.23 
a Yields of isolated products 
b 1H NMR shifts of OH protons. 
C Synthesized by Muhammad Nawaz 
   
Two low field signals, assigned to hydroxyl protons, are observed also for products 6a-j
(Table 2). The signals assigned to the chromone-derived hydroxyl protons are in the 
11
range of δ = 11.39-12.20 ppm and again depend on the substitution pattern. In contrast, 
the signals of the other hydroxyl protons are found in a rather narrow range. 
1.3 Conclusion: 
In conclusion, we have reported the synthesis of highly functionalized polyketide-type 
phenols by domino Michael / retro-Michael / aldol reactions of 3-formylchromones with 
1-ethoxy-1,3,5-tris(trimethylsilyloxy)-1,3,5-hexatriene and its synthetic precursor, ethyl 
3,5-bis(trimethylsilyloxy)-2,4-hexadienoate. These products are not readily available by 
other methods. 
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2 Regioselective Synthesis of Functionalized Biaryls based on the 
First [3+3] Cyclocondensations of 4-Aryl-1,3-bis(trimethylsilyloxy)-1,3-
butadienes 
2.1 Introduction:
Functionalized biaryls containing a 3-arylsalicylate substructure occur in a variety of 
pharmacologically relevant natural products. The simple biaryls cynandione A-C have 
been isolated from many plant sources and show a considerable in vitro activity against 
hepatocytes, human bladder carcinoma T-24 cells, epidermoid carcinoma KB cells, and 
human hepatoma PLC/PRF/5 cells.11 A number of natural products, such as knipholone, 
6'-O-methylknipholone or (+)-asphodelin, contain an anthraquinone moiety.12 Other 
compounds, e. g. secalonic acid A or globulixanthone E, contain a bixanthenyl 
substructure.13 3-Arylsalicylates are also present in many flavones (e. g. 2,3-
dihydroamentoflavone,14a bartramiaflavone,14b robustaflavone,14c dichamanetin).14d,e For 
some derivatives, inhibition of the human liver cathepsin B and K has been reported.14f,g
The natural product anastatin A, which contains a hydroxylated dibenzofuran moiety, 
shows hepatoprotective activity.15  
The most important synthetic approach to biaryls relies on palladium(0)-catalyzed cross-
coupling reactions.16 Although these reactions are broadly applicable, the synthesis of 
sterically encumbered products can be difficult or not possible at all. In addition, the 
regioselective synthesis of the required aryl halides or triflates can be a very difficult 
task. Some years ago, Chan et al. developed17 a convenient approach to salicylates by 
formal [3+3] cyclizations18 of 1,3-bis(trimethylsilyloxy)-1,3-dienes19 with 3-
trimethylsilyloxy-2-en-1-ones. Recently, we developed a catalytic variant of this 
transformation.10 Herein, we report, for the first time, the synthesis of 4-aryl-1,3-
bis(trimethylsilyloxy)-1,3-butadienes and their application to the synthesis of 
functionalized biaryls. The sterically encumbered and functionalized biaryls reported 
herein are not readily available by other methods. 
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2.2 Results and Discussion 
The 4-arylacetoacetates 8a-e were prepared by LDA-mediated reaction of methyl acetate 
with the α-arylacetyl chlorides 7a-e (Scheme 1, Table 1). The silylation of 8a-e afforded 
the 3-silyloxy-2-en-1-ones 9a-e. The novel 4-aryl-1,3-bis(silyloxy)-1,3-dienes 10a-e were 
prepared by deprotonation (LDA) of 9a-e at −78 °C and subsequent addition of 
trimethylchlorosilane. The Me3SiOTf-catalyzed cyclization of 4-aryl-1,3-bis(silyloxy)-
1,3-dienes 10a-e with 1,1,3,3-tetramethoxypropane, afforded the 3-arylsalicylates 11a-e. 
During the optimization of this reaction, we had to modify the protocol recently reported 
by us.20 Noteworthy, the best yields were obtained when the cyclizations were carried out 
in a highly concentrated rather than in dilute solution. 
The structures of all products were established by spectroscopic methods. The structures 
of 11b, 11c21 13e, 13h and 13i were independently confirmed by X-ray crystal structure 
analysis (Figures 1-5).
14
                    
Cl
O
R2
R1
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O
OSiMe3Me3SiO
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OMeMeO
R2 R1OH
OMe
O
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R1
R2
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iii
ii
9a-e
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7a-e
+
Scheme 6. Synthesis of 11a-e; i: LDA, THF, –78  20 °C, 14 h; ii: Me3SiCl, NEt3, 
C6H6, 20 °C, 72 h; iii: LDA, THF, –78  20 °C; iv: Me3SiOTf (0.1 equiv.), CH2Cl2, –78 
 20 °C, 20 h 
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Table 3. Synthesis of biaryls 11a-e 
                              a Isolated yields 
                             b Synthesized by M.Abid Rashid 
                             c Synthesized by Rasheed Ahmad  
                                
The TiCl4-mediated [3+3] cyclization of 1,3-bis(silyloxy)-1,3-dienes 10a-e with 3-
silyloxy-2-en-1-ones 12a-c afforded the 3-arylsalicylates 13a-j (Scheme 2, Table 2). 
During the optimization, it proved to be important to carry out the reactions in a highly 
concentrated solution. 
             
Me Me
Me3SiO O
R3
13a-j
i
12a-c
+
OSiMe3Me3SiO
OMe
R2
R1
10a-e
R2 R1OH
OMe
O
MeMe
R3
Scheme 7. Synthesis of 13a-j; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
8-11 R1 R2 % 
(2)a
 %  
(3)a
 %  
(4)a
 %  
(5)a
a H H 60 82 80 44 
b H OMe 56 80 84 50 
c OMe H 48 75 82 34b
d H Cl 34 77 85 43 
e H Me 45 81 86 36c
16
Table 4. Synthesis of biaryls 13a-j 
a Isolated yields 
b Synthesized by M.Abid Rashid 
c Synthesized by Rasheed Ahmad 
        
Figure 4. Ortep plot of 11b 
10 12 13 R1 R2 R3 % (13)a
a a a H H H 41 
a b b H H Cl 40 
c a c OMe H H 26b
c b d OMe H Cl 30b
b b e H OMe Cl 38 
b a f H OMe H 37 
b c g H OMe Me 38 
a c h H H Me 35 
d b i H Cl Cl 40 
e b j H Me Cl 30c
17
         
Figure 5. Ortep plot of 11c 
            
Figure 6. Ortep plot of 13e 
18
                  
Figure 7. Ortep plot of 13h 
   
Figure 8. Ortep plot of 13i 
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The TiCl4-mediated reaction of 1,3-bis(silyloxy)-1,3-dienes 10a and 10d with 1,1-
diacetylcyclopropane (14) gave the 3-arylsalicylates 15a and 15b, respectively (Scheme 
3). Products 15a,b are formed by a domino [3+3]-cyclization-homo-Michael reaction.22  
          
OSiMe3Me3SiO
OMe
R
TiCl4
Me
O O
Me
O
OMe
MeMe
OH
Cl
R
i
10a,d
+
14 15a (R = H): 42%15b (R = Cl): 37%
Scheme 8. Synthesis of 15a,b; i: TiCl4, CH2Cl2, –78  20 °C, 20 h 
The TMSOTf-mediated reaction of 3-cyanochromone (16) with 1,3-
bis(trimethylsilyloxy)-1,3-butadiene 10a, d, e, afforded the condensation product 17 by 
regioselective attack of the terminal carbon atom of 10a, d, e onto carbon atom C-2 of 16
and subsequent hydrolysis. Treatment of an ethanol solution of crude 17 with 
triethylamine afforded 1-azaxanthone 18 (Scheme 1). The formation of 18 can be 
explained by a domino 'retro-Michael-lactonization-aldol' reaction. The base-mediated 
retro-Michael reaction of 17 gave open-chained intermediate B. The attack of the 
hydroxy group onto the nitrile gave intermediate C. The attack of the imino nitrogen 
atom onto the carbonyl group (intermediate D) and subsequent aromatization by 
extrusion of water afforded 18. The transformation of 17 into 18 can be regarded as a 
domino 'retro-Michael / nitrile-addition / heterocyclization' reaction. 23
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Scheme 9. Synthesis of 3-aryl-1-azaxanthone 18a-c: i: 1) 16, Me3SiOTf, 1 h, 20 °C, 2) 
10a, d, e, CH2Cl2, 0  20 °C, 12 h, 3) HCl (10%); ii: 1) NEt3, EtOH, 20 °C, 12 h, 2) HCl 
(1 M) 
Table 5. Synthesis of 1-azaxanthones 18a-c.
17,18   R  18a (%) 
a   H  62 
b   Me  63    
c   Cl  50 
a Yield of isolated products. 
The Me3SiOTf-catalyzed reaction of 1,3-bis(silyloxy)-1,3-butadiene 10e with 3-
formylchromone (19) afforded the highly functionalized biaryl 20 (Scheme 5). This 
product is formed by a domino Michael−retro-Michael−Mukaiyama-Aldol reaction.24 
                 
OSiMe3Me3SiO
OMe
O
O O
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O
OMe
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ii
19 20 (47%)
OH
Me
Me
Scheme 10. Synthesis of 20; i: Me3SiOTf (0.3 equiv), 20 °C, 10 min; ii: 1) 10e (1.3 
equiv), CH2Cl2, 0  20 °C, 12 h; 2) HCl (10%) 
2.3 Conclusions 
In conclusion, we have reported, for the first time, a new and regioselective approach to a 
variety of sterically encumbered biaryls based on formal [3+3] cyclizations of novel 4-
aryl-1,3-bis(trimethylsilyloxy)-1,3-dienes. The products are not readily available by other 
methods.
22
3. Synthesis of Functionalized Fluorenones based on the 
Combination of Formal [3+3] Cyclocondensations of 1,3-Bis(silyloxy)-
1,3-butadienes with Intramolecular Friedel-Crafts-Acylations 
3.1 Introduction 
Fluorenones occur in a number of natural products. This includes various highly 
hydroxylated derivatives, such as dengibsin, dengibsinin, or dendroflorin (Scheme 11).25
The first two fluorenone natural products, dengibsin und dengibsinin, were isolated 1985 
by Talapatra et al. from the Orchidee Dendrobium gibsonii Lindl.25a These products were 
first prepared by Sargent and coworkers.25b Fluorenones are of considerable 
pharmacological relevance.26 They have been used as probes for the redox activity of 
DNA.27 Amidofluorenone derivatives have been shown to be telomerase inhibitors which 
is important for the development of anti-cancer agents.28 In addition, fluorenones 
represent versatile synthetic intermediates. They have been used, for example, during the 
synthesis of the antibiotic kinamycin D.29  Fluorenones are also important compounds in 
photochemistry.30  
The most important synthetic approach to fluorenones includes intramolecular Friedel-
Crafts acylations of appropriate biaryls.31 Other syntheses rely on [4+2]-cycloadditions of 
conjugated enynes32 and on the oxidation of fluorenes.33 Snieckus and coworkers 
reported the synthesis of fluorenones based on remote aromatic metalation.34 Larock and 
coworkers reported the synthesis of fluorenones by palladium-catalyzed 
cyclocarbonylation of 2-halobiaryls.26 Valesco and Yu reported the synthesis of 
fluorenones based on the reaction of malonic acid dinitrile with aromatic aldehydes and 
methylketones.35 Ciske and Jones prepared fluorenones by Suzuki reaction of boronic 
acids, generated in situ from benzoic acid amides, with aryl triflates and subsequent 
cyclization by remote metalation.36 Fluorenones have been prepared by acid-mediated 
intramolecular Friedel-Crafts cyclation of 2-methoxycarbonyl-biaryls. Recently, the 
synthesis of the latter by Suzuki reactions of salicylate-derived enol triflates has been 
reported.37  
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Salicylates are available by various synthetic strategies. An important approach to 
salicylates, first reported by Chan and coworkers,38 relies on the formal [3+3] cyclization 
of 1,3-bis(silyloxy)-1,3-butadienes39 with 3-silyloxy-2-en-1-ones. In recent years, we 
have reported the application of this methodology to the synthesis of a variety of 
functionalized arenes.40 Recently, we have reported41 a convenient four-step synthesis of 
fluorenones: The [3+3] cyclization of 1,3-bis(silyloxy)-1,3-butadienes with 3-silyloxy-2-
en-1-ones afforded salicylates which were transformed into their enol triflates. The 
Suzuki cross-coupling reaction of the latter with arylboronic acids afforded 2-
methoxycarbonyl-biaryls which were subsequently transformed into the target molecules 
by intramolecular Friedel-Crafts acylation. Herein, we report full details of these studies. 
In addition, we report the synthesis of 1-hydroxyfluorenones by cyclization of 3-aryl-3-
silyloxy-2-en-1-ones with 1,3-bis(silyloxy)-1,3-butadienes and subsequent intramolecular 
Friedel-Crafts acylation of the 6-arylsalicylates thus formed.42 In this context, the 
synthesis of novel cyclopenta[def]phenanthren-4-ones is reported. The advantage of the 
two synthetic strategies outlined herein relies on the fact that various substitution patterns 
are readily available based on a building-block strategy. The products are not readily 
available by other methods. 
O
HO
OH
MeO
O
HO
OH
MeO
Dengibsin Dendroflorin
OH
O
OMe
MeO
OH
HO
Dengibsinin
Scheme 11. Fluorenone natural products 
24
3.2 Results and Discussion 
The reaction of 1,3-bis(silyl enol ether) 21a,c with 3-silyloxy-2-en-1-one 22h-k, prepared 
from arylketones, resulted in regioselective formation of salicylates 23i-m, which were 
transformed into fluorenones 24y-ac (Scheme 2, Table 3). The regioselective formation 
of 23i-m can be explained by isomerization of 22h-k into iso-22h-k and subsequent 
cyclization as described above. 
The structure of all products was established by spectroscopic methods. The structures of 
23j and 24ab were independently confirmed by an X-ray crystal structure analysis 
(Figures 9 and 10). The fluorenone is, as expected, a flat molecules. An intramolecular 
hydrogen bond is present. 
    Figure 9: Crystal Structure of 23j 
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Figure 10. Ortep-Plot of 24ab (50% probability level) 
iMe
O OSiMe3
OH
OR2
O
Me
OR2
OSiMe3Me3SiO
OH
Me
R3
O
Me
Me3SiO O
ii
23i-r4y-ah
21a,c-e
R1
R3 R4 R3 R4
R1
R3 R4R4
R1
22h-l iso-22h-l
Scheme 12. Synthesis of fluorenones 24y-ah, i: TiCl4, CH2Cl2, –78  20 °C; ii: conc. 
H2SO4, 1 h 
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Table 6. Products and yields 
21 22 23 24 R1 R2 R3 R4  % 
(23)a
 % 
(24)a
a h i y H Me Me H 43 68 
a i j z H Me H Cl 40 83 
c i k aa nHex Me H Cl 34 65 
a j l ab H Me Cl H 37 75 
d j m ac Me Me Cl H 32b 80b
e j n ad Et Et Cl H 35b 60b
a k o ae H Me F H 44 75 
d k p af Me Me F H 32b 51b
a l q ag H Me H F 44b 68b
e l r ah Et Et H F 44b 76b
a Yields of isolated products 
b Synthesized by M.A. Yawer and I. Hussain 
3.3 Conclusion: 
In conclusion, a method for the synthesis of functionalized fluorenones was developed. 
The approach relies on the [3+3] cyclization of 1,3-bis(silyloxy)-1,3-butadienes with 3-
silyloxy-2-en-1-ones to give salicylates. The cyclization of 3-aryl-3-silyloxy-2-en-1-ones 
with 1,3-bis(silyloxy)-1,3-butadienes afforded 6-arylsalicylates which were subsequently 
transformed into the products by intramolecular Friedel-Crafts acylation. In this context, 
the synthesis of novel cyclopenta[def]phenanthren-4-ones is reported. The advantage of 
the synthetic strategy outlined herein relies on the fact that various substitution patterns 
are readily available based on a building-block strategy. The products are not readily 
available by other methods. 
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4 Synthesis and Reactions of the First Fluorine-Containing                          
1,3-Bis(trimethylsilyloxy)-1,3-butadienes: 
4.1 Introduction: 
Organofluorine compounds play an important role in drug discovery43. They exhibit 
unique stereoelectronic properties: on the one hand the fluorine atom is fairly small, on 
the other hand its high electronegativity often results in a great improvement of drug-
receptor interactions. The carbon-fluorine bond is chemically and biologically stable 
which avoids undesired metabolic transformations. In addition, the high lipophilicity of 
organofluorine compounds improves their in vivo transport. They also show a very good 
solubility in fluorophilic solvents. Therefore, organo-fluorine compounds are used as 
ligands44 for catalytic reactions in fluorous biphase systems and supercritical carbon 
dioxide.45 The unique electronic properties of fluorinated arenes are widely used for 
applications in organocatalysis.46 Last but not least, fluorinated arenes and heteroarenes 
are versatile building blocks in transition metal-catalyzed cross coupling reactions.47 
The direct fluorination of arenes, heteroarenes and several open-chained molecules often 
suffers from several drawbacks, such as low chemo- and regioselectivity or multiple 
fluorination. An alternative strategy for the regioselective synthesis of organofluorine 
compounds relies on the use of appropriate fluorine-containing building blocks in 
condensation and cyclization reactions. For example, aryl fluorides have been prepared 
by [4+2] cycloaddition reactions of 2-fluoro-1-methoxy-3-trimethylsilyloxy-buta-1,3-
diene, 2-fluoro-3-methoxy-buta-1,3-diene and related dienes with alkenes or alkynes.48
Portella et al. reported the synthesis of fluorophenols by annulation reactions of 2,2-
difluoro-1,5-diketones which were prepared from trifluoromethyltrimethylsilane, 
acylsilanes and enones.49 
1,3-Bis(trimethylsilyloxy)-1,3-butadienes (e. g., Chan’s diene)50, 51 represent important 
synthetic building blocks which have been used in formal [3+2], [3+3], [4+2] and [4+3] 
cyclizations and other transformations.52 Herein, we report the synthesis and reactions of 
2-fluoro-1,3-bis(silyloxy)-1,3-butadienes which represent, to the best of our knowledge, 
the first fluorine-containing 1,3-bis(silyl enol ethers).53 Their  reactions with electrophiles 
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provide a convenient and regioselective approach to a variety of organofluorine 
compounds which are not readily available by other methods.  
4.2 Results and Discussion: 
The silylation of commercially available ethyl 2-fluoroacetoacetate (25) afforded silyl 
enol ether 26. The latter was transformed, by deprotonation (LDA) at −78 °C and 
subsequent addition of trimethylchlorosilane, into novel 1-ethoxy-2-fluoro-1,3-
bis(trimethylsilyloxy)-1,3-butadiene (27) (Scheme 13). Diene 27a can be stored at −20 
°C under inert atmosphere for several weeks. 
                                 
OEt
O O
OSiMe3Me3SiO
OEt
i
25
i i
OMe3SiO
OEt
F F
F
26 (81%)
27 (94%)
Scheme 13. Synthesis of diene 27: i: Me3SiCl, NEt3, benzene, 20 °C, 48 h; ii: 1) LDA, 
THF, −78 °C, 1 h, 2) Me3SiCl, −78 → 20 °C, 14 h. 
The TiCl4-mediated cyclization of 27 with epichlorohydrin, following our recently 
reported protocol,54 afforded the halogenated 2-alkylidenetetrahydrofuran 28 (Scheme 
14). The exocyclic double bond was formed with excellent Z-diastereoselectivity. 
OSiMe3Me3SiO
OEt
iF
27
28 (48%)
O F
O OEt
O
Cl
+
Cl
Scheme 14. Synthesis of 2-alkylidenetetrahydrofuran 28: i: TiCl4 (2.0 equiv.), CH2Cl2, 
−78 → 20 °C. 
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The Me3SiOTf-catalyzed condensation of 27 with 1-chloro-2,2-dimethoxyethane gave 
the 2-fluoro-6-chloro-5-methoxy-3-oxo-hexanoate 29 (Scheme 15). The DBU-mediated 
cyclization55 of 29 afforded the E-configured 4-methoxy-2-alkylidenetetrahydrofuran 30.  
                    
OSiMe3Me3SiO
OEt
i
F Cl
OMe O O
OEt
27 29 (72%)
F
O F
O
OEt
i i
MeO
30 (81%)
+
Cl
OMe
OMe
Scheme 15 Synthesis of 30: i: Me3SiOTf (0.5 equiv.), CH2Cl2, −78 → 20 °C; ii: 2.0 
equiv. DBU, THF, 20 °C. 
The treatment of 25 with trans-1, 4-dibromobutene gave Z-configured Ethyl 2-fluoro-2-
(5-vinyldihydrofuran-2(3H)-ylidene)acetate 31 (Scheme 16)56. 
   
O O
OEt
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Br
Br
i
O F
OEt
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31 (41%)
25
Scheme 16. Synthesis of 31. i: LDA (2.5 Equiv.), THF, 25 (1 Equiv.), BrCH2CH= 
CHCH2Br (1.2 Equiv.), −78 → 20 °C. 
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The reaction of 1-ethoxy-2-fluoro-1,3-bis(trimethylsilyloxy)-1,3-butadiene (27) with 2,3-
butenoxide57 afforded Z-configured 32 in good yield (Scheme17). 
                    
Me3SiO OSiMe3
OCH2CH3
F
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Me Me
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32 (27%)
Scheme 17. Synthesis of 32. (i) 27 (1 equiv.), 2,3-butenoxide (1 equiv.), TiCl4 (2 equiv.), 
CH2Cl2, Molecular Sieves (4Å), -78ºC (5 h) - 20ºC (12 h).
The reaction of 1-ethoxy-2-fluoro-1,3-bis(trimethylsilyloxy)-1,3-butadiene (27) with 
phthaloyl dichloride, following our recently reported protocol,58 afforded product 33
(Scheme 18). The best yield was obtained in the presence of any Lewis acid (TiCl4). An 
unexpected product was formed which was never observed from our previous studies. 
The structure of 33 was independently confirmed by X-ray crystal structure analysis 
(Figure 11). 
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Scheme 18. Synthesis of 33. i: CH2Cl2, TiCl4, -7820°C, HCl (10%). 
31
                 
Figure 11: Crystal Structure of 33
The Me3SiOTf-mediated reaction of 27 with 3-cyanochromones (33a-e) gave 
condensation products 34a-e. The latter was formed by regioselective attack of the 
terminal carbon atom of the diene onto C-2 of the cyanochromone and subsequent 
hydrolysis upon aqueous work-up. Treatment of an ethanol solution of crude 34a-e with 
triethylamine afforded the novel fluorinated 1-azaxanthones 35a-e (Scheme 19). These 
types of products are again not available by direct fluorination. The transformation of 
33a-e into 35a-e can be explained by a domino 'retro-Michael / nitrile-addition / 
heterocyclization' reaction.23 
                
32
          
O
O
CNR1
R3
i
OEt
Me3SiO OSiMe3
+ O
O
R1
R3
OEt
O O
CN
O N
O
R1
R3
OEt
O
ii
F
F
F
R2
R2
R2
33a-e
34a-e
35a-e
Scheme 19. Synthesis of 1-azaxanthones 35a-e: (i) (1) 33a-e, Me3SiOTf, 1 h, 20 °C, (2) 
34a-e, CH2Cl2, 020°C, 12 h, (3) HCl (10%); (ii) (1) NEt3, EtOH, 20°C, 12 h, (2) HCl 
(10 %). 
Table 7. Synthesis of 1-azaxanthones 35a-e.
33, 34, 35(a-e)  R1  R2  R3  35a (%) 
a   H  H  H  56 
b   Me  Me  H  46    
c   Cl  H  H  41 
d   Cl  H  Cl  35 
e   F  H  H  33 
a Yield of isolated products. 
33
Figure 12: ORTEP-plot of 35e (50% level) 
4.3 Conclusion: 
In conclusion, we have reported a building block strategy for the synthesis of novel 
organofluorine compounds based on reactions of 2-fluoro-1,3-bis(trimethylsilyloxy)-1,3-
butadienes – the first fluorinated 1,3-bis(silyl enol ethers). The products are not available 
by direct fluorination reactions. 
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4.4 Summary: 
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Scheme 20: Schematic Representation of 1-ethoxy-2-fluoro-1,3-bis(trimethylsilyloxy)-
1,3-butadiene (27).
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5 Synthesis and Reactions of the First 2-Chloro-1,3-
bis(trimethylsilyloxy)-1,3-butadienes: 
5.1 Introduction: 
Chlorinated  molecules are of considerable pharmacological relevance and occur in a 
number of natural products.59 In fact, arenes and hetarenes containing a chloride group 
often show a better pharmacological activity compared to their non-halogenated 
analogues.60 Chlorinated arenes and hetarenes also represent versatile building blocks in 
transition metal-catalyzed cross coupling reactions.61 However, the direct chlorination of 
arenes, hetarenes and open-chained molecules often suffers from several drawbacks, such 
as low regioselectivity or multiple chlorination. An alternative strategy for the 
regioselective synthesis of organochlorine compounds relies on the use of appropriate 
chlorine-containing building blocks in condensation and cyclization reactions. For 
example, Manzanares and coworkers reported the synthesis of a 4-chlorophenol by [4+2] 
cycloaddition of a chlorinated thiophene with dimethyl acetylenedicarboxylate.62  
1,3-Bis(trimethylsilyloxy)-1,3-butadienes (e. g. Chan’s diene)63,64 represent important 
synthetic building blocks which have been used in formal [3+2], [3+3], [4+2] and [4+3] 
cyclizations and other transformations.65 Herein, we report what are, to the best of our 
knowledge, the first 2-chloro-1,3-bis(silyloxy)-1,3-butadienes.66 Their  reactions with 
various electrophiles provide a convenient and regioselective approach to a variety of 
organochlorine compounds which are not readily available by other methods.  
5.2 Results and Discussion: 
The reaction of commercially available ethyl 2-chloroacetoacetate (36) with Me3SiCl and 
triethylamine afforded the silyl enol ether 37 (Scheme 21). The novel 2-chloro-1-ethoxy-
1,3-bis(silyloxy)-1,3-butadiene 38 were prepared by deprotonation (LDA) of 37 at −78°C 
and subsequent addition of trimethylchlorosilane. Noteworthy, the chloride group proved 
to be compatible with the reaction conditions.  
36
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Scheme 21. Synthesis of dienes 36: i: Me3SiCl, NEt3, benzene, 20 °C, 48 h; ii: 1) LDA, 
THF, −78, 1 h, 2) Me3SiCl, −78 → 20 °C, 14 h. 
Treatment of 36 and 39 with ethylchloroformate in LDA (2.2Eq) afforded novel 
tricarbonyl compounds 40 and 41 (Scheme22)67. Which can be further used to get variety 
of novel chlorinated compounds.  
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Scheme 22. Synthesis of 40 and 41. i: 36, 39 (1 equiv.), LDA (2.2 Equvi), THF, Ethyl 
Chloroformate (1.1 Equiv.),−78  20°C, Acetic Acid.  
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The Me3SiOTf-catalyzed condensation of 38 with 1-chloro-2,2-dimethoxyethane gave 
ethyl 2,6-dichloro-5-methoxy-3-oxohexanoate (42) in good yield (Scheme 23). The 
DBU-mediated cyclization55 of 42 afforded the Z-configured 4-methoxy-2-
alkylidenetetrahydrofuran 43.  
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Scheme 23. Synthesis of furan 43: i: 38 (1Equiv.), Me3SiOTf (0.5 equiv.), 1-Chloro-2,2-
dimethoxy ethane (1 Equiv.). CH2Cl2, −78 → 20 °C; ii: 42 DBU, (2.0 equiv). THF, 20 
°C. 
The Me3SiOTf-mediated reaction of 1-ethoxy-2-chloro-1,3-bis(trimethylsilyloxy)-1,3-
butadiene (38) with 1-azido-2,2-dimehtoxy ethane afforded the desired condensation 
product68 (44) with good regio- and chemoselectivity (Scheme 24). Several attempts to 
get the cyclized pyrolidene derivative by treatment of a THF solution of 44 at 45°C with 
PPh3 were not successful.   
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Scheme 24. Synthesis of 13: i: Me3SiOTf (0.5 equiv.), CH2Cl2, −78 → 20 °C. 
The treatment of 36 with trans-1, 4-dibromobutene gave Z-configured Ethyl 2-chloro-2-
(5-vinyldihydrofuran-2(3H)-ylidene)acetate 45 (Scheme 25)56. 
O O
OCH2CH3
Cl
+
Br
Br
O
Cl
OCH2CH3
O
45 (65%)
36
i
Scheme 25. Synthesis of 45: i: LDA (2.5 Equiv.), THF, 36 (1 Equiv.), BrCH2CH2= 
CH2CH2Br (1.2 Equiv.), −78 → 20 °C. 
The reaction of 1-ethoxy-2-chloro-1,3-bis(trimethylsilyloxy)-1,3-butadiene (38) with 2,3-
butenoxide57 afforded Z-configured 46 in good yield (Scheme 26). 
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Scheme 26. Synthesis of 46. (i) 38 (1 equiv.), 2,3-butenoxide (1 equiv.), TiCl4 (2 equiv.), 
CH2Cl2, Molecular Sieves (4Å), -78ºC (5 h) - 20ºC (12 h).
The TiCl4-mediated cyclization of 38 with epibromohydrin, following our recently 
reported protocol,54 afforded the halogenated 2-alkylidenetetrahydrofuran 47 (Scheme 
27). The exocyclic double bond was again formed with excellent Z-diastereoselectivity. 
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OEt
Cl
+
O
Br 47 (47%)
i38
Scheme 27. Synthesis of 47. (i) 3b (1 equiv.), Epibromohyrin (1 equiv.), TiCl4 (2 equiv.), 
CH2Cl2, Molecular Sieves (4Å), -78ºC (5 h) - 20ºC (12 h).
The TiCl4-mediated cyclization of 38 with epichlrohydrin, following our recently 
reported protocol,54 afforded the halogenated 2-alkylidenetetrahydrofuran 48 (Scheme 
28). The exocyclic double bond was again formed with excellent Z-and E-
diastereoselectivity. The configuration of 48 E and Z isomers was confirmed by 2D-NMR 
studies. 
40
O
Cl
OEt
O
Cl
Me3SiO OSiMe3
OEt
Cl
+
O
Cl
+
OCl
Cl
EtO
O
48 Z-isomer
(32%)
48 E-isomer
(17%)38
i
  
Scheme 28. Synthesis of 48 E and Z. (i) 38 (1 equiv.), Epichlorohydrin (1 equiv.), TiCl4
(2 equiv.), CH2Cl2, Molecular Sieves (4Å), -78ºC (5 h) - 20ºC (12 h).
The Me3SiOTf-mediated reaction of 38 with 3-cyanochromones (49a-d) gave 
condensation products 50a-d. The latter was formed by regioselective attack of the 
terminal carbon atom of the diene onto C-2 of the cyanochromone and subsequent 
hydrolysis upon aqueous work-up. Treatment of an ethanol solution of crude 49a-d with 
triethylamine afforded the novel fluorinated 1-azaxanthones 51a-d (Scheme 29). These 
types of products are again not available by direct fluorination. The transformation of 
49a-d into 51a-d can be explained by a domino 'retro-Michael / nitrile-addition / 
heterocyclization' reaction.23 
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Scheme 29. Synthesis of 1-azaxanthones 51a-d: (i) (1) 49a-d, Me3SiOTf, 1 h, 20 °C, (2) 
38, CH2Cl2, 020°C, 12 h, (3) HCl (10%); (ii) 50a-d: NEt3, EtOH, 20°C, 12 h, (2) HCl 
(10 %). 
Table 8. Synthesis of 1-azaxanthones 51a-d.
49,50,51a-d  R1  R2  51a (%) 
a   H  H  58 
b   Cl  H  60    
c   F  H  60 
d   Cl  Cl  39 
a Yield of isolated products. 
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The solvent free reaction of 38 with DMAD at -78°C afforded highly functionalized 
chlorinated arene 52 in good yield and its structure was independently confirmed by X-
ray crystal analysis. 52 will be used for further studies.  
Me3SiO OSiMe3
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+ OMe
OMe
O
O
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38
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i
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O
Scheme 30. Synthesis of 52 i: 38 (1 equiv.), DMAD (1.5 Equiv.), −78 → 20 °C (20h), 
HCl (10%). 
             
Figure 13: Crystal Structure of 52
5.3 Conclusion: 
In conclusion, we reported a building block strategy for the regioselective synthesis of a 
variety of chlorinated carba- and heterocycles and of chlorinated dicarbonyl compounds. 
Novel 2-chloro-1,3-bis(trimethylsilyloxy)-1,3-butadienes were prepared and reacted with 
various electrophiles. The products are not available by direct chlorination reactions.  
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5.4 Summary: 
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O
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Scheme 31: Schematic representation for reactions 1-ethoxy-2-chloro-1,3-
bis(trimethylsilyloxy)-1,3-butadiene (38).
44
6. Synthesis of Chlorinated Arenes and Hetarenes based on 
One-Pot Cyclocondensations of 1-Alkoxy-4-chloro-1,3-
bis(trimethylsilyloxy) -1,3-butadienes.  
6.1 Introduction: 
Functionalized chloroarenes are of considerable pharmacological relevance69 and 
represent increasingly important building blocks for transition metal-catalyzed cross-
coupling reactions.70 3-Chlorosalicylates and related compounds are present in a variety 
of natural products. This includes, for example, dihydronidulin.71 The spirocyclic 
griseofulvin72 and epigriseofulvin73 have been reported to show clastogenic, cytotoxic 
and antifungal activity.  Polyketide-derived xanthones,74 geodin75 and geodinhydrate-
methyl ester76 show, for example, antibacterial and antifungal activity. 7-Chlor-1-O-
methylemodin has been reported to exhibit antiviral activity.77 3-Chlorosalicylates and 
related compounds are also present in simple arenes, acetophenones (longissiminone B), 
benzophenones (chloroisosulochrin, pestalone) and diaryl ethers (methyl 
chloroasterrate),78 falconensin B,79 natural chromones,80 and in 7-chloro-8-hydroxy-6-
methoxy-3-methyl-isochroman-1-one.81  
1,3-Bis(trimethylsilyloxy)-1,3-butadienes (e. g. Chan’s diene)82 represent important 
synthetic building blocks which have been used in formal [3+2], [3+3], [4+2] and [4+3] 
cyclizations and various other transformations.83,84 We have recently reported the 
synthesis of 4-chlorophenols by cyclization of 1,3-bis(silyloxy)-1,3-butadienes with 2-
chloro-3-silyloxy-2-en-1-ones85 and the synthesis of chlorinated hetero- and carbacycles 
by cyclization reactions of 2-chloro-1,3-bis(silyloxy)-1,3-butadienes.86 Recently, we have 
reported87 the synthesis of 4-chloro-1,3-bis(silyloxy)-1,3-butadienes and their application 
to the synthesis of chlorinated arenes and hetarenes. Herein, we report full details of these 
studies and studies related to the scope and limitations. 
The one-pot cyclizations reported herein provide a convenient and regioselective 
approach to various sterically encumbered, heavily substituted chlorinated products 
which are not readily available by other methods. Classic syntheses of chloroarenes, 
based on direct chlorinations, suffer from many drawbacks, such as low regioselectivities 
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and yields. In addition, the synthesis of the required starting materials, highly substituted 
and functionalized arenes, can be a difficult and tedious task 
6.2 Results and Discussion: 
The silylation of commercially available ethyl and methyl 4-chloroacetoacetate (53a,b)
gave 3-silyloxy-2-en-1-one 54a,b (Scheme 32). 4-Chloro-1-alkoxy-1,3-bis(silyloxy)-1,3-
butadiene (55a,b) were prepared by the deprotonation (LDA) of 54 at -78°C and 
subsequent addition of trimethylchlorosilane. Noteworthy, the chloro group proved to be 
compatible with the reaction conditions. Diene 55a,b can be stored at -20°C under inert 
atmosphere for several weeks. 
                        
OR
O O
OSiMe3Me3SiO
OR
i
53a,b
ii
OMe3SiO
OR
54a (R = Me): 86%
54b (R = Et): 87%
55a (R = Me): 82%
55b (R = Et): 95%
Cl Cl
Cl
Scheme 32. Synthesis of dienes 55a, b: i: Me3SiCl, NEt3, benzene, 20 °C, 48 h; ii: 1) 
LDA, THF, −78, 1 h, 2) Me3SiCl, −78 → 20 °C, 14 h. 
The Me3SiOTf-catalyzed reaction of 1,3-bis(silyloxy)-1,3-dienes 55a,b with 3-
formylchromones 57 a-e afforded the chlorinated 2,4’-dihydroxybenzophenones 57a-e in 
good yields (Scheme 32, Table 9). The products are formed by a domino Michael−retro-
Michael−Mukaiyama-Aldol reaction.88  
The structures of all products were confirmed by spectroscopic studies. The structure of 
57a was independently confirmed by X-ray crystal structure analysis (Figure 14).  
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57a-e
OR3
ii
i
OSiMe3Me3SiO
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R2
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R1R1
R2 R2
Cl
ClCl
OH
Scheme 32. Synthesis of 57a-e. Reagents and conditions: (i) 56a-e, Me3SiOTf (0.3 
equiv), 20 °C, 10 min; (ii) (1) 55a, b (1.3 equiv), CH2Cl2, 020 °C, 12 h; (2) HCl (10%). 
Table 9. Synthesis of 3-chlorosalicylates 57a-e 
56,57 R1 R2 R3  % (57)a
a H H OEt 42 
b Me H OEt 40 
c NO2 H OEt 40 
d Br H OEt 36 
e Cl H OEt 36b
a Yields of isolated products. 
b From Stefanie Reim 
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Figure 14. Ortep plot of 57a (50% probability level) 
The Me3SiOTf-catalyzed reaction of 1,3-bis(silyloxy)-1,3-diene 55b with 3-
cyanochromones 58a-d afforded products 59a-d which were transformed, by treatment 
with triethylamine, into the chlorinated azaxanthones 60a-d (Scheme 33, Table 10). The 
formation of the products can be explained that products are formed by a domino Retro-
Michael / nitrile-addition / heterocyclization reaction.89 The structure of 60c was 
independently confirmed by X-ray crystal structure analysis (Figure 15). 
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Scheme 33. Synthesis of 1-azaxanthones 60a–d: (i) (1) 58a–d, Me3SiOTf, 1 h, 20 °C, (2) 
59a–d, CH2Cl2, 0  20°C, 12 h, (3) HCl (10%); (ii) (1) NEt3, EtOH, 20°C, 12 h, (2) HCl 
(10 %). 
Figure 15. Ortep plot of 60c (50% probability level) 
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Table 10. Synthesis of 1-azaxanthones 60a–d 
58,59,60 R1 R2  % (60)a
a H H 58 
b Me Me 34 
c F H 37 
d Cl H 40 
a Yields of isolated products (from 58) 
The TiCl4-mediated [3+3] cyclization of 4-chloro-1,3-bis(silyloxy)-1,3-dienes 55a,b with 
3-aryl-3-silyloxy-2-en-1-ones 61a-e, prepared by silylation of the corresponding 
benzoylacetones, afforded the chlorinated biaryls 62a-e (Scheme 34, Table 11). During 
the optimization, it proved to be important to carry out the reactions in a highly 
concentrated solution. All products were formed with very good regioselectivity which 
can be explained, following a mechanism first suggested by Chan et al.,82a, 84 by TiCl4-
mediated isomerization of 61a-e, conjugate addition by attack of carbon atom C-4 of 55
onto 61 and subsequent cyclization.  
The structures of all products were confirmed by spectroscopic studies. The structures of 
62b, 62c, 62d, and 62f were independently confirmed by X-ray crystal structure analysis 
(Figures 16-19).  
OSiMe3O
R1 R2
Cl
OR3
OSiMe3Me3SiO
R2R1
H3C
OH
Cl
OR3
O
+
61a-f
55a,b
62a-f
i
Scheme 34. Synthesis of 62a–f. Reagents and conditions: (i) TiCl4, CH2Cl2, -78º 20ºC, 
20 h. 
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Table 11. Synthesis of 4-chlorobiphenyls 62a-f 
61,62 R1 R2 R3  % (62)a
a H H Me 42 
b H H Et 41 
c H F Et 48 
d Cl H Et 50 
e 
f 
Me 
F 
H 
H 
Et 
Et 
40  
45 
a Yields of isolated products. 
         
Figure 16. Ortep plot of 62b (50% probability level) 
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Figure 17. Ortep plot of 62c (50% probability level) 
Figure 18. Ortep plot of 62d (50% probability level) 
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Figure 19. Ortep plot of 62f (50% probability level) 
        
The reaction of 4-chloro-1,3-bis(silyloxy)-1,3-diene 55b with phthaloyl dichloride (63), 
following our recently reported protocol,90 afforded product 64 (Scheme 35). The best 
yield was obtained in the absence of any Lewis acid. Unexpectedly, the regioisomer 
derived from attack of the central, rather than the terminal carbon atom of the diene onto 
63 was formed. In our previous studies,90 we have observed this irregular reaction pattern 
for 1,3-diketone-derived 1,3-bis(silyloxy)-1,3-butadienes. For -ketoester-derived dienes, 
those regioisomers derived from attack of the terminal carbon atom onto 63 was usually 
observed.  
The structure of 64 was independently confirmed by X-ray crystal structure analysis 
(Figure 20). 
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Cl
Cl
O
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Me3SiO OSiMe3
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EtO
O
Cl
63
55b 64 (36%)
i
Scheme 35. Synthesis of 64. i: CH2Cl2,  -7820°C. 
Figure 20. Ortep plot of 64 (50% probability level) 
The TiCl4-mediated cyclization of 4-chloro-1,3-bis(trimethylsilyloxy)-1,3-butadiene 55b
with phthalic aldehyde (65), following our recently reported procedure,91 afforded the 
chlorinated benzotropone 66 (Scheme 36). The structure of 66 was independently 
confirmed by X-ray crystal structure analysis (Figure 21). 
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35b
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i
Scheme 36. Synthesis of benzotropone 66, i: TiCl4, CH2Cl2, –78  20 °C. 
                                  
Figure 21. Ortep plot of 66 (50% probability level) 
6.3 Conclusion: 
In conclusion, a variety of highly substituted chlorinated arenes and hetarenes were 
regioselectively prepared by one-pot cyclizations of 4-chloro-1,3-bis(trimethylsilyloxy)-
1,3-butadienes with various dielectrophiles. The products are not readily available by 
other methods. 
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6.4 Summary: 
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Scheme 37: Schematic representation of reaction of 4-Chloro-1-alkoxy-1,3-bis(silyloxy)-
1,3-butadiene (55a,b).
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7. Synthesis of 2,6-Dioxo-1,2,3,4,5,6-hexahydroindoles by Acid-
Catalyzed Cyclization of Acetal-Protected (2,4-Dioxocyclohex-1-
yl)acetamides and their Transformation into 5,8,9,10-Tetrahydro-6H-
indolo[2,1-a] isoquinolin -9- ones.
7.1 Introduction 
Erythrina alkaloids occur in various tropical and subtropical plants92 and show a wide 
range of interesting biological properties.93 This includes, for example, curare-like, 
hypotensive, sedative, anticonvulsive, and CNS-depressive activity.94 Erythrina alkaloids 
have been prepared, for example, using photochemical [2+2] cycloadditions or Diels-
Alder reactions as the key steps.95 An important strategy for the synthesis of erythrina
alkaloids relies on the acid-mediated domino reaction of (2-oxocyclohex-1-yl)acetic 
amides.95-97 This transformation proceeds by acid-mediated cyclization of the amide to 
give a N-(2-arylethyl)-2-oxo-1,2,3,4,5,6-hexahydroindole which is transformed in situ 
into the erythrina-type spirocyclic product by a Pictet-Spengler reaction. For example, 
spirocycle I has been directly prepared from the amide II under various conditions 
(Scheme xxx). However, the preparative scope of this reaction is very narrow and its 
success strongly depends on the structure of the substrate (substitution pattern of the aryl 
group, length of the linker between the aryl group and the nitrogen atom etc.). This is a 
severe limitation because the synthesis of specific target molecules heavily relies on 
functional group transformations of the spiro-compounds obtained by the domino 
process.  
To address this problem, we planned to prepare the unknown erythrina derivative III, 
which contains an additional carbonyl group, from the corresponding amide IV (Scheme 
38). The carbonyl group of III was expected to be a useful tool for the synthesis of 
erythrina-type natural products and their non-natural analogues. It was planned to prepare 
the required starting material IV from (2,4-dioxocyclohex-1-yl)acetic acid which, 
therefore, represents an important key intermediate of the present study.  
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Scheme 38. Strategy for the synthesis of the novel erythrina-type spiro-compound III
containing an additional carbonyl group 
Recently, we have reported98 our preliminary results related to the synthesis of (2,4-
dioxocyclohex-1-yl)acetic amides, such as IV. Their reaction with para-toluenesulfonic 
acid (PTSA) resulted in the formation of 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles rather 
than the expected erythrina-type spiro-compounds. Herein, we report a full account of the 
preparative scope of this methodology which provides, to the best of our knowledge, the 
yet most general approach to 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles.99 In addition, we 
report for the first time the reaction of 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles with triflic 
acid which results in the formation of novel 5,8,9,10-tetrahydro-6H-indolo[2,1-
a]isoquinolin-9-ones.  
7.2 Results and Discussion 
The synthesis of (2,4-dioxocyclohex-1-yl)acetic acid (70) has, to the best of our 
knowledge, not been reported to date. The synthesis of 70 proved to be very difficult in 
our hands, despite its structural simplicity. The reaction of the dianion100,101 of 
cyclohexane-1,3-dione (67) with 1-bromo-2,2-diethoxyethane and epibromohydrin 
afforded products 68 and 69, respectively (Scheme 39). The low yield of 68 and 69 can 
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be explained by the β-oxygen effect. However, all attempts to prepare 70 by oxidation of 
68 and 69 failed. 
Deslongchamps and Guay reported the synthesis of 4-(3-oxopropyl)cyclopentane-1,3-
dione by ozonolysis of 4-(homoallyl)cyclopentane-1,3-dione.102 However, the ozonolysis 
of 4-allylcyclohexane-1,3-dione (71a), prepared by reaction of the dianion of 66a with 
allylbromide,103 afforded the triacid 75 rather than the desired aldehyde 74 (Scheme 40). 
The triacid 75 was also isolated when the oxidation was carried out using KMnO4, 
KMnO4/NaIO4 in acetone, or KMnO4/CuSO45H2O in CH2Cl2/tBuOH/H2O. The 
formation of 75 can be explained by oxidative cleavage of the enolic double bond. The 
problem was solved by protection of the carbonyl groups of 71a to give the bis(acetal) 
72a. The oxidation of 72a by KMnO4/NaIO4 (in acetone) afforded the acid 63a. 
Likewise, derivative 63b was prepared in three steps from 67b. The bis(acetal) 63a can 
be deprotected to give the desired (2,4-dioxocyclohex-1-yl)acetic acid (70) which, 
however, proved to be unstable. Therefore, bis(acetals) 73a,b were directly used for all 
further transformations.  
                     
O
HO i
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Br O
HO
O
OEt
OEt
OEtBr
OEt
HO
O
O
HO
O
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O
Pb(OAc)4
CrO3
H2SO4i
69 (8%) 70
Scheme 39. Attempted synthesis of 70; i, 1) 2.5 LDA, HMPTA, THF, −78 °C, 1 h, 2) 
electrophile, −40 → 20 °C, 12 h  
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The DCC-mediated reaction of 73a,b with various amines afforded the amides 76a-v
(Table 1). Reflux of an acetone solution of 76a-v in the presence of para-toluenesulfonic 
acid (PTSA) afforded the 2,6-dioxo-1,2,3,3a,4,5-tetrahydroindoles 77a-v. The formation 
of an erythrina-type spiro-compound, such as III (see Scheme 38), was not observed. 
Products 77e,m,v were prepared from the mono-acetals mono-76e,m,v. The latter were 
prepared from the mono-acetals mono-73a,b which are available by acetalization of 
71a,b using only one (rather than two) equivalents of glycol.  
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HO
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67a (R = H)
67b (R = Me)
iii
R
R
R
R
R
R
72a (R = H): 90%
72b (R = Me): 40%
73a (R = H): 65%
73b (R = Me): 98%
O
HO
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R
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71b (R = Me): 95%
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CO2H
iv
O
O
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74 75
Scheme 40. Synthesis of 73a,b; i, 1) 2.5 LDA, HMPTA, THF, −78 °C, 1 h, 2) 
allylbromide, −40 → 20 °C, 12 h; ii, HO(CH2)2OH, toluene, PTSA; iii, NaIO4, KMnO4, 
acetone; iv, 1) O3, 2) Me2S or other conditions (see text) 
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OR2
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R1
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ii
NHR2
O
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O
OO
R1
R1
H2NR2
Conditions: i, 1) DCC, N-hydroxysuccinimide, CH2Cl2, 1 h, 0 °C, then 12 h, 20 °C, 2) 
R2NH2, 2 h, 20 °C; ii, PTSA, acetone, 6 h, reflux 
                           
Table 12: Synthesis of 77 a-v.
OH
O
O
O
O
R1
R1
mono-73a,b
NHR2
O
O
O
O
R1
R1
mono-76e,m,v
76,77 R1 R2 % (76)a % (77)a
a H H 62 90 
b H nHept        57 64 
c H iBu 76 81 
d H cPr 65 51 
e H cPent   86 b 91 
f H cHex 46 73 
g H Allyl 65 93 
h H PhCH2 67 86 
i H (4-ClC6H4)CH2 79 71 
j H Ph(Me)CH    49 c
k H Ph(CH2)2  64 85 
l H [2-(MeO)C6H4](CH2)2    45 c
m H [3-(MeO)C6H4](CH2)2    89 b 53 
n H [4-(MeO)C6H4](CH2)2  85 72 
o H  [3,4-(MeO)2C6H3](CH2)2 64 65 
61
p H HO(CH2)2 73 83 
q H Ph 70 78 
r Me [3-(MeO)C6H4]CH2    43 c
s Me [3,4-(MeO)2C6H3]CH2   86 c
t Me [2-(MeO)C6H4](CH2)2   58 c
u Me [4-(MeO)C6H4](CH2)2 90 84 
v Me [3,4-(MeO)2C6H3](CH2)2  74 b 65 
a Yields of isolated products;  
b these products were prepared from mono-76a,b and were isolated in the form of mono-
76e,m,v (structures see above);  
c overall yield based on 73a,b 
The structures of all products were established by spectroscopic methods. The structures 
of 76o, 77o, and 77e were independently confirmed by X-ray crystal structure analyses 
(Figures 22-24).104 
             
Figure 22. Ortep plot of 76o  (50% probability level)  
62
                   
Figure 23. Ortep plot of 77o (50% probability level)
      Figure 24. Ortep plot of 77e (50% probability level) 
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The reaction of 73a with 1,4-bis(aminomethyl)benzene afforded the bis(amide) 77w
which was transformed into the bis(2,6-dioxo-1,2,3,3a,4,5-tetrahydroindole) 77v 
(Scheme 41).  
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Scheme 41. Synthesis of 77w: i, 1) DCC, N-hydroxysuccinimide, CH2Cl2, 1 h, 0 °C, then 
12 h, 20 °C, 2) RNH2, 2 h, 20 °C; ii, PTSA, acetone, 6 h, reflux. 
For comparison, we studied the reaction of PTSA with amide 76x which contains one 
free carbonyl group (Scheme 42). The amide 76x was prepared by DCC-mediated 
reaction of 2-(3,4-dimethoxyphenyl)ethylamine with the known acid 73c.105 The reaction 
of 76x with PTSA afforded the erythrina-type spiro-compound 78 in excellent yield. 
Tietze and coworkers recently reported the synthesis of 78 by AlMe3/In(OTf)3-mediated 
reaction of 2-(3,4-dimethoxyphenyl)ethylamine with the ethyl ester of 73c.106 The 
formation of 78 can be explained, as outlined in the introduction, by acid-mediated 
reaction of the keto group with the electron-rich phenyl group to give intermediate A, 
protonation of the enamine moiety to give iminium salt B, and subsequent Pictet-
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Spengler reaction. It is important to be noted that this reaction is not general: The reaction 
of PTSA with amides 76y,z, again prepared from 73c in good yields, afforded the 2-oxo-
1,2,3,4,5,6-hexahydroindoles 77y,z rather than the expected spirocyclic products 
(Scheme 42). This can be explained by the higher strain of a 5,5,6- compared to a 5,6,6-
spirocyclic system. 
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Scheme 42. Synthesis of 78: i, 1) DCC, N-hydroxysuccinimide, CH2Cl2, 1 h, 0 °C, then 
12 h, 20 °C, 2) RNH2, 2 h, 20 °C; ii, PTSA, acetone, 6 h, reflux 
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Our next plan was to study the transformation of 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles 
77 into erythrina-type spirocycles, such as III, under more forcing conditions. 2,6-Dioxo-
1,2,3,4,5,6-hexahydroindoles 77 represent poly-functionalized heterocycles containing an 
enone, enamine, and lactam moiety. In principle, a nucleophilic attack might occur at the 
enone moiety (1,2- or 1,4-addition) or at the amide group. Protonation of the enamine 
moiety might result in the formation of an iminium ion which might be subsequently 
attacked by a nucleophile.  
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Scheme 43. Synthesis of 77y,z: i, 1) DCC, N-hydroxysuccinimide, CH2Cl2, 1 h, 0 °C, 
then 12 h, 20 °C, 2) RNH2, 2 h, 20 °C; ii, PTSA, acetone, 6 h, reflux 
Heating of 2,6-dioxo-1,2,3,4,5,6-hexahydroindole 77o in the presence of PTSA for an 
extended period of time (48 h) did not result in any conversion. Therefore, we have 
choosed triflic acid (TfOH) as a more reactive reagent. The reaction of 77o with triflic 
acid (TfOH) afforded the 5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-9-one 80a
(84% yield) rather than the erythrina-type spirocycle 79 (Scheme 44, Table 13). The 
formation of 80a can be explained by protonation of the amide oxygen atom to give the 
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cationic intermediate C, cyclization via the electron-rich aryl group (intermediate D), and 
subsequent extrusion of water and double bond migration.  
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Scheme 44. Possible mechanism of the formation of 80a: i, TfOH, CH2Cl2, reflux, 4 h 
         
ON
O
77o,l,v
N
R3
R3
O
R3
R3
80a-c
TfOH
R1 R1 R1 R1
R2 R2
i
Conditions: i, TfOH, CH2Cl2, reflux, 4 h 
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Table 13. Synthesis of 5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-9-ones 80a-c 
77 80 R1 R2 R3 %
(80)a
o a H H OMe 84 
l b H OMe H 32 
v c Me H OMe 57 
                                                  a Yields of isolated products 
The reaction of TfOH with 2,6-dioxo-1,2,3,4,5,6-hexahydroindoles 77l and 77v afforded 
the 5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-9-ones 80b and 80c, respectively 
(Table 13). In contrast, the reaction of TfOH with 77k resulted in the formation of a 
complex mixture. This result suggests that the cyclization is only possible for substrates 
containing an electron-rich phenyl group. This can be explained by the high reactivity of 
activated, electron-rich arenes in electrophilic substitution reactions. The reaction of 
TfOH with 77s also gave a complex mixture. This can be explained by the higher strain 
of 5,5,6- compared to 5,6,6-tricyclic products.  
Padwa and Wang have recently reported the TfOH-mediated transformation of a 2,6-
dioxo-1,2,3,4,5,6-hexahydroindole into a 5,6-dihydroindolo[2,1-a]isoquinolin-9-ol.97,106
This reaction, which involves a cyclization, decarboxylation and an aromatization step, 
presumably proceeds by a mechanism similar to that suggested for the formation of 
5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-9-ones 80a-c. The synthesis of 5,8,9,10-
tetrahydro-6H-indolo[2,1-a]isoquinolin-9-ones has, to the best of our knowledge, not 
been reported to date.107
7.3 Conclusion: 
In conclusion, we have reported the synthesis of the first (2,4-dioxocyclohex-1-yl)acetic 
amides. Their reaction with PTSA provides a general method for the synthesis of 2,6-
dioxo-1,2,3,4,5,6-hexahydroindoles. The reaction of the latter with triflic acid afforded 
5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-9-ones rather than erythrina-type 
spirocycles.  
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8 Experimental Section: 
8.1 General: Equipments, chemicals and work techniques 
1H NMR Spectroscopy: Bruker: AM 250, Avance 250, AC 250 (250 MHz); ARX 300, 
Avance 300 (300 MHz); Varian VXR 500 S, Avance 500 (500 MHz);  = 0.00 ppm for 
Tetramethylsilane;  = 2.04 ppm for Acetone d-6;  = 7.26 ppm for Deuterochloroform 
(CDCl3); Characterization of the signal fragmentations: s = singlet, d = doublet, dd = 
double of doublet, ddd = doublet of a double doublet, t = triplet, q = quartet, quint = 
quintet; sext = Sextet, sept = Septet, m = multiplet, br = broadly. Spectra were evaluated 
according to first order rule. All coupling constants are indicated as (J). 
13C NMR Spectroscopy: Bruker: AM 250, Avance 250, AC 250 (62.9 MHz); ARX 300, 
Avance 300 (75 MHz); Varian VXR 500 S, Avance 500 (125 MHz);  = 128.00 ppm for 
Acetone d-6;  = 77.00ppm for CDCl3. The multiplicity of the carbon atoms was 
determined by the DEPT 135 and APT technique (APT = Attached Proton Test) and 
quoted as CH3, CH2, CH and C for primary, secondary, tertiary and quaternary carbon 
atoms. Characterization of the signal fragmentations: quart = quartet the multiplicity of 
the signals was determined by the DEPT recording technology and/or the APT recording 
technology. 
Mass Spectroscopy: AMD MS40, AMD 402 (AMD Intectra), Varian MAT CH 7, MAT 
731.  
High Resolution mass spectroscopy:  Finnigan MAT 95 or Varian MAT 311; Bruker 
FT CIR, AMD 402 (AMD Intectra). 
Infrared spectroscopy (IR): Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 
460, Nicolet 360 Smart Orbit (ATR); KBr, KAP, Nujol, and ATR; Abbreviations for 
signal allocations: w = weak, m = medium, s = strong, br = broad.  
Elementary analysis: LECO CHNS-932, Thermoquest Flash EA 1112. 
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X-ray crystal structure analysis: Bruker X8Apex Diffractometer with CCD-Kamera 
(Mo-Ka und Graphit Monochromator,  = 0.71073 Å).56 
Melting points: Micro heating table HMK 67/1825 Kuestner (Büchi apparatus); Melting 
points are uncorrected. 
Column chromatography: Chromatography was performed over Merck silica gel 60 
(0,063 -0,200 mm, 70 - 230 mesh) as normal and/or over mesh silica gel 60 (0,040 - 
0,063 mm, 200 -400 mesh) as Flash Chromatography. All solvent were distilled before 
use. 
TLC: Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm 
without dipping reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL 
anisaldehyde consisting in 100 mL stock solution of 85% methanol, 14% acetic acid and 
1% sulfuric acid). 
Chemicals and work technique: All solvents used, were distilled by standard methods. 
All reactions were carried out under an inert atmosphere, oxygen and humidity exclusion. 
All of the chemicals are standard, commercially available from Merck®, Aldrich®, 
Arcos® and others. The order of the characterized connections effected numerically, but 
does not correspond to the order in the main part of dissertation.  
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8.2 Procedures and spectroscopic data: 
Ethyl 3,5-Bis(trimethylsiloxy)hexa-2,4-dienoate (2). To a stirred 
benzene solution (95 ml) of 1 (5.36 g, 31.16 mmol), was added 
triethylamine (13 ml, 93.6 mmol), After stirring for 2 h TMSCl 
(14.18 ml, 112.32 mmol) was added. After stirring for 72 h, the 
solvent was removed in vacuo and to the residue was added Hexane (50 ml) to give a 
suspension. The latter was filtered under Argon atmosphere. The filtrate was distilled in 
vacuo to give 2 as yellow oil (8.10 g, 82%); 1H NMR (250 MHz, CDCl3): δ = 0.14-0.21 
(brs, 18H, CH3), 1.16 (t, 3H, J = 7.1Hz, CH3), 2.01 (s, 3H, CH3), 4.01 (q, 2H, J = 6.8 Hz, 
OCH2), 5.71 (s, 1H, CH), 6.67 (s, 1H, CH),  13C NMR (62.90 MHz, CDCl3): δ = 0.02-
1.17 (6C, CH3), 14.3 (CH3), 21.57 (CH3), 60.9 (OCH2), 96.6, 103.5 (CH), 160.6, 165.0 
(COSi(CH3)3), 167.3 (C=O). 
1,3,5-Tris (trimethylsiloxy)-1-ethoxyhexa-1,3,5-triene (3). 
Starting with LDA (38 mmol, 1.5 equiv.), 2 (8 g, 25.30 mmol), 
TMSCl (8.0 ml, 63.25 mmol) and THF (45ml), 3 was isolated as 
a yellow oil (7.80 g, 80%). 1H NMR (250 MHz, CDCl3): 
δ = 0.11-0.43 (brs, 27H, CH3), 1.14 (t, 3H, J = 7.2 Hz, CH3), 4.11 (q, 2H, J = 7.0 Hz, 
OCH2), 4.20 (s, 1H, CH), 4.51 (d, 1H, J = 2 Hz, CH), 4.82 (s, 1H, CH), 5.57 (d, 1H, J = 2 
Hz, CH), 13C NMR (62.90 MHz, CDCl3): δ = 0.05-1.23 (9C, CH3), 14.0 (CH3), 62.9 
(OCH2), 78.4 (CH), 92.1 (CH2), 105.4 (CH), 153.0, 155.0, 158.7 (COSi(CH3)3). 
General procedure for the synthesis of 5: To 3-formylchromone 4 (1.0 equiv.) was 
added Me3SiOTf (0.3 equiv.) at 20 °C. After stirring for 10 min CH2Cl2 (8 mL/m.mole) 
was added, the solution was cooled to 0 °C and the Ethyl 3,5-Bis(trimethylsiloxy)hexa-
2,4-dienoate 2 (1.1 equiv.) was added. The mixture was stirred for 12 h at 20 °C and was 
subsequently poured into an aqueous solution of hydrochloric acid (10%). The organic 
and the aqueous layer were separated and the latter was extracted with CH2Cl2 (3 x 80 
mL). The combined organic layers were washed with brine, dried (Na2SO4), filtered and 
Me3SiO O
OEt
OSiMe3
Me3SiO OSiMe3
OEt
OSiMe3
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the filtrate was concentrated in vacuo. The residue was purified by column 
chromatography (silica gel, nheptane/EtOAc = 10:1). 
Ethyl 3-acetyl-2-hydroxy-5-(2-hydroxybenzoyl)benzoate 
(5a): Starting with 3-formylchromone 4a (261 mg, 1.5 
mmol), 3,5-bis(silyl enol ether) 2 (521 mg, 1.65 mmol), and 
Me3SiOTf (0.08 mL, 0.45 mmol), 5a was isolated as a 
yellowish crystalline solid (390 mg, 79%), mp. = 111-113°C;  
1H NMR (250 MHz, CDCl3): δ = 1.35 (t, 3 H, J = 6.6 Hz, CH3), 2.66 (s, 3H, CH3), 4.35 
(q, 2 H, J = 7.8 Hz, OCH2), 6.80 (t, 1 H, J = 8.5 Hz, ArH), 6.98 (d, 1 H, J = 9.6 Hz, ArH), 
7.42-7.48 (m, 2 H, ArH), 8.26 (d, 1 H, J = 2.8 Hz, ArH), 8.37 (d, 1 H, J = 3.4 Hz, ArH), 
11.67 (s, 1 H, OH), 12.62 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 14.1, 30.6 
(CH3), 62.3 (OCH2), 115.6 (C), 118.6 (CH), 118.7 (C), 118.9 (CH), 125.3, 128.4 (C), 
132.7, 136.5, 136.6, 137.3 (CH), 163.0 (C-OH), 164.2 (C=O), 168.3 (C-OH) 198.3, 199.0 
(C=O); IR (neat): v = 3066 (w), 2985 (w), 2850 (w), 1737 (w), 1677 (s),  1624 (s), 1586 
(s), 1483 (m), 1454 (m), 1174 (s), 760 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 328 (M+, 
86), 282 (100), 254 (47), 239 (49), 211 (20), 121 (67); HRMS (EI) calcd for C18H16O6
[M+]: 328.09414, found 328.093983. 
Ethyl 3-acetyl-2-hydroxy-5-(2-hydroxy-5-methyl-
benzoyl)benzoate (5b): Starting with 6-methyl-3-
formylchromone 4b (282 mg, 1.5 mmol), 3,5-bis(silyl 
enol ether) 2 (521 mg, 1.65 mmol), and Me3SiOTf 
(0.08 mL, 0.45 mmol), 5b was isolated as a yellow 
crystalline solid (450 mg, 88%), mp. = 124-126°C; 1H NMR (250 MHz, CDCl3): δ = 1.35 
(t, 3 H, J = 7.7 Hz, CH3), 2.19 (s, 3H, CH3), 2.66 (s, 3H, CH3), 4.35 (q, 2 H, J = 9.0 Hz, 
CH2), 6.89 (d, 1 H, J = 7.7 Hz, ArH), 7.19-7.28 (m, 2 H, ArH), 8.26 (d, 1 H, J = 2.2 Hz, 
ArH), 8.36 (d, 1 H, J = 2.3 Hz, ArH), 11.47 (s, 1 H, OH), 12.62 (s, 1 H, OH); 13C NMR 
(62.90 MHz, CDCl3): δ = 14.1, 20.4, 30.6 (CH3), 62.3 (OCH2), 115.6 (C), 118.3 (CH), 
118.4, 125.2, 128.1, 128.5 (C), 132.3, 136.9, 137.3, 137.6 (CH), 161.0 (C-OH), 164.2 
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(C=O), 168.3 (C-OH) 198.2, 199.1 (C=O); IR (neat): v = 2983 (w), 2992 (w), 2855 (w), 
1737 (w), 1682 (s),  1662 (s), 1628 (s), 1583 (s), 1480 (m), 1455 (m), 1170 (s), 784 (s) 
cm−1; GC-MS (EI, 70 eV): m/z (%): 342 (M+, 77), 296 (100), 281 (18), 253 (41), 225 
(17), 134 (48); HRMS (EI) calcd for C19H18O6 [M+]: 342.10979, found 342.109773. 
Ethyl 3-acetyl-5-(5-ethyl-2-hydroxybenzoyl)-2-
hydroxy-benzoate (5c): Starting with 6-ethyl-3-
formylchromone 4c (303 mg, 1.5 mmol), 3,5-bis(silyl 
enol ether) 2 (521 mg, 1.65 mmol), and Me3SiOTf (0.08 
mL, 0.45 mmol), 5c was isolated as yellowish oil (337 
mg, 63%);   1H NMR (250 MHz, CDCl3): δ = 1.12 (t, 3H, J = 6.8 Hz, 3CH3), 1.35 (t, 3 H, 
J = 7.4 Hz, CH3), 2.456 (q, 2 H, J = 8.1 Hz, CH2),  2.66 (s, 3H, CH3), 4.35 (q, 2 H, J = 
7.4 Hz, OCH2), 6.92 (d, 1 H, J = 7.4 Hz, ArH), 7.28-7.32 (m, 2 H, ArH), 8.30 (d, 1 H, J = 
3.3 Hz, ArH), 8.39 (d, 1 H, J = 1.6 Hz, ArH), 11.48 (s, 1 H, OH), 12.64 (s, 1 H, OH); 13C 
NMR (62.90 MHz, CDCl3): δ = 14.1, 15.7 (CH3), 27.9 (CH2), 30.5 (CH3), 62.3 (OCH2), 
115.5 (C), 118.4 (CH), 125.3, 128.4, 128.5 (C), 131.2 (CH), 134.6 (C), 136.5, 136.8, 
137.5 (CH), 161.1 (C-OH), 164.2 (C=O), 168.2 (C-OH) 198.1, 199.1 (C=O); IR (neat): 
v = 2993 (w), 2966 (w), 2929 (w), 1737 (w), 1626 (m), 1584 (s), 1479 (m), 1322 (m), 
1245 (s), 1169 (s), 1020 (s), 789 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 356 (M+, 74), 
310 (100), 282 (22), 267 (37), 239 (15), 148 (49); HRMS (EI) calcd for C20H20O6 [M+]: 
356.12544, found 356.125099. 
Ethyl 3-acetyl-2-hydroxy-5-(2-hydroxy-5-
isopropyl-benzoyl)benzoate (5d): Starting with 6-
isopropyl-3-formylchromone 4d (324 mg, 1.5 
mmol), 3,5-bis(silyl enol ether) 2 (521 mg, 1.65 
mmol), and Me3SiOTf (0.08 mL, 0.45 mmol), 5d
was isolated as a yellowish oil (329 mg, 59%); 1H NMR (250 MHz, CDCl3): δ = 1.11 (d, 
6H, J = 7.0 Hz, 2CH3), 1.31 (t, 3 H, J = 7.2 Hz, CH3), 2.66 (s, 3H, CH3), 2.78 (m,1H, 
CH), 4.34 (q, 2 H, J = 7.6 Hz, OCH2), 6.92 (d, 1 H, J = 8.6 Hz, ArH), 7.30-7.36 (m, 2 H, 
ArH), 8.32 (d, 1 H, J = 2.5 Hz, ArH), 8.40 (d, 1 H, J = 2.5 Hz, ArH), 11.47 (s, 1 H, OH), 
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12.65 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 14.1 (CH3), 23.9 (2C, CH3), 30.4 
(CH3), 33.14 (CH), 62.3 (OCH2), 115.6 (C), 118.3 (CH), 125.3, 128.3, 128.4 (C), 129.8, 
135.2, 136.9, 137.6 (CH), 139.2 (C), 161.1 (C-OH), 164.3 (C=O), 168.2 (C-OH) 198.0, 
199.1 (C=O); IR (neat): v = 3067 (w), 2960 (w), 2928 (w), 2871 (w), 1731 (w), 1674 (s),  
1628 (s), 1584 (s), 1480 (m), 1453 (m), 1176 (s), 788 (s) cm−1; GC-MS (EI, 70 eV): m/z
(%): 370 (M+, 81), 324 (100), 309 (90), 281 (26), 162 (26), 147 (93); HRMS (EI) calcd 
for C21H22O6 [M+]: 370.14109, found 370.140795. 
Ethyl 3-acetyl-5-(5-nitro-2-hydroxybenzoyl)-2-
hydroxy-benzoate (5e): Starting with 6-nitro-3-
formylchromone 4e (138 mg, 0.63 mmol), 3,5-bis(silyl 
enol ether) 2 (218 mg, 0.69 mmol), and Me3SiOTf 
(0.03 mL, 0.18 mmol), 5e was isolated as a crystalline 
solid (100 mg, 43%), mp. = 107-109°C; 1H NMR (250 MHz, CDCl3): δ = 1.36 (t, 3 H, J 
= 7.0 Hz, CH3), 2.68 (s, 3H, CH3), 4.40 (q, 2 H, J = 8.1 Hz, CH2), 7.11 (d, 1 H, J = 8.9 
Hz, ArH), 8.31-8.35 (m, 2 H, ArH), 8.40 (d, 1 H, J = 2.1 Hz, ArH), 8.45 (d, 1 H, J = 2.6 
Hz, ArH), 12.28 (s, 1 H, OH), 12.70 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 
14.1, 30.7 (CH3), 62.6 (OCH2), 115.8, 117.6 (C), 119.7 (CH) 126.1, 126.9 (C), 128.7, 
131.0, 136.4, 137.4 (CH), 139.58 (C), 164.9 (C-OH), 167.7 (C=O), 168.2 (C-OH) 197.2, 
198.4 (C=O); IR (neat): v = 3074 (w), 2990 (w), 2914 (m), 1731 (m), 1667 (s), 1620 (s), 
1446 (s), 1331 (s), 1175 (s), 749 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 373 (M+, 35), 
327 (82), 312 (100), 299 (43), 189 (16), 166 (20), 135 (41); HRMS (EI) calcd for 
C18H15NO8 [M+]: 373.07922, found 373.078896. 
Ethyl 3-acetyl-5-(5-bromo-2-hydroxybenzoyl)-2-
hydroxybenzoate (5f): Starting with 6-bromo-3-
formylchromone 4f (253 mg, 1.0 mmol), 3,5-bis(silyl 
enol ether) 2 (348 mg, 1.1 mmol), and Me3SiOTf (0.05 
mL, 0.3 mmol), 5f was isolated as a crystalline solid 
(219 mg, 54%), mp. = 118-120°C; 1H NMR (250 MHz, CDCl3): δ = 1.37 (t, 3 H, J = 7.1 
Hz, CH3), 2.68 (s, 3H, CH3), 4.40 (q, 2 H, J = 7.1 Hz, OCH2), 6.91 (d, 1 H, J = 8.4 Hz, 
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ArH), 7.51-7.57 (m, 2 H, ArH), 8.27 (d, 1 H, J = 2.6 Hz, ArH), 8.36 (d, 1 H, J = 3.6 Hz, 
ArH), 11.55 (s, 1 H, OH), 12.66 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 14.1, 
30.6 (CH3), 62.4 (OCH2), 110.5, 115.7, 120.0 (C), 120.7 (CH), 125.6, 127.7 (C), 134.6, 
136.6, 137.3, 139.1 (CH), 161.9 (C-OH), 164.5 (C=O), 168.2 (C-OH) 197.2, 198.8 
(C=O); IR (neat): v = 3072 (w), 2942 (w), 2929 (w), 1731 (w), 1673 (s), 1627 (s), 1586 
(s), 1462 (m), 1446 (s), 1407 (s), 1316 (s), 1174 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 
408 (M+,81Br, 48), 406 (M+,79Br, 46),  362(98), 360 (100), 345 (22), 334 (28), 332 (24), 
317 (30), 201 (43); HRMS (EI) calcd for C18H15BrO6 [M+, 79Br]: 406.00465, found 
406.003581. 
Ethyl 3-acetyl-5-(3,5-dibromo-2-hydroxybenzoyl)-2-
hydroxybenzoate (5g): Starting with 6,8-dibromo-3-
formylchromone 4g (331 mg, 1.0 mmol), 3,5-bis(silyl 
enol ether) 2 (348 mg, 1.1 mmol), and Me3SiOTf (0.05 
mL, 0.3 mmol), 5g was isolated as a crystalline solid 
(219 mg, 56%), mp. = 139-141°C; 1H NMR (250 MHz, CDCl3): δ = 1.37 (t, 3 H, J = 7.1 
Hz, CH3), 2.67 (s, 3H, CH3), 4.40 (q, 2 H, J = 7.1 Hz, OCH2), 7.55 (d, 1 H, J = 2 Hz, 
ArH), 7.83 (d, 1 H, J = 2.3 Hz, ArH), 8.27 (d, 1 H, J = 2.3 Hz, ArH),  8.36 (d, 1 H, J = 2 
Hz, ArH), 12.10 (s, 1 H, OH), 12.68 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 
14.1, 30.6 (CH3), 62.5 (OCH2), 110.5, 113.5, 115.7, 120.5, 125.8, 127.2 (C), 133.8, 
136.6, 137.4, 141.4 (CH), 158.4 (C-OH), 164.8 (C=O), 168.2 (C-OH) 196.8, 198.5 
(C=O); IR (neat): v = 3079 (w), 3062 (w), 2994 (w), 1731 (w), 1669 (s), 1622 (s), 1587 
(s), 1434 (m), 1414 (s), 1247 (s), 1159 (s), 787 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 
488 (M+, [2 × 81Br], 12), 486 (M+, [81Br79Br], 25), 484 (M+, [2 × 79Br],12), 442 (48), 440 
(100), 412 (23), 279 (18), 189 (36). HRMS (EI) calcd for C18H14Br2O6 [M+, 2 X 79Br]: 
483.91516, found 483.915551. 
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Ethyl 3-acetyl-5-(5-chloro-2-hydroxybenzoyl)-2-
hydroxybenzoate (5h): Starting with 6-chloro-3-
formylchromone 4h (208 mg, 1.0 mmol), 3,5-bis(silyl 
enol ether) 2 (348 mg, 1.1 mmol), and Me3SiOTf (0.05 
mL, 0.3 mmol), 5h was isolated as a crystalline solid 
(279 mg, 76%), mp. = 124-125°C; 1H NMR (250 MHz, CDCl3): δ = 1.37 (t, 3 H, J = 7.2 
Hz, CH3), 2.68 (s, 3H, CH3), 4.40 (q, 2 H, J = 8.4 Hz, CH2), 6.96 (d, 1 H, J = 9.8 Hz, 
ArH), 7.39-7.42 (m, 2 H, ArH), 8.27 (d, 1 H, J = 2.4 Hz, ArH), 8.36 (d, 1 H, J = 2.4 Hz, 
ArH), 11.54 (s, 1 H, OH), 12.65 (s, 1 H, OH); 13C NMR (75.46 MHz, CDCl3): δ = 14.1, 
30.7 (CH3), 62.5 (OCH2), 115.3, 119.4 (C), 120.3 (CH) 123.7, 127.8, 127.9 (C), 131.5, 
136.4, 136.5, 137.2 (CH), 161.5 (C-OH), 164.5 (C=O), 168.2 (C-OH) 197.3, 198.3 
(C=O); IR (neat): v = 3077 (w), 3005 (w), 2938 (w), 1738 (w), 1672 (s), 1622 (s), 1587 
(s), 1455 (s), 1409 (s), 1318 (s), 1175 (s), 780 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 364 
(M+, 37Cl, 17), 362 (M+, 35Cl, 54), 316 (100), 301 (26), 273 (28), 245 (13), 189 (16), 155 
(31); HRMS (EI) calcd for C18H15ClO6 [M+, 35Cl]: 362.05517, found 362.054803. 
Ethyl 3-acetyl-5-(5-fluoro-2-hydroxybenzoyl)-2-
hydroxybenzoate (5j): Starting with 6-fluoro-3-
formylchromone 4j (192 mg, 1.0 mmol), 3,5-bis(silyl 
enol ether) 2 (348 mg, 1.1 mmol), and Me3SiOTf (0.05 
mL, 0.3 mmol), 5j was isolated as a crystalline solid (270 
mg, 79%), mp. = 111-112°C; 1H NMR (250 MHz, CDCl3): δ = 1.36 (t, 3 H, J = 6.5 Hz, 
CH3), 2.66 (s, 3H, CH3), 4.36 (q, 2 H, J = 9.1 Hz, CH2), 6.95-7.00 (m, 1 H, ArH), 7.10-
7.24 (m, 2 H, ArH), 8.26 (d, 1 H, J = 2.5 Hz, ArH), 8.35 (d, 1 H, J = 2.5 Hz, ArH), 11.36 
(s, 1 H, OH), 12.63 (s, 1 H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 14.1, 30.7 (CH3), 
62.4 (OCH2), 115.6 (C), 117.2, 119.9, 123.9 (CH), 125.6, 127.9 (C), 136.4, 137.2 (CH), 
152.7, 156.5, (C) 159.1 (C-OH), 164.4 (C=O), 168.3 (C-OH) 197.3, 198.7 (C=O); IR 
(neat): v = 3078 (w), 3008 (w), 2928 (w), 1737 (w), 1668 (s), 1591 (s), 1468 (s), 1420 (s), 
1318 (s), 1241 (s), 783 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 346 (M+, 56), 300 (100), 
272 (32), 257 (37), 229 (16), 189 (13); HRMS (EI) calcd for C18H15FO6 [M+]: 346.08471, 
found 346.0084999. 
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General procedure for the synthesis of 6: To 3-formylchromone 4 (1.0 equiv.) was 
added Me3SiOTf (0.3 equiv.) at 20 °C. After stirring for 10 min CH2Cl2 (8 mL/m.mole) 
was added, the solution was cooled to 0 °C and the 1,3,5-Tris (trimethylsiloxy)-1-
ethoxyhexa-1,3,5-triene 3 (1.1 equiv.) was added. The mixture was stirred for 12 h at 20 
°C and was subsequently poured into an aqueous solution of hydrochloric acid (10%). 
The organic and the aqueous layer were separated and the latter was extracted with 
CH2Cl2 (3 x 80 mL). The combined organic layers were washed with brine, dried 
(Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was purified by 
column chromatography (silica gel, nheptane/EtOAc = 10:1). 
Ethyl 3-(2-hydroxy-5-(2-hydroxy-5-
methylbenzoyl)-phenyl)-3-oxopropanoate (6b): 
Starting with 6-methyl-3-formylchromone 4b (282 
mg, 1.5 mmol), 1,3,5-tris(silyl enol ether) 3 (641 
mg, 1.65 mmol), and Me3SiOTf (0.08 mL, 0.45 
mmol), 6b was isolated as a yellow solid (186 mg, 36%), mp. = 81-84°C; 1H NMR (250 
MHz, CDCl3): δ = 1.31 (t, 3 H, J = 7.1 Hz, CH3), 2.32 (s, 3H, CH3), 4.07 (s, 2H, CH2), 
4.25 (q, 2 H, J = 7.1 Hz, CH2), 7.06 (d, 1 H, J = 9.0 Hz, ArH), 7.13 (d, 1 H, J = 9.0 Hz, 
ArH), 7.36 (m, 2 H, ArH), 7.89 (dd, 1H, J = 2.0 Hz, J = 8.7 Hz, ArH), 8.16 (d, 1H, J = 
2.0 Hz, ArH), 11.60 (s, 1 H, OH), 12.29 (s, 1 H, OH); 13C NMR (75.46 MHz, CDCl3): δ
= 14.0, 20.4 (CH3), 45.7 (CH2), 61.9 (OCH2), 118.3 (CH),  118.4, 118.5 (C), 118.7 (CH), 
128.0, 129.2 (C), 132.4, 132.9 (CH), 136.7, 137.8 (CH), 161.0, 165.6 (COH), 166.4, 
198.3, 198.5 (C=O); IR (neat): v = 2970 (w), 2930 (w), 2859 (w), 1726 (s), 1630 (s), 
1587 (s), 1479 (s), 1324 (s), 1207 (s), 1170 (s), 785 (s) cm−1; GC-MS (EI, 70 eV): m/z
(%): 342 (M+, 86), 296 (100), 281 (23), 268 (31), 253 (48), 225 (19), 189 (12), 134 (45); 
HRMS (EI) calcd for C19H18O6 [M+]: 342.10979, found 342.109866. 
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Ethyl 3-(5-(5-ethyl-2-hydroxybenzoyl)-2-hydroxy-
phenyl)-3-oxopropanoate (6c): Starting with 6-
ethyl-3-formylchromone 4c (303 mg, 1.5 mmol), 
1,3,5-tris(silyl enol ether) 3 (641 mg, 1.65 mmol), 
and Me3SiOTf (0.08 mL, 0.45 mmol), 6c was 
isolated as a yellowish brown solid (240 mg, 45%), mp. = 55-58°C; 1H NMR (250 MHz, 
CDCl3): δ = 1.22 (t, 3 H, J = 7.5 Hz CH3), 1.30 (t, 3 H, J = 7.1 Hz CH3), 2.456 (q, 2 H, J
= 8.1 Hz, CH2), 4.05 (s, 2H, CH2), 4.12 (q, 2 H, J = 6.0 Hz, OCH2), 7.03 (d, 1H, J = 8.3 
Hz, ArH), 7.13 (d, 1H, J = 8.7 Hz, ArH), 7.39-7.7.43 (m, 2 H, ArH), 7.90 (dd, 1 H, J = 
1.9 Hz, J = 8.7 Hz, ArH), 8.16 (d, 1H, J = 1.95 Hz, ArH), 11.60 (s, 1 H, OH), 12.30 (s, 1 
H, OH); 13C NMR (62.90 MHz, CDCl3): δ = 14.0, 15.7 (CH3), 27.9, 45.6 (CH2), 61.9 
(OCH2), 118.4 (CH),  118.4, 118.5 (C), 118.7 (CH),  129.2 (C), 131.3, 132.9 (CH), 134.6 
(C), 136.3, 137.8 (CH), 161.1, 165.6 (COH), 166.4, 198.1, 198.5 (C=O); IR (neat): v = 
2963 (m), 2930 (m), 1735 (m), 1680 (w), 1628 (s),  1583 (s), 1479 (s), 1352 (m), 1285 
(s), 1201 (s), 832 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 356 (M+, 30), 310 (75), 267 
(17), 241 (12), 148 (100), 133 (62), 84 (23); HRMS (EI) calcd for C20H20O6 [M+]: 
356.12544, found 356.125284. 
Ethyl 3-(2-hydroxy-5-(2-hydroxy-5 
isopropylbenzoyl)-phenyl)-3-oxopropanoate 
(6d). Starting with 6-isopropyl-3-
formylchromone 4d (324 mg, 1.5 mmol), 1,3,5-
tris(silyl enol ether) 3 (641 mg, 1.65 mmol), and 
Me3SiOTf (0.08 mL, 0.45 mmol), 6d was isolated as a yellow solid (260 mg, 47%), mp. 
= 60-63°C; 1H NMR (250 MHz, CDCl3): δ = 1.22-1.32 (m, 9 H, 3CH3), 2.88 (m,1H, 
CH), 4.07 (s, 2H, CH2), 4.25 (q, 2 H, J = 7.2 Hz, OCH2), 7.04 (d, 1 H, J = 8.6 Hz, ArH), 
7.14 (d, 1 H, J = 8.6 Hz, ArH), 7.40-7.48 (m, 2 H, ArH), 7.90 (dd, 1 H, J = 2.0 Hz, J = 
8.8 Hz, ArH), 8.17 (d, 1H, J = 2.1 Hz, ArH), 11.59 (s, 1 H, OH), 12.30 (s, 1 H, OH); 13C 
NMR (75.46 MHz, CDCl3): δ = 14.1, 23.9, 24.0 (CH3), 33.1 (CH), 45.7 (CH2), 61.9 
(OCH2), 118.3 (C),  118.4 (CH), 118.5 (C), 118.7 (CH),  129.2 (C), 129.9, 132.9, 134.9, 
137.8 (CH), 139.2 (C), 161.1, 165.6 (COH), 166.3, 198.5, 198.5 (C=O); IR (neat): v = 
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3058 (w), 2956 (m), 2924 (m), 1744 (s), 1681 (w), 1653 (m), 1628 (s),  1583 (s), 1480 
(s), 1343 (m), 1207 (s), 1181 (s), 832 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 370 (M+, 
77), 324 (53), 309 (78), 283 (17), 267 (23), 162 (46), 147 (100), 44 (37); HRMS (EI) 
calcd for C21H22O6 [M+]: 370.14109, found 370.140462. 
Ethyl 3-(2-hydroxy-5-(2-hydroxy-5-
nitrobenzoyl)-phenyl)-3-oxopropanoate (6e): 
Starting with 6-nitro-3-formylchromone 4e (328 
mg, 1.5 mmol), 1,3,5-tris(silyl enol ether) 3 (641 
mg, 1.65 mmol), and Me3SiOTf (0.08 mL, 0.45 
mmol), 6e was isolated as a yellow solid (160 mg, 29%), mp. = 130-133°C; 1H NMR 
(300 MHz, CDCl3): δ = 1.19 (t, 3 H, J = 7.1 Hz, CH3), 3.96 (s, 2H, CH2), 4.25 (q, 2 H, J
= 7.1 Hz, OCH2), 7.10 (m, 2 H, ArH), 7.84 (dd, 1 H, J = 2.1 Hz, J = 8.7 Hz, ArH), 8.14 
(d, 1 H, J = 2.0 Hz, ArH), 8.30 (m, 1 H, ArH), 8.55 (d, 1 H, J = 2.0 Hz, ArH), 12.30 (s, 2 
H, OH); 13C NMR (75.47 MHz, CDCl3): δ = 14.0 (CH3), 45.9 (CH2), 62.1 (OCH2), 
117.6, 118.7 (C), 119.5, 119.7, 128.8, 129.4, 130.8, 133.5 (CH), 137.5, 139.5 (C), 166.1, 
166.5 (COH), 167.7, 197.3, 198.3 (C=O); IR (neat): v = 3088 (w), 2969 (w), 2849 (w), 
1726 (s), 1628 (s), 1593 (s), 1519 (m), 1470 (s), 1338 (s), 1209 (s), 742 (s) cm−1; GC-MS 
(EI, 70 eV): m/z (%): 373 (M+, 37), 327 (100), 310 (23), 286 (64), 258 (40), 166 (40), 147 
(25), 120 (60); HRMS (EI) calcd for C18H15NO8 [M+]: 373.07922, found 373.078728. 
Ethyl 3-(5-(5-bromo-2-hydroxybenzoyl)-2-
hydroxy-phenyl)-3-oxopropanoate (6f): Starting 
with 6-bromo-3-formylchromone 4f (379 mg, 1.5 
mmol), 1,3,5-tris(silyl enol ether) 3 (641 mg, 1.65 
mmol), and Me3SiOTf (0.08 mL, 0.45 mmol), 6f was 
isolated as a yellow solid (190 mg, 31%), mp. = 117-120°C; 1H NMR (250 MHz, 
CDCl3): δ = 1.21 (t, 3 H, J = 6.9 Hz, CH3), 2.68 (s, 2H, CH2), 4.23 (q, 2 H, J = 7.1 Hz, 
OCH2), 6.91 (d, 1 H, J = 8.85 ArH), 7.06 (d, 1 H, J = 8.75 ArH), 7.51 (m,  1 H, ArH), 
7.79 (d, 1 H, J = 1.75 Hz,  ArH), 7.83 (d, J = 1.75 Hz, 1 H, ArH), 8.06 (d, J = 1.8 Hz, 1 
H, ArH), 11.56 (s, 1 H, OH), 12.24 (s, 1 H, OH); 13C NMR (75.46 MHz, CDCl3): δ = 
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14.0 (CH3), 45.7 (CH2), 62.0 (OCH2), 110.4, 118.6 (C), 119.1 (CH), 120.1 (C), 120.6 
(CH), 128.3 (C), 133.0, 134.5, 137.3, 138.9 (CH), 161.8, 166.0 (COH), 166.3, 197.2, 
198.5 (C=O);  IR (neat): v = 3073 (w), 3002 (w), 2966 (m), 1728 (s), 1680 (s), 1643 (s), 
1626 (m), 1447 (s), 1462 (s), 1422 (s), 786 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 408 
(M+, 81Br, 47), 406 (M+,79Br, 47), 362 (78), 360 (75), 291 (28), 200 (100), 147 (30), 120 
(41), 92 (14); HRMS (EI) calcd for C18H15BrO6 [M+, 79Br]: 406.00465, found 
406.004404. 
Ethyl 3-(5-(3,5-dibromo-2-hydroxybenzoyl)-2-
hydroxyphenyl)-3-oxopropanoate (6g). Starting 
with 6,8-dibromo-3-formylchromone 4g (331 mg, 
1.0 mmol), 1,3,5-tris(silyl enol ether) 3 (427 mg, 1.1 
mmol), and Me3SiOTf (0.05 mL, 0.3 mmol), 6g was 
isolated as a light brown solid (159 mg, 33%), mp. = 
101-103°C; 1H NMR (250 MHz, CDCl3): δ = 1.21 (t, 3 H, J = 6.9 Hz, CH3), 3.97 (s, 2H, 
CH2), 4.14 (q, 2 H, J = 7.1 Hz, OCH2), 7.06 (d, 1 H, J = 8.7 ArH), 7.58 (d, 1 H, J = 2.3 
ArH), 7.78-7.84 (m,  2H, ArH), 8.07 (d, J = 2.0 Hz, 1 H, ArH), 12.13 (s, 1 H, OH), 12.27 
(s, 1 H, OH); 13C NMR (75.46 MHz, CDCl3): δ = 14.0 (CH3), 45.7 (CH2), 62.1 (OCH2), 
110.4, 113.5, 118.7 (C), 119.2 (CH), 120.6, 128.3 (C), 133.3, 133.8, 137.6, 141.3 (CH), 
158.4, 166.2 (COH), 166.3, 197.0, 198.4 (C=O);  IR (neat): v = 3067 (w), 3002 (w), 2974 
(m), 2919 (m), 1735 (s), 1694 (w), 1651 (s), 1626 (s), 1583 (s), 1214 (s), 1159 (s), 771 (s) 
cm−1; GC-MS (EI, 70 eV): m/z (%): 488 (M+, [2 × 81Br], 13), 486 (M+, [81Br79Br], 27), 
484 (M+, [2 × 79Br],13), 442 (23), 440 (47), 399 (29), 371 (34), 278 (100), 147 (32), 120 
(40). HRMS (EI) calcd for C18H14Br2O6 [M+, 2 X 79Br]: 483.91516, found 483.915113. 
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Ethyl 3-(5-(5-chloro-2-hydroxybenzoyl)-2-
hydroxy-phenyl)-3-oxopropanoate (6h): Starting 
with 6,8-dibromo-3-formylchromone 4h (312 mg, 
1.5 mmol), 1,3,5-tris(silyl enol ether) 3 (641 mg, 1.65 
mmol), and Me3SiOTf (0.08 mL, 0.45 mmol), 6h
was isolated as a  reddish brown solid (203 mg, 37%), mp. = 98-99°C; 1H NMR (250 
MHz, CDCl3): δ = 1.30 (t, 3 H, J = 7.1 Hz CH3), 4.07 (s, 2H, CH2), 4.25 (q, 2 H, J = 7.1 
Hz, OCH2), 7.07 (d, 1H, J = 9.0 Hz, ArH), 7.16 (d, 1H, J = 8.7 Hz, ArH), 7.48-7.52 (m, 1 
H, ArH), 7.56 (d, 1H, J = 2.5 Hz, ArH), 7.90 (dd, 1 H, J = 2.0 Hz, J = 8.7 Hz, ArH), 8.16 
(d, 1H, J = 1.95 Hz, ArH), 11.63 (s, 1 H, OH), 12.33 (s, 1 H, OH); 13C NMR (75.46 
MHz, CDCl3): δ = 14.1 (CH3), 45.7 (CH2), 62.0 (OCH2),  118.6 (C), 119.1 (CH), 119.4, 
(C), 120.3 (CH), 123.6, 128.3 (C), 131.5, 133.0, 136.2, 137.6 (CH), 161.4, 164.5 (COH), 
166.3, 197.5, 198.4 (C=O); IR (neat): v = 3074 (w), 2978 (m), 2932 (w), 1728 (m), 1668 
(s), 1626 (s), 1587 (s), 1459 (s), 1274 (s), 1173 (s), 1095 (s), 834 (m) cm−1; GC-MS (EI, 
70 eV): m/z (%): 364 (M+, 37Cl, 20), 362 (M+, 35Cl, 47), 316 (100), 301 (25), 273 (34), 
245 (15), 207 (14), 155 (35), 44 (29); HRMS (EI) calcd for C18H15O6Cl [M+, 35Cl]: 
362.05517, found 362.054802. 
Ethyl 3-(5-(5-fluoro-2-hydroxybenzoyl)-2-hydroxy-
phenyl)-3-oxopropanoate (6j): Starting with 6,8-
dibromo-3-formylchromone 4j (288 mg, 1.5 mmol), 
1,3,5-tris(silyl enol ether) 3 (641 mg, 1.65 mmol), and 
Me3SiOTf (0.08 mL, 0.45 mmol), 6j was isolated as a  
light yellow solid (179 mg, 34%), mp. = 72-74°C; 1H NMR (250 MHz, CDCl3): δ = 1.22 
(t, 3 H, J = 7.1 Hz, CH3), 3.97 (s, 2H, CH2), 4.22 (q, 2 H, J = 7.1 Hz, OCH2), 6.96-6.99 
(m, 1H, ArH), 7.08 (d, 1 H, J = 8.75, ArH), 7.20 (m, 1 H, ArH), 7.81 (d, 1 H, J = 2.0 Hz, 
ArH), 7.85 (d, 1 H, J = 2.1 Hz,  ArH), 8.06 (d, 1 H, J = 2.0 Hz, ArH), 11.39 (s, 1 H, OH), 
12.23 (s, 1 H, OH); 13C NMR (75.46 MHz, CDCl3): δ = 14.1 (CH3), 45.7 (CH2), 62.0 
(OCH2),  118.6 (C), 119.1 (CH), 119.4, (C), 120.3 (CH), 123.6, 128.3 (C), 131.5, 133.0, 
136.2, 137.6 (CH), 161.4, 164.5 (COH), 166.3, 197.5, 198.4 (C=O); IR (neat): v = 3069 
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(w), 2998 (w), 2974 (w), 1726 (s), 1655 (s), 1634 (s), 1622 (m), 1470 (s), 1598 (s), 1469 
(s), 987 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 346 (M+, 50), 326 (18), 300 (44), 259 
(50), 231 (70), 139 (100), 120 (31), HRMS (EI) calcd for C18H15FO6 [M+]: 346.08472, 
found 346.084658. 
General procedure for the synthesis of methyl 3-arylacetoacetates 8a,b and d : A 
THF solution of LDA (2.3 equiv.) was prepared by addition of  nBuLi (0.93 mL, 2.3 
mmol, 2.5 M in hexane) to a THF solution (6 mL) of diisopropylamine (0.32 mL, 2.3 
mmol) at 0 °C. After the solution was stirred for 30 min, methyl acetate (0.09 mL, 1.1 
mmol) was added at 0 °C. After stirring for 45-60 min, to the solution was added a THF 
solution (4 mL) of the acid chloride (205 mg, 1.0 mmol) at −78 °C. The temperature was 
allowed to rise to ambient during 5-6 h and the solution was stirred at 20 °C for 10 h. To 
the solution was added a diluted aqueous solution of HCl and the mixture was extracted 
with EtOAc (3 x 200 mL). The combined organic layers were dried (Na2SO4) and 
filtered. The solvent of the filtrate was removed in vacuo and the residue was purified by 
chromatography (silica gel, EtOAc / n-heptane). 
Methyl 4-phenylacetoacetate (8a): Starting with 2-phenylacetyl 
chloride  (5.00 g, 32.3 mmol) and methyl acetate (2.83 mL, 35.6 
mmol), 8a was isolated as a yellowish oil (4.90 g, 60%). 1H NMR 
(250 MHz, CDCl3): δ = 3.35 (s, 2 H, CH2), 3.58 (s, 2 H, CH2), 3.70 
(s, 3 H, OCH3), 7.07 (m, 1 H, ArH), 7.11 (m, 2 H, ArH), 7.20 (m, 2 H, ArH). 13C NMR 
(75 MHz, CDCl3): δ = 47.9, 49.5 (CH2), 52.2, (OCH3), 126.9 (CH), 127.3 (2C, CH), 
128.6 (2C, CH), 130.7 (C), 167.5, 200.7 (C=O). IR (neat, cm−1): 	
 = 3087 (w), 3030 (w), 
3006 (m), 2954 (m), 1713 (s), 1602 (w), 1496 (w), 1437 (m), 1316 (m), 1301 (m), 1203 
(m), 1115 (m), 1012 (m), 848 (m), 799 (m), 698 (s). MS (EI, 70 eV): m/z (%): 192 (M+, 
35), 160 (6), 118 (47), 101 (37), 91 (100), 65(20), 59 (21). HRMS (EI, 70 eV): calcd for 
C11H12O3 (M+) 192.07810; found 192.07829. 
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Methyl 4-(4-methoxyphenyl)acetoacetate (8b): Starting with 2-
(4-methoxyphenyl)acetyl chloride  (5.00 g, 27.1 mmol) and methyl 
acetate (2.21 mL, 29.9 mmol), 8b was isolated as a yellowish oil 
(3.38 g, 56%).  1H NMR (250 MHz, CDCl3): δ = 3.37 (s, 3 H,
OCH3), 3.62 (s, 2 H, CH2), 3.67 (s, 2 H, CH2), 3.70 (s, 3 H, OCH3), 
6.77 (d, 2H, J = 8.6 Hz, ArH), 7.02 (d, 2 H, J = 8.8 Hz, ArH). 13C 
NMR (62 MHz, CDCl3): δ = 47.7, 49.1 (CH2), 52.2, 55.1 (OCH3), 114.0 (2C, CH), 125.1 
(C), 130.8 (2C, CH), 158.6 (C), 167.5, 200.7 (C=O). IR (neat, cm−1): 	
 = 3000 (w), 2954 
(m), 2837 (w), 1738 (s), 1713 (s), 1608 (m), 1510 (s), 1437 (m), 1317 (m), 1301 (m), 
1244 (s), 1176 (s), 1028 (s), 829 (m), 773 (w). MS (EI, 70 eV):  m/z (%): 222 (M+, 55), 
180 (15), 164 (9), 148 (25), 121 (100), 101(15), 91 (12). HRMS (EI, 70 eV): calcd for 
C12H14O4 (M+): 222.08866; found 222.08867. 
Methyl 4-(4-chlorophenyl)acetoacetate (8d): Starting with 2-(4-
chlorophenyl)acetyl chloride  (5.00 g, 26.4 mmol) and methyl 
acetate (2.31 mL, 29.1 mmol), 8d was isolated as a brownish oil 
(2.22 g, 34%). 1H NMR (250 MHz, CDCl3): δ = 3.40 (s, 2 H, CH2), 
3.64 (s, 2 H, CH2), 3.73 (s, 3 H, OCH3), 7.04 (d, 2H, J = 8.6 Hz, 
ArH), 7.19 (d, 2 H, J = 8.6 Hz, ArH). 13C NMR (75 MHz, CDCl3): 
δ = 48.1, 49.0 (CH2), 52.4 (OCH3), 129.9 (2C, CH), 130.9 (2C, CH), 134.2, 132.3 (C), 
167.3, 199.7 (C=O). IR (neat, cm−1): 	
 = 2999 (w), 2966 (m), 2932 (w), 2873 (w), 1721 
(m), 1631 (m), 1491 (s), 1437 (m), 1370 (m), 1336 (m), 1205 (m), 1088 (s), 1014 (s), 805 
(m), 756 (m), 593 (m). MS (EI, 70 eV): m/z (%): 228 (M+, 37Cl, 22), 226 (M+, 35Cl, 51), 
210 (5), 128 (42), 99 (4), 86 (100), 43 (51). HRMS (EI, 70 eV): calcd for C11H11O3Cl 
[M+, 35Cl]: 226.03912; found 226.03935. 
General procedure for the synthesis of biaryls 11a, b and d: To a dichloromethane 
solution (2 mL / mmol of 10) of 10 (1.0 mmol) and of 1,1,3,3-tetramethoxypropane was 
added TMSOTf (0.1 mmol) at –78 °C. The solution was allowed to warm to 20 °C within 
20 h. To the solution was added a diluted aqueous solution of HCl (15 mL). The organic 
and the aqueous layer were separated and the latter was extracted with dichloromethane 
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(3 x 15 mL). The combined organic layers were dried (Na2SO4), filtered, and the filtrate 
was concentrated in vacuo and the residue was purified by chromatography. 
Methyl 3-phenylsalicylate (11a): Starting with 1,1,3,3-
tetramethoxypropane (0.27 mL, 1.65 mmol) in CH2Cl2 (3.3 
mL), 1,3-bis(silyl enol ether) 10a (555 mg, 1.65 mmol), and 
TMSOTf (0.03 mL, 0.16 mmol), 11a was isolated as a 
highly viscous colourless oil (156 mg, 44%). 1H NMR (250 MHz, CDCl3): δ = 3.88 (s, 3 
H, OCH3), 3.86 (s, 3 H, CH3), 6.84 (t, 1 H, J = 7.7 Hz, ArH), 7.29 (m, 1 H, ArH), 7.35 
(m, 2 H, ArH), 7.45 (m, 1 H, ArH), 7.51 (m, 1 H, ArH), 7.76 (dd, 1 H, J = 6.1, 1.7 Hz, 
ArH), 11.21 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 51.4 (OCH3), 111.5 (C), 
118.0 (C, CH), 125.4 (CH), 126.3 (2C, CH), 128.3 (2C, CH), 129.8 (C), 135.5 (CH), 
136.1 (C), 157.9 (C), 169.9 (C=O). IR (neat, cm−1): 	
 = 3085 (w), 3059 (w), 3031 (w), 
2953 (m), 1669 (s), 1636 (w), 1427 (s), 1325 (s), 1283 (m), 1244 (s), 1197 (m), 1146 (s), 
1065 (m), 968 (m), 833 (m), 753 (s), 695 (s). GC-MS (EI, 70 eV): m/z (%): 228 (M+, 67), 
196 (100), 168 (95), 139 (55), 115 (13), 98 (7), 70 (7). HRMS (EI, 70 eV): calcd for 
C14H12O3 (M+): 228.07810; found 228.07832. 
Methyl 3-(4-methoxyphenyl)salicylate (11b): 
Starting with 1,1,3,3-tetramethoxypropane (0.27 mL, 
1.65 mmol) in CH2Cl2 (3.3 mL), 1,3-bis(silyl enol 
ether) 10b (604 mg, 1.65 mmol), and TMSOTf (0.03 
mL, 0.16 mmol), 11b was isolated as a colourless solid (189 mg, 50%), mp. = 93 °C. 1H 
NMR (250 MHz, CDCl3): δ = 3.75 (s, 3 H, OCH3), 3.86 (s, 3 H, OCH3), 6.80 (d, 1 H, J = 
7.7 Hz, ArH), 6.86 (d, 2 H, J = 8.8 Hz, ArH), 7.38 (d, 1 H, J = 1.7 Hz, ArH), 7.42 (d, 2H, 
J = 8.8, ArH), 7.71 (dd, 1H, J = 6.1, 1.7 Hz, ArH), 11.20 (s, 1 H, OH). 13C NMR (62 
MHz, CDCl3): δ = 51.3, 54.2 (CH3), 111.4 (C), 112.6 (2C, CH), 117.9 (CH), 127.7 (CH), 
128.5 (C), 129.0 (C), 129.4 (2C, CH), 135.2 (C), 142.6, 157.8 (C), 170.0 (C=O). IR (neat, 
cm−1): 	
 =  3188 (m), 3077 (w), 3004 (w), 2953 (m), 1668 (s), 1604 (m), 1512 (m), 1473 
(w), 1434 (m), 1334 (s), 1286 (s), 1249 (s), 1149 (m), 1062 (s), 749 (s), 695 (m), 586 (m) 
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cm−1. GC-MS (EI, 70 eV): m/z (%): 258 (M+, 58), 226 (100), 211 (6), 198 (16), 183 (40), 
155 (11), 127 (12). HRMS (EI, 70 eV): calcd for C15H14O4 (M+): 258.08866; found 
258.08877. 
Methyl-3-(4-chlorophenyl)salicylate (11d): Starting 
with 1,1,3,3-tetramethoxypropane (0.27 mL, 1.65 
mmol) in CH2Cl2 (3.3 mL), 1,3-bis(silyl enol ether) 10d
(612 mg, 1.65 mmol), and TMSOTf (0.03 mL, 0.16 
mmol), 11d was isolated as a colourless solid (170 mg, 43%), mp. = 113 °C. 1H NMR 
(250 MHz, CDCl3): δ = 3.87 (s, 3 H, OCH3), 6.82 (t, 1 H, J = 7.7 Hz, ArH), 7.28 (d, 2 H, 
J = 8.6 Hz, ArH), 7.38 (d, 1 H, J = 1.7 Hz, ArH), 7.41 (d, 2H, J = 8.8, ArH), 7.75 (dd, 
1H, J = 8.0, 1.7 Hz, ArH), 11.20 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 51.5 
(OCH3), 111.6 (C), 118.0 (CH), 127.2 (2C, CH), 128.0 (C), 128.5 (CH), 129.6 (2C, CH), 
132.3, 134.5 (C), 135.3 (CH), 157.7 (C), 169.8 (C=O). IR (neat, cm−1): 	
 = 3123 (m), 
2962 (w), 2852 (w), 1677 (s), 1610 (m), 1594 (m), 1434 (s), 1344 (m), 1327 (m), 1245 
(m), 1195 (m), 1051 (m), 1061 (m), 964 (m), 826 (s), 747 (s), 583 (m) cm−1. GC-MS (EI, 
70 eV): m/z (%): 264 (M+, 37Cl, 29), 262 (M+, 35Cl, 89), 230 (100), 202 (34), 167 (13), 
149 (9), 139 (98), 97 (57). Anal.: calcd (%) for C14H11O3Cl: C 64.01, H 4.22; found: C 
63.97, H 4.28. 
General procedure for the synthesis of biaryls 13a,b and e-i: To a dichloromethane 
solution (2 mL / mmol of 10) of 10 (1.0 mmol) and of 12 (1.0 mmol) was added TiCl4
(1.0 mmol) at –78 °C. The solution was allowed to warm to ambient temperature within 
20 h. To the solution was added a saturated solution of NaHCO3 (15 mL). The organic 
and the aqueous layers were separated and the latter was extracted with diethyl ether (3 x 
20 mL). The filtrate was concentrated in vacuo and the residue was purified by 
chromatography (silica gel, EtOAc / n-heptane = 1:4). 
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Methyl 4,6-dimethyl-3-phenylsalicylate (13a): Starting 
with  3-(siloxy)alk-2-en-1-one 12a (284 mg, 1.65 mmol), 
1,3-bis(silyl enol ether) 10a (555 mg, 1.65 mmol), and TiCl4
(0.18 mL, 1.65 mmol), 13a was isolated as colourless solid 
(172 mg, 41%), mp. = 123 °C. 1H NMR (250 MHz, CDCl3): δ = 1.98 (s, 3 H, CH3), 2.46 
(s, 3 H, CH3), 3.86 (s, 3 H, OCH3), 6.59 (s, 1 H, ArH), 7.13 (m, 1 H, ArH), 7.26 (m, 2 H, 
ArH), 7.33 (m, 2 H, ArH), 11.51 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 19.7, 
22.7 (CH3), 51.0 (OCH3), 108.8 (C), 123.5, 126.0 (CH), 127.2 (2C, CH), 128.9 (2C, CH), 
135.8, 138.7, 142.2, 159.3 (C), 171.4 (C=O). IR (neat, cm−1): 	
 =  2955 (m), 2930 (m), 
2871 (w), 2835 (w), 1725 (w), 1652 (s), 1607 (m), 1556 (w), 1512 (m), 1430 (m), 1369 
(s), 1297 (s), 1257 (s), 1240 (s), 1172 (m), 1203 (s), 1172 (s), 1070 (m), 1022 (s), 987 
(m), 955 (m), 810 (s), 750 (m). GC-MS (EI, 70 eV): m/z (%): 256 (M+, 73), 224 (100), 
196 (46), 181 (64), 165 (37), 152 (25), 128 (16). HRMS (EI, 70 eV): calcd for C16H15O3
(M+): 256.10940; found 256.10992.  
Methyl 4,6-dimethyl-5-chloro-3-phenylsalicylate (13b): 
Starting with 3-(siloxy)alk-2-en-1-one 12b (455 mg, 2.2 
mmol), 1,3-bis(silyl enol ether) 10b (740 mg, 2.2 mmol), 
and TiCl4 (0.24 mL, 2.2 mmol), 13b was isolated as a yellow 
oil (252 mg, 40%). 1H NMR (250 MHz, CDCl3): δ = 2.08 (s, 
3 H, CH3), 2.57 (s, 3 H, CH3), 3.89 (s, 3 H, OCH3), 7.13 (m, 1 H, ArH), 7.29 (m, 2 H, 
ArH), 7.34 (m, 2 H, ArH), 10.62 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 18.7, 
19.0 (CH3), 51.4 (OCH3), 111.4 (C), 112.9 (2C, CH), 125.4 (CH), 127.2 (2C, CH), 128.7 
(2C, CH), 135.6, 140.5 (C), 170.4 (C=O). IR (neat, cm−1): 	
 = 3081 (w), 3058 (m), 3025 
(m), 3003 (w), 2959 (m), 2954 (s), 2929 (s), 1731 (m), 1660 (s), 1604 (s), 1550 (w), 1497 
(w), 1441 (s), 1388 (s), 1354 (s), 1295 (s), 1253 (w), 1212 (s), 1093 (m), 1067 (m), 1009 
(m),  807 (s), 704 (s), 604 (m). GC-MS (EI, 70 eV): m/z (%): 292 (M+, 37Cl, 19), 290 
(M+, 35Cl, 58), 258 (100), 230 (24), 195 (79), 165 (41), 152 (25), 111 (16). HRMS (EI, 70 
eV): calcd for C16H15O3Cl [M+, 35Cl]: 290.07127; found 290.070944. 
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Methyl 4,6-dimethyl-5-chloro-3-(4-
methoxyphenyl)salicylate (13e): Starting with 3-
(siloxy)alk-2-en-1-one 12b (450 mg, 2.2 mmol), 1,3-
bis(silyl enol ether) 10b (806 mg, 2.2 mmol), and 
TiCl4 (0.241 mL, 2.2 mmol), 13e was isolated as a 
colourless solid (241 mg, 38%), mp. = 94 °C. 1H NMR (250 MHz, CDCl3): δ = 2.10 (s, 3 
H, CH3), 2.56 (s, 3 H, CH3), 3.77 (s, 3 H, OCH3), 3.89 (s, 3 H, OCH3), 6.89 (d, 2 H, J = 
8.8 Hz, ArH), 7.03 (d, 2 H, J = 8.8 Hz, ArH), 10.54 (s, 1 H, OH). 13C NMR (62 MHz, 
CDCl3): δ = 19.0, 19.4 (CH3), 51.4, 54.2 (OCH3), 111.5 (C), 112.9 (2C, CH), 126.8, 
127.6, 128.3 (C), 129.9 (2C, CH), 135.3, 140.8, 156.1, 157.8 (C), 170.5 (C=O). IR (KBr, 
cm−1): 	
 =  3430 (m), 3050 (w), 3002 (w), 2959 (m), 2931 (m), 2837 (m), 1653 (s), 1607 
(m), 1572 (w), 1514 (s), 1444 (s), 1373 (m), 1361 (s), 1297 (s), 1253 (s), 1220 (s),  1176 
(m), 1092 (m), 1036 (m)  810 (m), 686 (m) cm−1. GC-MS (EI, 70 eV): m/z (%): 322 (M+, 
37Cl, 16), 320 (M+, 47), 288 (100), 260 (11), 245 (27), 225 (29), 181 (7), 152 (12). HRMS 
(EI, 70 eV): calcd for C17H17O4Cl [M, 35Cl]: 320.08099; found 320.08088. 
Methyl 4,6-dimethyl-3-(4-
methoxyphenyl)salicylate (13f): Starting with 3-
(siloxy)alk-2-en-1-one 12a (284 mg, 1.65 mmol), 
1,3-bis(silyl enol ether) 10b (604 mg, 1.65 mmol), 
and TiCl4 (0.18 mL, 1.65 mmol), 13f was isolated colourless solid (173 mg, 37%), mp. = 
66 °C. 1H NMR (250 MHz, CDCl3): δ = 2.00 (s, 3 H, CH3), 2.46 (s, 3 H, CH3), 3.77 (s, 3 
H, OCH3), 3.87 (s, 3 H, OCH3), 6.59 (s, 1 H, ArH), 6.89 (d, 2 H, J = 7.5 Hz, ArH), 7.06 
(d, 2 H, J = 8.8 Hz, ArH), 11.51 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 19.7, 22.9 
(CH3), 51.0, 54.1 (OCH3), 108.7 (C), 112.7 (2C, CH), 123.5 (CH), 126.9 (C), 127.8 (C), 
129.9 (2C, CH), 138.5, 142.6, 157.5, 159.5 (C), 171.5 (C=O). IR (neat, cm−1): 	
 = 3080 
(w), 3061 (w), 3023 (w), 2957 (m), 1725 (w), 1650 (s), 1613 (m), 1558 (w), 1430 (m), 
1392 (m), 1360 (m), 1295 (s), 1255 (s), 1197 (s), 1087 (m), 1066 (m), 955 (m),  807(s), 
767 (s), 700 (s), 570 (m) cm−1. GC-MS (EI, 70 eV): m/z (%): 286 (M+, 55), 254 (100), 
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226 (11), 211 (55), 153 (8), 127 (11). HRMS (EI, 70 eV): calcd for C17H18O4 (M+): 
286.11996; found: 286.11977. 
Methyl 4,5,6-trimethyl-3-(4-
methoxyphenyl)salicylate (13g): Starting with 3-
(siloxy)alk-2-en-1-one 12c (184 mg, 1.65 mmol), 
1,3-bis(silyl enol ether) 10b (604 mg, 1.65 mmol), 
and TiCl4 (0.18 mL, 1.65 mmol), 13g was isolated as 
a colourless solid (170 mg, 38%), mp. = 108 °C. 1H NMR (250 MHz, CDCl3): δ = 1.96 
(s, 3 H, CH3), 2.12 (s, 3 H, CH3), 2.38 (s, 3 H, CH3), 3.76 (s, 3 H, OCH3), 3.86 (s, 3 H, 
OCH3), 6.88 (d, 2 H, J = 8.8 Hz, ArH), 7.03 (d, 2 H, J = 8.8 Hz, ArH), 9.97 (s, 1 H, 
OH). 13C NMR (62 MHz, CDCl3): δ = 15.0, 17.8, 18.1 (CH3), 51.0, 54.2 (OCH3), 
111.2 (C), 112.9 (2C, CH), 126.4, 126.8, 128.7 (C), 130.2 (2C, CH), 135.4, 140.7, 
154.8, 157.6 (C), 171.1 (C=O). IR (neat, cm−1): 	
 =  2996 (w), 2953 (w), 2939 (w), 
2839 (w), 1650 (m), 1598 (m), 1514 (m), 1434 (m), 1393 (m), 1318 (m), 1215 (s), 
1295 (s), 1175 (m), 1030 (m), 804 (s), 762 (m), 696 (m), 562 (m) cm−1. GC-MS (EI, 70 
eV): m/z (%): 300 (M+, 39), 268 (100), 240 (31), 225 (47), 197 (6), 134 (9) 69 (25). 
HRMS (EI, 70 eV): calcd for C18H20O4 (M+): 300.13561; found 300.13568. 
Methyl 4,5,6-trimethyl-3-phenylsalicylate (13h): Starting 
with 3-(siloxy)alk-2-en-1-one 12c (308 mg, 1.65 mmol), 1,3-
bis(silyl enol ether) 10a (555 mg, 1.65 mmol), and TiCl4
(0.180 mL, 1.65 mmol), 13h was isolated as a colourless 
solid (140 mg, 35%), mp. = 65°C. 1H NMR (250 MHz, 
CDCl3): δ = 1.90 (s, 3 H, CH3), 2.08 (s, 3 H, CH3), 2.35 (s, 3 H, CH3), 3.82 (s, 3 H, 
OCH3), 7.06−7.12 (m, 2 H, ArH), 7.22−7.32 (m, 3 H, ArH), 10.02 (s, 1 H, OH). 13C 
NMR (62 MHz, CDCl3): δ = 16.5, 19.3, 19.8 (CH3), 52.6 (OCH3), 112.6 (C), 127.5 (CH) 
127.9 (C), 128.8 (2C, CH), 130.6 (2C, CH), 137.2, 138.2, 142.0, 156.2 (C), 172.6 (C=O). 
IR (neat, cm−1): 	
 = 3022 (w), 2953 (w), 2922 (m), 2853 (w), 1727 (w), 1650 (m), 1604 
(m), 1557 (w), 1427 (m), 1392 (m), 1316 (s), 1215 (s), 1068 (m), 961 (w), 807 (m), 773 
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(m), 722 (m), 699 (m). GC-MS (EI, 70 eV): m/z (%): 270 (M+, 46), 238 (100), 210 (45), 
195 (52), 165 (21), 97 (23), 83(34), 69 (34), 57 (49). Anal.: calcd (%) for C17H18O3: C 
75.53, H 6.71; found: C 73.84, H 7.03. 
Methyl 4,6-dimethyl-5-chloro-3-(4-
chlorophenyl)salicylate (13i): Starting with 3-
(siloxy)alk-2-en-1-one 12b (332 mg, 1.65 mmol), 1,3-
bis(silyl enol ether) 10d (612 mg, 1.65 mmol), and 
TiCl4 (0.18 mL, 1.65 mmol), 13i was isolated as a 
colourless solid (190 mg, 40%), mp. = 96 °C. 1H NMR (250 MHz, CDCl3): δ = 2.07 (s, 3 
H, CH3), 2.56 (s, 3 H, CH3), 3.88 (s, 3 H, OCH3), 7.03 (d, 2 H, J = 8.6 Hz, ArH), 7.31 (d, 
2 H, J = 8.5 Hz, ArH), 10.85 (s, 1 H, OH). 13C NMR (62 MHz, CDCl3): δ = 18.7, 19.44 
(CH3), 51.52 (OCH3), 111.2, 126.4, 127.5 (C), 127.6 (2C, CH), 130.3 (2C, CH), 132.4, 
134.0, 136.1, 140.5, 156.2(C), 170.5 (C=O). IR (KBr, cm−1): 	
 =  3029 (w), 2950 (m), 
2925 (w), 2849 (w), 1658 (s), 1591 (m), 1493 (m), 1434 (m), 1355 (s), 1288 (s), 1207 (s), 
1082 (m), 1068 (m), 1008 (s), 980 (m), 956 (m), 824 (m),  802 (s), 727 (s), 607 (m) cm−1. 
GC-MS (EI, 70 eV): m/z (%): 326 (M+, 37Cl, 35Cl, 29), 324 (M+, 2 x 35Cl, 44), 299 (100), 
264 (10), 257 (28), 229 (45), 165 (45), 128 (10), 82 (22). Anal.: calcd (%) for 
C16H14O3Cl2: C 63.65, H 5.34; found: C 63.45, H 5.67. 
Ethyl 2-(5-oxo-3-phenyl-5H-chromeno[2,3-b]pyrid-2-
yl)acetate (18a): Starting with 3-cynochromone 16 (256 
mg, 1.5 mmol), 10a (656 mg, 1.95 mmol), Me3SiOTf 
(0.35 mL, 1.95 mmol), and Et3N (0.45 mL, 3.0 mmol), 18a
was isolated as a colourless solid (320 mg, 62%), mp. = 
152 °C. 1H NMR (CDCl3, 250 MHz): δ = 3.85 (s, 3 H, CH3), 4.65 (s, 2 H, CH2), 
7.11−7.27 (m, 5H, ArH), 7.38 (m, 2 H, ArH), 7.54 (m, 1 H, ArH), 7.72 (m, 1 H, 7-H), 
8.21 (dd, 3J = 7.9 Hz, 4J = 1.5 Hz, 1 H, Ar-H), 9.13 (s, 1 H, ArH). 13C NMR (62 MHz, 
CDCl3): δ = 42.5 (CH3), 52.6 (CH2), 114.3 (C), 118.6 (CH), 121.6, 123.2 (C), 125.1, 
126.5, 126.8 (CH), 128.4, 129.2 (2C, CH), 135.9 (CH), 138.1 (C), 141.1 (CH), 155.5, 
160.5, 165.1 (C), 167.7, 176.8 (C=O). IR (neat, cm–1): ~ν  = 3048 (w), 3061 (w), 3028 
(w), 3007 (w), 2948 (w), 2929 (w), 1725 (s), 1669 (s), 1595 (s), 1547 (m), 1466 (s), 1413 
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(s), 1314 (m), 1270 (s), 1214 (s), 1069 (m), 968 (m), 765 (s), 742 (s), 690 (s). GC-MS 
(EI, 70 eV): m/z (%) = 345 (M+, 100), 313 (56), 286 (28), 256 (8), 228 (12). HRMS (EI): 
calcd for C21H15O4N (M+, 35Cl): 345.09956, found 345.09971. 
Synthesis of 3-aryl-1-azaxanthone (18b): To neat 
3-cyanochromone 16 (256 mg, 1.5 mmol) was 
added Me3SiOTf (433 mg, 0.35 mL, 1..95 mmol) 
and CH2Cl2 (13.5 mL) at 20 °C. After stirring for 1 
h, CH2Cl2 and 1,3-bis(trimethylsilyloxy)-1,3-
butadiene 10e (683 mg, 1.95 mmol) were added at 0 °C. The mixture was stirred for 12 h 
at 20 °C and subsequently poured into hydrochloric acid (10%). The organic and the 
aqueous layer were separated and the latter was extracted with CH2Cl2 (3 x 100 mL). The 
combined organic layers were washed with water, dried (Na2SO4), filtered and the filtrate 
was concentrated in vacuo. The residue was filtered through a pad of silica gel 
(EtOAc/hexane = 5:1) to give crude 17. To an ethanol solution (15 mL) of 17 was added 
NEt3 (326 mg, 0.44 mL, 3.0 mmol) and the solution was stirred for 12 h at 20 °C. To the 
solution were subsequently added an aqueous solution of hydrochloric acid (1 M) and 
ether (50 mL). The organic and the aqueous layer were separated and the latter was 
extracted with ether (3 x 100 mL). The combined organic layers were washed with water, 
dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography (silica gel, EtOAc/hexane) to give 18b as a yellow 
solid (333 mg, 63%), mp. = 173-174 °C. 1H NMR (CDCl3, 250 MHz): δ = 2.23(s, 3H, 
CH3), 3.85 (s, 3 H, CH3), 4.60 (s, 2 H, CH2), 6.98(d, J = 7.8 Hz, 2 H, ArH), 7.15 (d, 2 H, 
ArH), 7.33-7.39 (m, 1 H, ArH), 7.53 (d, J = 7.87 Hz, 1H, ArH), 7.67-7.74 (m, 1H, ArH), 
8.20 (m, 1H, ArH), 9.10 (s, 1H, ArH) 13C-NMR (62 MHz, CDCl3): δ = 21.0 (CH3), 42.1 
(CH2), 52.5 (OCH3), 114.3 (C), 118.6 (CH), 121.6, 123.2 (C), 125.1, 126.8 (CH), 129.0 
(2C, CH), 129.1 (2C, CH), 135.0 (C), 135.8 (CH), 136.1 (C), 141.1(CH), 155.6, 160.5, 
165.3 (C), 168.0, 176.8 (C=O). IR (KBr, cm–1): 	
 = 3084 (w), 3058 (w), 3009 (w), 2948 
(w), 1720 (s), 1671 (s), 1613 (m), 1600 (s), 1597 (s), 1548 (m), 1467 (s), 1442 (m), 1412 
(s), 1314 (m), 1271 (s), 1253 (s), 1216 (s), 1150 (s), 1069 (s), 793 (m), 755 (s), 615 (m). 
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GC-MS (EI, 70 eV): m/z (%): 359 (M+, 100), 327 (M+, 70), 298 (17), 285 (5), 256 (5), 
228(4), 150 (7); HRMS (EI) calcd for C22H17O4N (M+): 359.114605; found 359.11521. 
Ethyl 2-[3-(4-chlorophenyl)-5-oxo-5H-
chromeno[2,3-b]pyrid-2-yl]acetate (18c): Starting 
with 16 (256 mg, 1.5 mmol), 10d (723 mg, 1.95 
mmol), Me3SiOTf (0.36 mL, 1.95 mmol), and NEt3
(0.45 mL, 3.0 mmol), 18c was isolated as a colourless 
solid (284 mg, 50%), mp. = 182 °C. 1H NMR (CDCl3, 250 MHz): δ = 3.78 (s, 3 H, CH3), 
4.52 (s, 2 H, CH2), 7.06−7.17 (m, 4H, ArH), 7.30 (m, 1 H, ArH), 7.45 (m, 1 H, ArH), 
7.61 (m, 1 H, ArH), 8.13 (dd, 3J = 7.8 Hz, 4J = 1.4 Hz, 1 H, Ar-H), 9.06 (s, 1 H, ArH). 
13C NMR (62 MHz, CDCl3): δ = 41.8 (CH3), 52.6 (CH2), 114.5 (C), 118.6 (CH), 121.6, 
123.0 (C), 125.8, 126.8 (CH), 128.5, 130.6 (2C, CH), 132.4 (C), 135.9 (CH), 136.5 (C), 
141.3 (CH), 155.5, 160.5, 165.1 (C), 167.2, 177.3 (C=O). IR (KBr, cm–1): ~ν  = 3076 (w), 
3048 (w), 2952 (w), 2918 (w), 1729 (s), 1664 (s), 1613 (m), 1600 (s), 1547 (m), 1492 
(w), 1483 (s), 1414 (s), 1338 (w), 1310 (m), 1271 (s), 1247 (s), 1216 (s), 1139 (m), 1065 
(m), 943 (m), 765 (s). GC-MS (EI, 70 eV): m/z (%) = 381 (M+, 37Cl, 34), 379 (M+ 35Cl, 
100), 347 (46), 320 (15), 312 (59), 284 (13), 256 (14), 228 (9). HRMS (EI): calcd for 
C21H14O4NCl (M+, 35Cl): 379.06059, found 379.06052.  
Synthesis of methyl 5-(2-hydroxy-3-
bromobenzoyl)-3-(4-tolyl)salicylate (20): To 6-
bromo-3-formylchromone 19 (379 mg, 1.5 mmol) 
was added Me3SiOTf (0.355 mL, 1.95 mmol) at 20 
°C. After stirring for 10 min, CH2Cl2 (13.5 mL) was 
added, the solution was cooled to 0 °C and 1,3-
bis(silyl enol ether) 10e (683 mg, 1.95 mmol) was 
added. The mixture was stirred at 20 °C for 12 h and was subsequently poured into an 
aqueous solution of HCl (10%). The organic and the aqueous layer were separated and 
the latter was extracted with CH2Cl2 (3 x 15 mL). The combined organic layers were 
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washed with brine (25 mL) and dried over Na2SO4. The mixture was filtered and the 
solvent of the filtrate was removed under reduced pressure. The crude product was 
purified by chromatography (silica gel, EtOAc / n-heptane) to give 20 as a yellow solid 
(310 mg, 47%), mp. = 173−174 °C. 1H NMR (250 MHz, CDCl3): δ = 2.36 (s, 3 H, CH3), 
3.94 (s, 3 H, OCH3), 6.90 (d, J = 8.9 Hz, 1 H, ArH), 7.18−7.22 (m, 2 H, ArH), 7.40−7.44 
(m, 2 H, ArH), 7.49−7.54 (m, 1 H, ArH), 7.68 (d, J = 2.3 Hz, 1 H, ArH), 7.81 (d, J = 1.9 
Hz, 1 H, ArH), 8.15 (d, J = 2.3 Hz, 1 H, ArH), 11.60 (s, 1 H, OH), 11.80 (s, 1 H, OH). 
13C NMR (62 MHz, CDCl3): δ = 21.2 (CH3), 52.9 (OCH3), 110.3, 112.3, 120.3 (C), 120.5 
(CH), 128.1 (C), 129.11 (2C, CH), 129.17 (2C, CH), 131.1(CH), 131.2, 132.8 (C), 134.9 
(CH), 136.8 (CH), 137.9 (C), 138.7 (CH), 161.8, 162.4 (C), 170.4, 198.0 (C=O). IR 
(neat): 	
 = 3104 (w), 2961(m), 2920 (m), 2857 (w), 1783 (w), 1678 (s), 1629 (s), 1588 
(s), 1565 (m), 1467 (m), 1437 (s), 1362 (s), 1332 (m), 1286 (s), 1255 (s), 1225 (m), 1198 
(s), 1086 (s), 1022 (w), 958 (s), 889 (m), 814 (s), 683 (s), 646 (m) cm−1. GC-MS (EI, 70 
eV): m/z (%): 440 (M+, 79Br, 90), 411 (24), 408 (93), 242 (19), 210 (65), 182 (30), 153 
(34). Anal.: calcd (%) for C22H17BrO5: C 59.88, H 3.88; found: C 59.48, H 4.11.  
General procedure for the synthesis of salicylates 23: To a CH2Cl2 solution of 3-
silyloxy-2-en-1-ones 21 (1.0 equiv.) and of 1,3-bis(silyl enol ethers) 22 (1.0 equiv.), 
TiCl4 (1.0 equiv.) was added dropwise at –78 °C under argon atmosphere. The solution 
was stirred for 30 min at –78 °C and was then allowed to warm to 20 °C during 18 h. To 
the reaction mixture was added an aqueous solution of HCl (10%). The organic layer was 
separated and the aqueous layer was repeatedly extracted with CH2Cl2. The combined 
organic extracts were dried (Na2SO4) and filtered. The filtrate was concentrated in vacuo
and the residue was purified by chromatography (silica gel, n-heptane/EtOAc) to gave 
salicylates 23. 
92
3-Hydroxy-5,2'-dimethyl-biphenyl-2-carboxylic acid methyl 
ester (23i): Starting with 1,3-bis(silyl enol ether) 21a (0.287 g, 
1.10 mmol), 4-o-tolyl-4-trimethylsilyloxy-but-3-en-2-one 22i
(0.273 g, 1.10 mmol) and TiCl4 (0.1 mL, 1.10 mmol) in CH2Cl2
(2 mL), 23i was isolated as a yellow oil (0.120 g, 43%). 1H 
NMR (300 MHz, CDCl3): δ = 2.03 (s, 3H, CH3), 2.33 (s, 3H, CH3), 3.43 (s, 3H, OCH3), 
6.50 (s, 1H, CH), 6.82 (s, 1H, CH), 6.99-7.02 (m, 1H, CH), 7.15-7.20 (m, 3H, CH), 11.11 
(s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 18.8, 20.6 (CH3), 50.6 (OCH3), 108.3 (C), 
115.8, 122.5, 123.9, 125.7, 128.4, 132.3 (CH), 133.7, 141.7, 143.2, 144.2 (C), 161.0 
(COH), 170.3 (CO2Me). IR (neat, cm-1): 	
 = 3069 (w) 3015 (w), 2954 (m), 2853 (w), 
1661 (s), 1612 (m), 1572 (m), 1438 (m), 1353 (m), 1259 (s), 1215 (s), 1123 (m), 1013 (s). 
MS (EI, 70 eV): m/z (%) = 256 (M+, 28), 225 (19), 224 (100), 181 (19), 153 (26). HRMS 
(EI): calcd for C16H16O3 (M+): 256.10940, found 256.110114.  
4'-Chloro-3-hydroxy-5-methyl-biphenyl-2-carboxylic 
acid methyl ester (23j): Starting with 1,3-bis(silyl enol 
ether) 21a (0.573 g, 2.20 mmol), 4-(4-chlorophenyl)-4-
trimethylsilyloxy-but-3-en-2-one 22i (0.591 g, 2.20 mmol) 
and TiCl4 (0.2 mL, 2.20 mmol) in CH2Cl2 (4 mL), 23j was 
isolated as a colourless solid (0.242 g, 40%); mp 94-96 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 3.50 (s, 3H, OCH3), 6.56 (br s, 1H, 
CH), 6.82 (br s, 1H, CH), 7.11-7.16 (m, 2H, CH), 7.29-7.34 (m, 2H, CH), 10.83 (s, 1H, 
OH). 13C NMR (75 MHz, CDCl3): δ = 21.6 (CH3), 51.6 (OCH3), 109.0 (C), 117.3, 123.9, 
127.7, 129.4 (CH), 132.7, 141.4, 143.4, 145.0 (C), 161.9 (COH), 171.1 (CO2Me). IR 
(neat, cm-1): 	
 = 3060 (w) 3020 (w), 2960 (m), 2848 (w), 1664 (s), 1612 (m), 1572 (m), 
1438 (m), 1353 (m), 1259 (s), 1215 (s), 1123 (m), 1013 (s). MS (EI, 70 eV): m/z
(%) = 278 (M+, 37Cl, 10), 276 (M+, 35Cl, 30), 246 (33), 244 (100), 216 (26), 152 (27). 
HRMS (EI): calcd for C15H13ClO3 (M+, 35Cl): 276.05477, found 276.05567. 
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4'-Chloro-4-hexyl-3-hydroxy-5-methyl-
biphenyl-2-carboxylic acid methyl ester 
(23k): Starting with 1,3-bis(silyl enol ether) 21c
(0.758 g, 2.20 mmol), 4-(4-chlorophenyl)-4-
trimethylsilyloxy-but-3-en-2-one 22i (0.591 g, 
2.20 mmol) and TiCl4 (0.2 mL, 2.20 mmol) in CH2Cl2 (4 mL), 23k was isolated as a 
yellow oil (0.273 g, 34%). 1H NMR (250 MHz, CDCl3): δ = 0.76-0.82 (m, 3H, CH3), 
1.19 (m, 8H, (CH2)4), 2.04 (s, 3H, CH3), 3.43 (m, 2H, CH2), 3.63 (s, 3H, OCH3), 6.72 (s, 
1H,  CH), 7.34 (d, 2H, J = 8.6 Hz, CH), 7.76 (d, 2H, J = 8.6 Hz, CH), 11.00 (s, 1H, OH). 
13C NMR (62 MHz, CDCl3): δ = 14.0, 17.6 (CH3), 19.2, 27.3, 28.8, 31.7, 48.1 (CH2), 
52.3 (OCH3), 124.2, 128.7, 128.9 (CH), 137.2, 139.1, 154.5, 166.9, 189.6 (C), 200.8 
(CO2Me). IR (neat, cm-1): 	
 = 3074 (w) 3022 (w), 2955 (m), 2860 (w), 1665 (s), 1617 
(m), 1568 (m), 1429 (m), 1353 (m), 1259 (s), 1215 (s), 1123 (m), 1013 (s). MS (EI, 
70 eV): m/z (%) = 362 (M+, 37Cl, 16), 360 (M+, 35Cl, 49), 313 (67), 311 (28), 257 (68), 
223 (100), 165 (46). HRMS (EI): calcd for C21H25ClO3 (M+, 35Cl): 360.14867, found 
360.147678. 
2'-Chloro-3-hydroxy-5-methyl-biphenyl-2-carboxylic acid 
methyl ester (23l): Starting with 1,3-bis(silyl enol ether) 21a
(0.537 g, 2.20 mmol), 4-(2-chlorophenyl)-4-trimethylsilyloxy-
but-3-en-2-one 22j (0.591 g, 2.20 mmol) and TiCl4 (0.2 mL, 
2.20 mmol) in CH2Cl2 (4 mL), 23l was isolated as a colourless 
solid (0.226 g, 37%). 1H NMR (300 MHz, CDCl3): δ = 2.24 (s, 3H, CH3), 3.39 (s, 3H, 
OCH3), 6.42 (s, 1H, CH), 6.77 (s, 1H, CH), 7.08-7.11 (m, 1H, CH), 7.14-7.20 (m, 2H, 
CH), 7.26-7.29 (m, 1H, CH), 11.05 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 20.6 
(CH3), 50.8 (OCH3), 108.4 (C), 116.7, 122.6, 125.8, 127.5, 128.9, 130.6 (CH), 134.5, 
140.3, 140.7, 144.3 (C), 160.9 (COH), 169.9 (CO2Me). IR (neat, cm-1): 	
 = 3070 (w) 
3017 (w), 2952 (m), 2857 (w), 1660 (s), 1612 (m), 1572 (m), 1433 (m), 1353 (m), 1259 
(s), 1215 (s), 1123 (m), 1013 (s). MS (EI, 70 eV): m/z (%) = 278 (M+, 37Cl, 10), 276 (M+, 
35Cl, 30), 244 (29), 241 (100), 152 (21). HRMS (EI): calcd for C15H13ClO3 (M+, 35Cl): 
276.05477, found 276.054962. 
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2'-Fluoro-3-hydroxy-5-methyl-biphenyl-2-carboxylic acid 
methyl ester (23o). Starting with 1,3-bis(silyl enol ether) 21a
(0.287 g, 1.10 mmol), 4-(2-fluorophenyl)-4-trimethylsilyloxy-
but-3-en-2-one 22k (0.278 g, 1.10 mmol) and TiCl4 (0.1 mL, 
1.10 mmol) in CH2Cl2 (2 mL), 23o was isolated as a yellowish 
oil (0.127 g, 44%). 1H NMR (300 MHz, CDCl3): δ = 2.33 (s, 3H, CH3), 3.51 (s, 3H, 
OCH3), 6.59 (s, 1H, CH), 6.85 (s, 1H, CH), 7.03 (t, J = 9.3 Hz, 1H, CH), 7.12-7.17 (m, 
1H, CH), 7.20-7.23 (m, 1H, CH), 7.27-7.32 (m, 1H, CH), 11.02 (s, 1H, OH). 13C NMR 
(75 MHz, CDCl3): δ = 21.6 (CH3), 51.7 (OCH3), 109.7 (C), 114.4, 114.6, 117.8, 123.7, 
124.3, 128.7, 128.8, 130.0 (CH), 130.4, 130.6, 137.7, 145.3, 157.7, 161.0, 161.9 (C), 
171.0 (CO2Me). IR (neat, cm-1): 	
 = 3060 (w) 3025 (w), 2960 (m), 2851 (w), 1653 (s), 
1612 (m), 1572 (m), 1438 (m), 1353 (m), 1259 (s), 1215 (s), 1112 (m), 1013 (s). MS (EI, 
70 eV): m/z (%) = 260 (M+, 37), 229 (18), 228 (100), 200 (42), 171 (17). HRMS (EI): 
calcd for C15H13FO3 (M+) 260.08432, found 260.083875. 
General procedure for the synthesis of fluorenones 24. Compound 23 was dissolved in 
concentrated H2SO4. After stirring for 1 h, the solution was poured into ice water and 
extracted (3x) with diethyl ether. The combined organic layers were dried (Na2SO4), 
filtered and the filtrate was concentrated in vacuo to give 24.
1-Hydroxy-3,5-dimethyl-fluoren-9-one (24y). Starting with 23i
(0.118 g, 0.46 mmol) and conc. H2SO4 (5.7 mL), 24y was isolated 
as a yellow solid (0.070 mg, 68%), mp 140-145 °C. 1H NMR 
(300 MHz, CDCl3): δ = 2.35 (s, 3H, CH3), 2.52 (s, 3H, CH3), 6.54 
(s, 1H, CH), 6.89 (s, 1H, CH), 7.13-7.23 (m, 2H, CH), 7.46 (d, 
3J = 7.1 Hz, 1H, CH), 8.60 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 20.1, 22.6 
(CH3), 115.5 (C), 117.5, 121.5, 128.7 (CH), 134.1, 135.1 (C), 137.0 (CH), 141.6, 144.7, 
149.1 (C), 157.5 (COH), 196.1 (C=O). IR (neat, cm-1): 	
 = 3339 (s), 2355 (m), 2923 (m), 
1675 (s), 1627 (s), 1602 (s), 1587 (m), 1457 (m), 1334 (m), 1295 (m), 1238 (m), 1207 
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(m), 1172 (m). MS (EI, 70 eV): m/z (%) = 224 (M+, 100), 195 (17), 181 (37), 165 (16), 
152 (20). HRMS (EI): calcd for C15H12O2 (M+): 224.08318, found 224.083191.  
7-Chloro-1-hydroxy-3-methyl-fluoren-9-one (24z). 
Starting with 23j (0.199 g, 0.72 mmol) and conc. H2SO4 
(8.9 mL), 24z was isolated as a yellow solid (0.146 g, 83%), 
mp 165-167 °C. 1H NMR (300 MHz, CDCl3): δ = 2.35 (s, 
3H, CH3), 6.58 (br s, 1H, CH), 6.84 (br s, 1H, CH), 7.40-7.41 
(m, 2H, CH), 7.56 (br s, 1H, CH), 8.22 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 22.4 (CH3), 114.4 (CH), 115.3 (C), 118.2, 121.7, 124.2, 133.8 (CH), 135.0, 136.4, 
142.0, 143.0, 149.8 (C), 157.4 (COH), 194.0 (C=O). IR (neat, cm-1): 	
 = 3402 (s), 2917 
(w), 1680 (s), 1624 (s), 1604 (s), 1445 (m), 1391 (w), 1309 (s), 1257 (m), 1217 (m), 1190 
(s), 1160 (m), 1098 (m). MS (EI, 70 eV): m/z (%) = 246 (M+, 37Cl, 34), 244 (M+, 35Cl, 
100), 181 (17), 152 (30). HRMS (EI): calcd for C14H9ClO2 (M+, 35Cl): 244.02856, found 
244.028552.
7-Chloro-2-hexyl-1-hydroxy-3-methyl-
fluoren-9-one (24aa). Starting with 23k
(0.249 g, 0.69 mmol) and conc. H2SO4 (8.5 mL), 
24aa was isolated as a yellowish solid (0.147 g, 
65%), mp 73-75 °C. 1H NMR (250 MHz, 
CDCl3): δ = 0.86-0.91 (m, 3H, CH3), 1.24-1.33 (m, 8H, CH2), 2.32 (s. 3H, CH3), 2.56-
2.62 (m, 2H, CH2), 6.81 (s, 1H, CH), 7.35-7.41 (m, 2H, CH), 7.53 (dd, 3J = 1.7 Hz, 
5J = 0.6 Hz, 1H, CH), 8.49 (s, 1H, OH). 13C NMR (62 MHz, CDCl3): δ = 14.1, 20.5 
(CH3), 22.6, 25.4, 28.9, 29.5, 31.7 (CH2), 115.4, 121.5, 124.2 (CH), 127.6, 131.1 (C), 
133.7 (CH), 134.4, 136.4, 139.7, 142.4, 146.9 (C), 156.1 (COH), 194.8 (C=O). IR 
(neat, cm-1): 	
 = 3349 (w), 2949 (m), 2918 (s), 2851 (m), 1676 (s), 1624 (m), 1596 (m), 
1451 (m), 1384 (w), 1298 (m), 1258 (m), 1168 (s), 1115 (m), 1094 (m), 1031 (w). MS 
(EI, 70 eV): m/z (%) = 330 (M+, 37Cl, 7), 328 (M+, 35Cl, 21), 260 (18), 258 (55), 257 
(100), 165 (19). HRMS (EI): calcd for C20H21ClO2 (M+, 35Cl): 328.12246, found 
328.122093. 
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5-Chloro-1-hydroxy-3-methyl-fluoren-9-one (24ab). Starting 
with 23l (0.219 g, 0.79 mmol) and conc. H2SO4 (9.7 mL), 24ab 
was isolated as a colourless solid (0.145 g, 75%), mp 145-150 °C. 
1H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3H, CH3), 6.59 (s, 1H, 
CH), 7.19 (t, 3J = 7.6 Hz, 1H, CH), 7.36-7.39 (m, 2H, CH), 7.50 
(d, 3J = 7.6 Hz, 1H, CH), 8.44 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): δ = 22.7 (CH3), 
115.2 (C), 118.3 (CH), 118.4 (C), 118.5, 122.1, 129.8, 135.7 (CH), 137.1, 140.1, 142.2, 
149.7 (C), 157.5 (COH), 194.2 (C=O). IR (neat, cm-1): 	
 = 3345 (s), 2918 (m), 1694 (s), 
1619 (s), 1592 (s), 1445 (m), 1412 (w), 1377 (w), 1316 (m), 1296 (s), 1239 (m), 1168 (s). 
MS (EI, 70 eV): m/z (%) = 246 (M+, 37Cl, 38), 244 (M+, 35Cl, 100), 216 (17), 181 (32), 
152 (31). HRMS (EI): calcd for C14H9ClO2 (M+, 35Cl): 244.02856, found 244.028810. 
5-Fluoro-1-hydroxy-3-methyl-fluoren-9-one (24ae). Starting 
with 23o (0.120 g, 0.46 mmol) and conc. H2SO4 (5.7 mL), 24ae 
was isolated as a colourless solid (0.079 g, 75%), mp 113-118 °C.
1H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3H, CH3), 6.59 (s, 1H, 
CH), 7.03 (s, 1H, CH), 7.13-7.19 (m, 1H, CH), 7.23-7.29 (m, 1H, 
CH), 7.43 (d, 3J = 7.2 Hz, 1H, CH), 8.30 (s, 1H, OH). 13C NMR (75 MHz, CDCl3): 
δ = 22.9 (CH3), 113.9 (C), 117.1, 118.8, 121.2 (CH), 128.3 (C), 129.7 (CH), 136.4, 139.7, 
148.9, 155.2, 156.4, 158.5 (C), 193.3 (C=O). IR (neat, cm-1): 	
 = 3341 (s), 2923 (s), 2853 
(m), 1649 (s), 1620 (s), 1585 (s), 1455 (m), 1305 (m), 1240 (s), 1199 (s), 1144 (s), 1113 
(m). MS (EI, 70 eV): m/z (%) = 228 (M+, 100), 200 (15), 199 (41), 171 (12), 170 (22). 
HRMS (EI): calcd for C14H9FO2 (M+): 228.05811, found 228.0577962. 
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(Z)-ethyl 2-(5-(chloromethyl)dihydrofuran-2(3H)-
ylidene)-2-fluoroacetate (28)  : Starting with 1,3-Bis-silyl 
Enol Ether 27 (748mg, 2.5 mmoles), epichlorohydrin 
(277mg, 0.23 mL, 3 mmole), TiCl4 (948mg, 1.09 mL, 5mmole) and molecular sieves (3g) 
in CH2Cl2 (19mL) 28 was obtained as yellow oil (320 mg, 48 %). 1H NMR (250 MHz, 
CDCl3):  = 1.32 (t, 3 H, J = 7.5 Hz, CH3), 2.02-2.16 (m, 1H, CH2), 2.26-2.40 (m, 1H, 
CH2), 2.96-3.28 (m, 2H, CH2), 3.63-3.71 (m, 2H, CH2), 4.24 (q, 2 H, J = 7.5 Hz, OCH2), 
4.71-4.81 (m, 1H, CH); 13C NMR (62 MHz, CDCl3):  = 14.3 (CH3), 27.1, 29.0, 45.1 
(CH2),  60.7 (OCH2), 83.3 (CH), 132.8 (C), 155.4 (d, J = 10.59 Hz, CF), 169.0 (d, J = 
31.80 Hz, C=O); 19F NMR (235 MHz, CDCl3): δ = -160.61 (CF). IR (ATR): v = 3430 
(w), 2983 (w), 2942 (w), 1739 (m), 1693 (m), 1620 (s), 1372 (w), 1282 (s), 1189 (w), 
1074 (s), 944 (m) cm−1; MS (GC, 70 eV): m/z (%):224 (M+, 37Cl, 31), 222 (M+, 35Cl, 85), 
194 (61), 179 (20), 176 (100), 159 (44), 141 (42), 132 (25), 104 (36); HRMS (EI) calcd 
for C9H12O3ClF [M+, 35Cl]: 222.04535 found 222.044988. 
Ethyl 6-chloro-2-fluoro-5-methoxy-3-oxohexanoate (29): 
Starting with 1,3-Bis-silyl Enol Ether 27 (0.731g, 2.5 
mmoles), 1-chloro-2,2-dimethoxyethane (0.311g, 0.28 mL, 
2.5 mmole)  and Me3SiOTf (0.270g, 0.22 mL, 1.25 mmole) in CH2Cl2 (10ml), 29 was 
isolated as yellow oil (501 mg, 72%). 1H NMR (250 MHz, CDCl3): δ = 1.23 (t, 3 H, J= 
7.5 Hz, CH3), 2.84-3.09 (m, 2H, CH2), 3.35 (s, 3H, OCH3), 3.57 (d, 2H,  J = 5 Hz, CH2), 
3.88-3.98 (m, 1H, CH), 4.23 (q, 2H, J = 7.5 Hz, OCH2), 5.12 (dd, 1H, JF, H= 44.3 Hz, JF, 
H= 5.62 Hz, CHF). 13C NMR (75.47 MHz, CDCl3): δ = 13.8 (CH3), 41.1 (d, J = 6.1 Hz, 
CH2), 44.3 (d, J = 5.0 Hz, CH2), 57.5 (d, J = 6.7 Hz, OCH3), 62.6 (OCH2), 75.5 (d, 1J = 
19.2 Hz, CH), 90.1 (d, J = 198 Hz, CF), 163.4 (d, J = 25.6 Hz, C=O), 198.4 (dd, J = 18.9 
Hz,  J = 4.1 Hz, C=O). 19F NMR (235 MHz, CDCl3): δ = -187.79 (CF). IR (ATR, cm−1): 
~ν  = 2958 (w), 2938 (w), 2832 (w), 1758 (s), 1732 (s), 1462 (w), 1370 (m), 1263 (m), 
1094 (s), 1014 (s). MS (GC, 70 eV): m/z (%): 240 (M+, 2), 191 (53), 135 (41), 93 (100), 
85 (69); HRMS (EI) calcd for C9H14FClO4 [M+]: 240.05592, found 240.056012. 
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(Z)-ethyl 2-fluoro-2-(4-methoxydihydrofuran-2(3H)-
ylidene)acetate (30): Starting with 29 (420 mg, 1.74 mmole) 
and DBU (530mg, 0.52 ml, 3.48 mmole) in 4 ml of THF, 30
was isolated as yellow oil (286 mg, 81%). 1H NMR (250 MHz, CDCl3): δ = 1.29 (t, 3 H, 
J= 7.3 Hz, CH3), 2.92-3.04 (m, 1H, CH2),  3.29-3.36 (m, 1H, CH), 3.30 (s, 3H, OCH3), 
4.13-4.17 (m, 1H, CH2), 4.19-4.27 (m, 1H, CH2), 4.21-4.27 (m, 2H, OCH2), 4.40 (m, 1H, 
CH2). 13C NMR (75.47 MHz, CDCl3): δ = 13.7 (CH3), 35.1 (CH2), 55.9 (OCH3), 60.0 
(CH2), 75.9 (CH), 129.1 (C), 132.8 (C), 154.2 (d, J = 10.5 Hz, C), 161.5 (d, J = 31.5 Hz, 
C=O). 19F NMR (235 MHz, CDCl3): δ = -161.27 (CF). IR (ATR, cm−1): ~ν  = 3467 (w), 
2922 (m), 2851 (w), 1732 (s), 1443 (w), 1371 (m), 1023 (s). MS (GC, 70 eV): m/z (%): 
204 (M+, 55), 172 (65), 159 (47), 145 (100), 127 (43), 99 (74), 74 (67); HRMS (EI) calcd 
for C9H13FO4 [M+]: 204.07924, found 204.079401. 
(Z)-ethyl 2-fluoro-2-(5-vinyldihydrofuran-2(3H)-
ylidene)acetate (31): Starting with LDA (12.5 mmoles), 25 
(748mg, 0.62 mL, 5 mmole) and trans-1,2-dibromo butene 
(1.27g , 30 mmole) at -78°C, 31 was isolated as light yellow oil (441mg, 44%). 1H NMR 
(250 MHz, CDCl3):  δ = 1.24 (t, 3H, J = 7.7 Hz, CH3), 1.76-1.91 (m, 1H, CH2), 2.16-2.30 
(m, 1H, CH2),  2.84-3.15 (m, 2H, CH2), 4.13 (q, 2 H, J = 7.0 Hz, OCH2), 4.80 (q, 1H, J = 
7.5 Hz, CH), 5.15-5.31 (m, 2H, C=CH2), 5.74-5.90 (m, 1H, CH), 13C NMR (75.47 MHz, 
CDCl3): δ = 14.2 (CH3), 29.0, 29.9 (CH2), 60.4 (OCH2), 85.1 (CH), 117.7 (CH2), 132.3 
(C), 135.2 (CH), 155.7 (d, J = 8.66 Hz, CF), 162.2 (d, J = 27.0 Hz, C=O). 19F NMR (235 
MHz, CDCl3): δ = -161.67 (CF). IR (ATR): v = 3467 (w), 2983 (w), 2907 (w), 1747 (m), 
1712 (s), 1665 (s), 1372 (m), 1320 (s), 1187 (s), 1135 (s), 1059 (s), 929 (s), 760 (m) cm−1; 
GC-MS (EI, 70 eV): m/z (%): 200 (M+, 44), 155 (M+, 21), 134 (40), 105 (100), 87 (23), 
67 (44); HRMS (EI) calcd for C10H13O3F [M+]: 200.08432 found 216.084561. 
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(Z)-ethyl 2-(4,5-dimethyldihydrofuran-2(3H)-ylidene)-2-
fluoroacetate (32): Starting with 1,3-Bis-silyl Enol Ether 27
(890 mg, 3 mmole), 2,3-butenoxide (210mg, 0.260 mL, 3 
mmole), TiCl4 (1.13 g, 0.65 mL, 6mmole) and molecular sieves (3g) in CH2Cl2 (23mL) 
32 was obtained as yellow oil (156 mg, 27 %). 1H NMR (250 MHz, CDCl3): δ = 1.43 (d, 
3 H, J = 6.47 Hz, CH3), 1.65 (t, 3H, J = 7.12 Hz, CH3), 1.72 (d, 3H, J = 6.17 Hz, CH3), 
2.28-2.38 (m, 1H, CH2), 2.64-2.96 (m, 1H, CH2), 3.64-3.74 (m, 1H, CH), 4.35-4.46 (m, 
1H, CH), 4.57 (q, 2H, J = 7.3Hz, OCH2). 13C NMR (75.47 MHz, CDCl3): δ = 14.3, 15.9, 
18.6 (CH3), 37.7 (CH2), 39.4 (CH), 60.4 (OCH2), 87.3 (CH), 129.2 (C), 155.6 (d, J = 12.3 
Hz, CF), 162.5 (d, J = 27.8 Hz, C=O). 19F NMR (235 MHz, CDCl3): δ = -163.01 (CF). 
IR (ATR, cm−1): ~ν  = 3435 (w), 2972 (w), 2875 (w), 1739 (s), 1448 (w), 1372 (m), 1297 
(s), 1012 (s), MS (GC, 70 eV): m/z (%): 202 (M+, 98), 157 (59), 136 (48), 108 (100), 87 
(30), 55 (97); HRMS (EI) calcd for C10H15FO3 [M+]: 202.09997, found 202.100294. 
(E)-ethyl 2-fluoro-2-(3-oxoisobenzofuran-1(3H)-ylidene)acetate 
(33): Starting with phthalyl dichloride (500mg, 0.35ml, 2.5 
mmole), 1,3-Bissilylenol Ether 27 (1.12 g, 3.75 mmole), TiCl4 
(270mg, 0.158ml, 2.5mmole), Molecular Sieves 4Å (2.5g) in 
CH2Cl2 (25ml) 33 was obtained ad crystalline solid (330mg, 57%) 
mp. = 96-98 °C. 1H NMR (300 MHz, CDCl3): δ = 1.41 (t, 3 H, J= 7.4 Hz, CH3), 4.40 (q, 
2H, J= 7.1 Hz, OCH2), 7.67-7.72 (m, 1H, ArH), 7.79-7.85 (m, 1H, ArH), 7.89-7.92 (m, 
1H, ArH), 7.98-8.03 (m, 1H, ArH). 13C NMR (75.47 MHz, CDCl3): δ = 14.1 (CH3), 62.2 
(OCH2), 124.1 (C), 125.6, 126.1 (CH), 131.2 (C), 135.5, 136.0 (CH), 142.7 (C), 159.1 (d, 
J = 30.9 Hz, CF), 162.7, 165.0 (C=O). 19F NMR (235 MHz, CDCl3): δ = -153.78 (CF). 
IR (ATR, cm−1): ~ν  = 3098 (w), 2992 (m), 2931 (w), 1850 (m), 1788 (s), 1758 (s), 1673 
(m), 1469 (m), 1285 (m), 1254 (s), 1108 (s), 1006 (s), 901 (s), 710 (s). MS (GC, 70 eV): 
m/z (%): 236 (M+, 45), 208 (12), 191 (12), 164 (100), 135 (14), 107 (37), 76 (17); HRMS 
(EI) calcd for C12H9FO4 [M+]: 236.04794, found 236.047639. 
OMe
Me
F
OEt
O
O
O
OEt
F O
100
General Procedure for the synthesis of Azaxanthones 35a-e. 
General procedure for Azaxanthones 35a-e is same as 18. 
Ethyl 2-fluoro-2-(5-oxo-5H-chromeno[2,3-b]pyridin-
2-yl)acetate (35a): Starting with 3-cyanochromone 33a
(256 mg, 1.5 mmol), Me3SiOTf (433 mg, 0.35 mL, 
1.95 mmol), 27 (602 mg, 1.95 mmol), CH2Cl2
(13.5 mL), EtOH (15 mL), and triethylamine (303 mg, 0.42 mL, 3 mmol), 35a was 
isolated as a white solid (253 mg, 56 %), mp. = 147-148 °C. 1H NMR (250 MHz, 
CDCl3): δ = 1.23 (t, 3 H, J= 7.2 Hz, CH3), 4.18-4.31 (m, 2 H, OCH2), 5.82 (d, 1H, JF, H= 
47.5 Hz, CH), 7.35-7.41 (m, 1H, ArH), 7.54-7.63 (m, 2H, ArH), 7.70-7.77 (m, 1H, ArH), 
8.22 (dd, 1 H, J = 6.4 Hz, J = 1.6 Hz, ArH), 8.72 (d, 1H, J = 8.7 Hz, ArH). 13C NMR 
(62.90 MHz, CDCl3): δ = 14.0 (CH3), 63.1 (OCH2), 88.1-90.6 (d, J = 187 Hz, CF), 116.9 
(C), 118.0 (d, JF,C = 5.28 Hz, CH), 118.5 (CH), 121.5 (C), 124.9, 126.7, 135.9, 138.9 
(CH), 155.6 (C), 158.2 (d, JF,C = 25.0 Hz, C), 159.6 (C), 166.1 (d, JF,C = 25.6 Hz, C=O), 
177.0 (C=O). 19F NMR (235 MHz, CDCl3): δ = -187.79 (CF). IR (ATR, cm−1): ~ν  = 3071 
(w), 2980 (w), 2868 (w), 1757 (s), 1669 (s), 1600 (m), 1397 (s), 1205 (s), 1087 (s), 753 
(s). MS (GC, 70 eV): m/z (%): 301 (M+, 41), 229 (100), 200 (31), 146 (8); HRMS (EI) 
calcd for C16H12FNO4 [M+]: 301.07449, found 301.074205. 
Ethyl 2-(7,8-dimethyl-5-oxo-5H-chromeno[2,3-
b]pyridin-2-yl)-2-fluoroacetate (35b): Starting 
with 6,7-dimethyl-3-cyanochromone 33b
(298 mg, 1.5 mmol), Me3SiOTf (433 mg, 
0.35 mL, 1.95 mmol), 27 (602 mg, 1.95 mmol), CH2Cl2 (13.5 mL), EtOH (15 mL), and 
triethylamine (303 mg, 0.42 mL, 3 mmol), 35b was isolated as a yellow solid (227 mg, 
46 %), mp. = 134-136°C.  1H NMR (250 MHz, CDCl3): δ = 1.27 (t, 3 H, J= 7.3 Hz, 
CH3),    2.34 (s, 3H, CH3), 2.39 (s, 3H, CH3), 4.19-4.38 (m, 2H, OCH2), 5.87 (d, 1H, JF, 
H= 46.9 Hz, CH), 7.32 (s, 1H, ArH), 7.63-7.60 (d, 1H, J= 7.8 Hz, ArH), 7.97 (s, 1H, 
ArH), 8.73 (d, 1H, J = 7.82 Hz, ArH). 13C NMR (62.90 MHz, CDCl3): δ = 13.9, 19.1, 
20.6 (CH3),  62.4 (OCH2), 87.9-90.9 (d, J = 225.9 Hz, CF), 116.9 (C), 117.7, 118.5, 119.2 
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(CH), 126.2 (CH),  134.2 (C), 138.8 (CH), 146.8 (C), 154.1 (C), 157.7 (d, JF,C = 25.1 Hz, 
C), 159.5 (C), 166.2 (d, J = 30.12 Hz, C=O), 176.7 (C=O), 19F NMR (235 MHz, CDCl3): 
δ = -187.93 (CF). IR (ATR, cm−1): ~ν  = 3067 (w), 2958 (w), 2920 (w), 1745 (s), 1658 (s),  
1625 (s), 1602 (s), 1398 (s), 1207 (s), 1089 (s), 761 (m); MS (GC, 70 eV): m/z (%): 329 
(M+, 65), 257 (100), 228 (42), 213 (9); HRMS (EI) calcd for C18H16NFO4 [M+]: 
329.10579, found 329.105736. 
Ethyl 2-(7-chloro-5-oxo-5H-chromeno[2,3-
b]pyridin-2-yl)-2-fluoroacetate (35c): Starting 
with 6-chloro-3-cyanochromone 33c (205 mg, 
1.0 mmol), Me3SiOTf (288 mg, 0.23 mL, 
1.30 mmol), 27 (380 mg, 1.30 mmol), CH2Cl2 (9.0 mL), EtOH (10 mL), and 
triethylamine (202 mg, 0.28 mL, 2 mmol), 35c was isolated as a yellow solid (137 mg, 41 
%), mp. = 135-137°C. 1H NMR (250 MHz, CDCl3): δ = 1.28 (t, 3 H, J= 7.2 Hz, CH3), 
4.23-4.35 (m, 2 H, OCH2), 5.82 (d, 1H, JF, H= 47.8 Hz, CH), 7.54 (d, 1H, J = 9.0 Hz, 
ArH), 7.67-7.74 (m, 2H, ArH), 8.23 (d, 1H, J = 2.7 Hz, ArH), 8.75 (d, 1H, J = 8.7 Hz, 
ArH). 13C NMR (62.90 MHz, CDCl3): δ = 14.0 (CH3), 62.5 (OCH2), 88.0-90.5 (d, J = 
187.8 Hz, CF), 116.5 (C), 118.0 (d, JF,C = 5.23 Hz, CH), 120.2 (CH), 122.3 (C). 126.0 
(CH), 130.8 (C), 135.6, 139.0 (CH), 153.9 (C), 158.2 (d, JF,C = 24.4 Hz, C), 159.4 (C), 
166.1 (d, JF,C = 26.1 Hz, C=O), 176.0 (C=O). 19F NMR (235 MHz, CDCl3): δ = -187.93 
(CF). IR (ATR, cm−1): ~ν  = 3081 (w), 2985 (w), 2941 (w), 1756 (s), 1667 (s), 1601 (s), 
1470 (s), 1434 (s), 1392 (s), 1202 (s), 1086 (s), 825 (m). MS (GC, 70 eV): m/z (%): 337 
(M+, 37Cl, 17), 335 (M+, 35Cl, 52), 263 (100), 234 (24), 180 (5); HRMS (EI) calcd for 
C16H11ClNFO4 [M+, 35Cl]: 335.03552, found 335.035272. 
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Ethyl 2-(7,9-dichloro-5-oxo-5H-chromeno[2,3-
b]pyridin-2-yl)-2-fluoroacetate (35d): Starting 
with 6,8-dichloro-3-cyanochromone 33d (240 mg, 
1.0 mmol), Me3SiOTf (288 mg, 0.23 mL, 
1.30 mmol), 27 (380 mg, 1.30 mmol), CH2Cl2 (9.0 mL), EtOH (10 mL), and 
triethylamine (202 mg, 0.28 mL, 2 mmol), 35d was isolated as a yellow solid (130 mg, 
35 %), mp. = 164-166°C. 1H NMR (250 MHz, CDCl3): δ = 1.29 (t, 3 H, J= 7.2 Hz, CH3), 
4.20-4.39 (m, 2 H, OCH2), 5.90 (d, 1H, JF, H= 47.6 Hz, CH), 7.73 (d, 1H, J = 8.25 Hz, 
ArH), 7.81 (d, 1H, J= 3 Hz, ArH), 8.13 (d, 1H, J= 3 Hz, ArH), 8.74 (d, 1H, J = 8.25 Hz, 
ArH). 13C NMR (62.90 MHz, CDCl3): δ = 13.9 (CH3), 62.6 (OCH2), 88.0-90.5 (d, J = 
188.5 Hz, CF), 116.2 (C), 118.8 (CH), 123.2 (C), 124.6 (CH), 130.5 (2C), 135.7, 139.0 
(CH), 150.0 (C), 159.0 (d, JF,C = 10.2 Hz, C), 159.5 (C), 165.9 (d, J = 26.40 Hz, C=O),
175.4 (C=O), 19F NMR (235 MHz, CDCl3): δ = -187.54 (CF). IR (ATR, cm−1): ~ν  = 3082 
(w), 2987 (w), 2872 (w), 1745 (s), 1668 (s), 1608 (s), 1444 (s), 1238 (s), 1086 (s), 776 
(s); MS (GC, 70 eV): m/z (%): 373 (M+, 2 × 37Cl, 4), 371 (M+, 37Cl, 35Cl, 25), 369 (M+, 2 
× 35Cl, 39), 297 (100), 268 (17); HRMS (EI) calcd for C16H10O4NCl2F [M+, 2 × 35Cl]: 
368.99654 found 368.995651. 
Ethyl 2-fluoro-2-(7-fluoro-5-oxo-5H-
chromeno[2,3-b]pyridin-2-yl)acetate (35e):
Starting with 6-flouro-3-cyanochromone 33e
(184 mg, 1.0 mmol), Me3SiOTf (288 mg, 0.23 mL, 
1.30 mmol), 27 (380 mg, 1.30 mmol), CH2Cl2 (9.0 mL), EtOH (10 mL), and 
triethylamine (202 mg, 0.28 mL, 2 mmol), 35e was isolated as a crystalline solid 
(105 mg, 33 %), mp. = 134-136°C. 1H NMR (250 MHz, CDCl3): δ = 1.28 (t, 3 H, J= 7.2 
Hz, CH3), 4.20-4.39 (m, 2 H, OCH2), 5.87 (d, 1H, JF, H= 47.1 Hz, CH), 7.47-7.54 (m, 1H, 
ArH), 7.59-7.69 (m, 2H, ArH), 7.89-7.94 (m, 1H, ArH), 8.76 (d, 1H, J = 8.0 Hz, ArH). 
13C NMR (62.90 MHz, CDCl3): δ = 13.9 (CH3), 62.5 (OCH2), 88.0-90.5 (d, J = 189.3 Hz, 
CF), 111.4 (d, J = 24.1 Hz, CH), 116.5 (C), 118.1 (d, JF,C = 5.0 Hz, CH), 120.5 (d, JF,C = 
5.0 Hz, CH), 122.4 (d, JF,C = 7.5 Hz, C), 123.7 (d, JF,C = 25.2 Hz, CH), 138.9 (CH), 151.7 
(C), 157.5 (C), 158.5 (d, JF,C = 24.4 Hz, C), 159.3 (C), 160.7 (C=O), 165.0 (d, J = 27.9 
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Hz, C=O). 19F NMR (235 MHz, CDCl3): δ = -115.30, -187.93 (CF). IR (ATR, cm−1): 
~ν  = 3072 (w), 2978 (w), 2926 (w), 1752 (s), 1672 (s), 1592 (s), 1566 (m), 1484 (s), 1447 
(s), 1395 (s), 1243 (m), 1208 (s), 1140 (s), 888 (m) MS (GC, 70 eV): m/z (%): 319 (M+, 
42), 247 (52), 218 (26), 164 (7); HRMS (EI) calcd for C16H11NF2O4 [M+]: 319.06507, 
found 319.065232. 
Diethyl 2-chloro-3-oxopentanedioate (40): Starting with 
LDA (22 mmole), 36 (1.64g, 0.91 mL, 10 mmoles) and 
ethylchloroformate (1.19g, 1.05 mL, 11 mmole) at -78°C, 40 
was obtained as yellow oil (639 mg, 27%). 1H NMR (250 MHz, CDCl3): δ = 1.20-1.34 
(m, 6H, CH3), 3.50-3.80 (m, 2H, CH2), 4.12-4.29 (m, 4H, OCH2), 4.98 (s, 1H, CH). 
13C NMR (75.47 MHz, CDCl3): δ = 13.6 (2C, CH3), 45.1 (CH2), 60.4 (CH), 61.6 (OCH2), 
63.0 (OCH2), 164.1, 165.7, 191.4 (C=O). IR (ATR, cm−1): ~ν  = 2984 (m), 2940 (w), 2875 
(w), 1727 (s), 1651 (w), 1446 (w), 1369 (m), 1245 (s), 1019 (s). MS (ESI-TOF/MS): 
(ESI+) C9H13ClNaO5 (M+Na)+ 259.03463. (ESI-) C9H12ClO5 (M-H)- 235.03787.  
(E)-ethyl 4-chloro-5-hydroxy-3-oxohex-4-enoate (41): Starting 
with LDA (110 mmole), 39 (6.72g, 5.56 mL, 50 mmoles) and 
ethylchloroformate (2.7g, 2.40 mL, 25 mmole) at -78°C, 41 was 
obtained as yellow oil (3.82g, 37%). 1H NMR (250 MHz, CDCl3): δ = 1.26 (t, 3H, J = 7.0 
Hz, CH3), 2.25 (s, 3H, CH3), 3.59 (s, 2H, OCH2), 4.12 (q, 1H, J = 7.4 Hz, OCH2), 14.99 
(s, 1H, OH). 13C NMR (62.9 MHz, CDCl3): δ = 14.0, 23.4 (CH3), 43.4 (CH2), 61.7 
(OCH2), 108.2 (C), 166.8 (CO), 184.5, 188.4 (C=O). IR (ATR, cm−1): ~ν  = 2978 (m), 
2936 (w), 2874 (w), 1739 (s), 1687 (m), 1590 (m), 1367 (m), 1253 (s), 1146 (s), 1029 (s), 
903 (M). MS (GC, 70 eV): m/z (%): 208 (M+, 37Cl, 5), 206 (M+, 35Cl, 11), 164 (28), 160 
(49), 132 (72), 119 (62), 43 (100); HRMS (EI) calcd for C8H11ClO4 [M+, 35Cl]: 
206.03404, found 256.034290. 
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Ethyl 2,6-dichloro-5-methoxy-3-oxohexanoate (42): 
Starting with 1,3-Bis-silyl Enol Ether 38 (0.772 g, 2.5 
mmoles), 1-chloro-2,2-dimethoxyethane (0.28 mL, 2.5 
mmole)  and Me3SiOTf (0.22 mL, 1.25 mmole) in CH2Cl2 (10ml), 42 was isolated as 
yellow oil (460 mg, 72%). 1H NMR (250 MHz, CDCl3): δ = 1.25 (t, 3 H, J = 7.2 Hz, 
CH3), 2.94-3.04 (m, 2H, CH2),  3.34 (s, 3H, OCH3), 3.55-3.57 (m, 2H, CH2), 3.84-3.92 
(m, 1H, CH), 4.21 (q, 1H, J = 7.2 Hz, OCH2), 4.80 (d, 1H, J = 2.2 Hz, CH). 13C NMR 
(62.90 MHz, CDCl3): δ = 13.7 (CH3), 41.4, 44.4 (CH2), 57.5 (OCH3), 61.3 (CH), 63.0 
(OCH2), 75.9 (CH), 164.4, 196.5 (C=O). IR (ATR, cm−1): ~ν  = 2984 (w), 2938 (w), 2831 
(w), 1727 (s), 1446 (s), 1369 (m), 1117 (m), 1095 (s), 1017 (s), 748 (m). MS (GC, 70 
eV): m/z (%): 258 (M+, 37Cl, 5), 256 (M+, 35Cl, 4), 207 (21), 135 (50), 93 (100), 85 (43), 
71 (16); HRMS (EI) calcd for C9H14Cl2O4 [M+, 35Cl]: 256.02637, found 256.026928. 
(Z)-ethyl 2-chloro-2-(4-methoxydihydrofuran-2(3H)-
ylidene)acetate (43): Starting with 42 (300 mg, 1.16 mmole) 
and DBU (0.35 ml, 2.32 mmole) in 4 ml of THF, 43 was 
isolated as yellow oil (188 mg, 73%). 1H NMR (250 MHz, CDCl3): δ = 1.32 (t, 3 H, J= 
7.0 Hz, CH3), 3.02-3.12 (m, 1H, CH2), 3.32 (s, 3H, OCH3), 3.49-3.56 (m, 1H, CH2), 4.19 
(q, 2 H, J = 7.0 Hz, OCH2), 4.25-4.33 (m, 2H, CH2), 4.48-4.52 (m, 1H, CH). 13C NMR 
(75.47 MHz, CDCl3): δ = 14.1 (CH3), 38.1 (CH2), 56.2 (OCH3), 60.9 (OCH2), 76.6 
(CH2), 78.2 (CH), 96.2, 164.0 (C), 168.0 (C=O). IR (ATR, cm−1): ~ν  = 2922 (m), 2852 
(w), 1737 (w), 1697 (m), 1623 (s), 1461 (m), 1367 (m), 1280 (s), 1214 (s), 1077 (s), 950 
(m). MS (GC, 70 eV): m/z (%): 222 (M+, 37Cl, 16), 220 (M+, 35Cl, 46), 188 (84), 175 (52), 
161 (100), 143 (62), 125 (40); HRMS (EI) calcd for C9H13ClO4 [M+, 35Cl]: 220.04969, 
found 220.050278. 
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Ethyl 6-azido-2-chloro-5-methoxy-3-oxohexanoate (44): 
Starting with 1,3-Bis-silyl Enol Ether 38 (0.772 g, 2.5 
mmoles), 1-azido-2,2-dimethoxyethane (420mg, 3.25 
mmole)  and Me3SiOTf (0.14 mL, 0.38 mmole) in CH2Cl2 (25ml), 44 was isolated as 
yellow oil (690 mg, 82%). 1H NMR (250 MHz, CDCl3): δ = 1.25 (t, 3 H, J = 7.2 Hz, 
CH3), 2.73-2.84 (m, 1H, CH2),  2.92-3.08 (m, 1H, CH2), 3.16-3.24 (m, 1H, CH2), 3.34 (s, 
3H, OCH3), 3.37-3.44 (m, 1H, CH2), 3.76-3.85 (m, 1H, CH), 4.21 (q, 2H, J = 7.2 Hz, 
OCH2), 4.81 (d, 1H, J = 2.2 Hz, ArH). 13C NMR (75.47 MHz, CDCl3): δ = 13.7 (CH3), 
41.0, 52.5 (CH2), 57.5 (OCH3), 61.2 (CH), 63.0 (OCH2), 75.7 (CH), 164.4, 196.2 (C=O). 
IR (ATR, cm−1): ~ν  = 2983 (w), 2932 (w), 2833 (w), 2098 (s), 1726 (s), 1643 (w), 1607 
(w), 1369 (w), 1250 (s), 1019 (s). MS (EI, 70 eV): m/z (%): 265 (M+, 37Cl, 2), 263 (M+, 
35Cl, 4), 207 (33), 85 (100). HRMS (EI) calcd for C9H14ClN3O4 [M+, 35Cl]: 263.06674, 
found 263.066749. 
(Z)-ethyl 2-chloro-2-(5-vinyldihydrofuran-2(3H)-
ylidene)acetate (45): Starting with LDA (62.5 mmoles), 36 
(3.51 mL, 25 mmole) and trans-1,2-dibromo butene (6.41g , 
30 mmole) at    -78°C 45 was isolated as light yellow oil (3.5g, 65%). 1H NMR (250 
MHz, CDCl3):  δ = 1.21 (t, 3H, J = 7.5 Hz, CH3), 1.77-1.92 (m, 1H, CH2), 2.18-2.32 (m, 
1H, CH2),  2.92-3.06 (m, 1H, CH2), 3.12-3.25 (m, 1H, CH2), 4.34 (q, 2 H, J = 7.5 Hz, 
OCH2), 4.84 (q, 1H, J = 7.5 Hz, CH),  5.13-5.29 (m, 2 H, C=CH2), 5.72-5.85 (m, 1H, 
CH), 13C NMR (75.47 MHz, CDCl3): δ = 14.1 (CH3), 30.1, 31.6 (CH2), 60.8 (CH2), 85.2 
(CH), 95.4 (C), 117.9 (CH2), 135.0 (CH), 164.15 (C), 169.4 (C=O); IR (ATR): v = 3087 
(w), 2982 (w), 2905 (w), 1744 (w), 1695 (s), 1614 (s), 1367 (m), 1275 (s), 1225 (s), 1059 
(s), 936 (s) cm−1; GC-MS (EI, 70 eV): m/z (%): 218 (M+, 37Cl, 16), 216 (M+, 35Cl, 49), 
171 (31), 149 (35), 135 (69), 121 (100), 103 (34); HRMS (EI) calcd for C10H13O3Cl 
[M+]: 216.05477 found 216.054810. 
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(Z)-ethyl 2-chloro-2-(4,5-dimethyldihydrofuran-2(3H)-
ylidene)acetate (46):  Starting with 1,3-Bis-silyl Enol Ether 38
(926 mg, 3 mmoles), 2,3-butenoxide (210mg, 0.260 mL, 3 mmole), 
TiCl4 (1.13 g, 0.65 mL, 6mmole) and molecular sieves (3g) in CH2Cl2 (23mL) 46 was 
obtained as yellow oil (237mg, 37 %). 1H NMR (250 MHz, CDCl3): δ = 1.03 (d, 3H, J = 
7.5 Hz, CH3), 1.23 (t, 3H, J = 7.5 Hz, CH3), 1.34 (d, 3H, J = 7.5 Hz, CH3), 1.93-2.06 (m, 
1H, CH2), 2.52-2.63 (m, 1H, CH),  3.42-3.52 (m, 1H, CH2), 4.03-4.11 (m, 1H, CH),  4.12 
(q, 2 H, J = 7.5 Hz, OCH2), 13C NMR (75.47 MHz, CDCl3): δ = 14.2, 16.0, 18.6 (CH3), 
39.8 (CH), 40.55 (CH2), 60.9 (OCH2), 87.3 (CH), 94.9, 164.5 (C), 169.2 (C=O); IR 
(ATR): v = 2974 (w), 2933 (w), 1743 (w), 1695 (m), 1615 (s), 1386 (m), 1277 (s), 1232 
(s), 1061 (s), 958 (m) cm−1; GC-MS (EI, 70 eV): m/z (%): 220 (M+, 37Cl, 31), 218 (M+, 
35Cl, 97), 203 (30), 173 (62), 157 (37), 137 (55), 55 (100); HRMS (EI) calcd for 
C10H15O3Cl [M+]: 218.07042 found 218.070647. 
(Z)-ethyl 2-(5-(bromomethyl)dihydrofuran-2(3H)-
ylidene)-2-chloroacetate (47): Starting with 1,3-Bis-silyl 
Enol Ether 38 (772 mg, 2.5 mmoles), epibromohydrin 
(342mg, 0.200 mL, 2.5 mmole), TiCl4 (948 mg, 0.54 mL, 5mmole) and molecular sieves 
(3g) in CH2Cl2 (38mL) 47 was obtained as yellow oil (335mg, 47 %).1H NMR (250 
MHz, CDCl3):  = 1.27 (t, J = 7.5 Hz, 3 H, CH3), 1.97-2.12 (m, 1H, CH2), 2.29-2.42 (m, 
1H, CH2), 3.01-3.15 (m, 1H, CH2), 3.24-3.35 (m, 1H, CH2), 3.47-3.52 (m, 1H, CH2), 
3.24-3.35 (m, 1H, CH2), 3.83-3.94 (m, 1H, CH), 4.14 (q, 2 H, J = 7.5 Hz, OCH2), 4.70-
4.80 (m, 1H, CH2); 13C NMR (62 MHz, CDCl3):  = 14.4 (CH3), 28.8, 32.0, 33.2 (CH2),  
61.5 (OCH2), 83.1 (CH), 96.3, 164.4 (C),  169.4 (C=O); IR (ATR): v = 3435 (w), 2979 
(w), 2936 (w), 1737 (m), 1618 (m), 1279 (m), 1282 (s), 1067 (s), 1232 (s), 1067 (s), 940 
(m) cm−1; GC-MS (GC, 70 eV): m/z (%): 286 (M+, 37Cl, 81Br, 18), 284 (M+, 35Cl, 81Br, 
71), 282 (M+, 35Cl, 79Br, 51), 218 (M+, 35Cl, 97), 238 (100), 203 (22), 175 (45), 157 (55), 
121 (58), 103(48); HRMS (EI) calcd for C9H12O3BrCl [M+, 35Cl, 81Br]: 283.96324 found 
283.963505. 
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(E)-ethyl2-chloro-2-(5-(chloromethyl)dihydrofuran-2(3H)-
ylidene)acetate (48): Starting with 1,3-Bis-silyl Enol Ether 38
(1.54 g, 5 mmoles), epichlorohydrin (550mg, 0.47 mL, 6 
mmole), TiCl4 (1.89 g, 1.09 mL, 10mmole) and molecular sieves (5g) in CH2Cl2 (38mL) 
48 was obtained as yellow oil (72 mg, 17 %). 1H NMR (250 MHz, CDCl3):  = 1.27 (t, J 
= 7.5 Hz, 3 H, CH3), 1.91-2.06 (m, 1H, CH2), 2.16-2.30 (m, 1H, CH2), 3.18-3.03 (m, 2H, 
CH2), 3.59-3.72 (m, 2H, CH2), 4.17 (q, 2 H, J = 7.5 Hz, OCH2), 4.82-4.93 (m, 1H, CH); 
13C NMR (62 MHz, CDCl3):  = 14.6 (CH3), 25.9, 32.9, 45.5 (CH2),  61.4 (OCH2), 86.1 
(CH),  98.2, 162.6 (C),  168.4 (C=O); IR (ATR): v = 2981 (w), 2938 (w), 1740 (m), 1698 
(m), 1618 (m), 1369 (w), 1280 (s), 1183 (s), 1068 (s), 940 (m) cm−1; MS (GC, 70 eV): 
m/z (%): 242 (M+, 2 × 37Cl, 5), 240 (M+, 37Cl, 35Cl, 28), 238 (M+, 2 × 35Cl, 46), 210 (10), 
194 (68), 192 (100), 175 (15), 157 (35), 147 (19), 103 (35); HRMS (EI) calcd for 
C9H12O3Cl2 [M+, 2 × 35Cl]: 238.01580 found 238.015571. 
(Z)-ethyl 2-chloro-2-(5-(chloromethyl)dihydrofuran-
2(3H)-ylidene)acetate  (48): Starting with 1,3-Bis-silyl 
Enol Ether 38 (1.54 g, 5 mmoles), epichlorohydrin (550mg, 
0.47 mL, 6 mmole), TiCl4 (1.89 g, 1.09 mL, 10mmole) and molecular sieves (5g) in 
CH2Cl2 (38mL) 48 was obtained as yellow oil (136 mg, 32 %). 1H NMR (250 MHz, 
CDCl3):  = 1.27 (t, J = 7.5 Hz, 3 H, CH3), 2.00-2.15 (m, 1H, CH2), 2.25-2.39 (m, 1H, 
CH2), 3.02-3.30 (m, 2H, CH2), 3.65-3.67 (m, 2H, CH2), 4.14 (q, 2 H, J = 7.5 Hz, OCH2), 
4.72-4.82 (m, 1H, CH); 13C NMR (62 MHz, CDCl3):  = 14.3 (CH3), 27.4, 31.8, 45.2 
(CH2),  61.1 (OCH2), 82.9 (CH), 95.8, 164.3 (C),  169.0 (C=O); IR (ATR): v = 3434 (w), 
2981 (w), 2939 (w), 1742 (m), 1697 (m), 1618 (s), 1368 (w), 1279 (s), 1185 (w), 1067 
(s), 940 (m) cm−1; MS (GC, 70 eV): m/z (%): 242 (M+, 2 × 37Cl, 5), 240 (M+, 37Cl, 35Cl, 
29), 238 (M+, 2 × 35Cl, 45), 210 (12), 194 (69), 192 (100), 175 (13), 157 (33), 147 (18), 
103 (31); HRMS (EI) calcd for C9H12O3Cl2 [M+, 2 × 35Cl]: 238.01580 found 238.016442. 
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Ethyl 2-chloro-2-(9-oxo-9H-xanthen-3-yl)acetate 
(51a): Starting with 3-cyanochromone 49a (256 mg, 
1.5 mmol), Me3SiOTf (433 mg, 0.35 mL, 1.95 mmol), 
38 (602 mg, 1.95 mmol), CH2Cl2 (13.5 mL), EtOH 
(15 mL), and triethylamine (303 mg, 0.42 mL, 3 mmol), 51a was isolated as a yellow 
solid (276 mg, 58 %), mp. = 91-93 °C. 1H NMR (250 MHz, CDCl3): δ = 1.29 (t, 3 H, J= 
7.2 Hz, CH3), 4.25 (q, 2 H, J = 6.8 Hz, OCH2), 5.56 (s, 1H, CH), 7.41 (t, 1H, J = 7.9 Hz, 
ArH), 7.59 (d, 1 H, ArH), 7.73-7.82 (m, 2 H, ArH), 8.34 (dd, 1 H, J = 6.4 Hz, J = 1.6 Hz, 
ArH), 8.76 (d, 1H, J = 8.8 Hz, ArH). 13C NMR (62.90 MHz, CDCl3): δ = 13.9 (CH3), 
58.9 (CH), 63.1 (OCH2), 116.5 (C), 118.5, 119.8 (CH), 121.5 (C), 124.9, 126.7 135.8, 
138.9 (CH), 155.6, 159.3, 159.8 (C), 166.6, 176.9 (C=O). IR (ATR, cm−1): ~ν  = 2962 (w), 
2925 (w), 2853 (w), 1747 (m), 1664 (s), 1598 (s), 1462 (m), 1403 (s), 1317 (m), 1182 (s), 
1022 (s), 805 (m), 750 (s). MS (GC, 70 eV): m/z (%): 319 (M+, 37Cl, 11), 317 (M+, 35Cl, 
32), 283 (11), 245 (100), 211 (27), 182 (11), 126 (8); HRMS (EI) calcd for C16H12ClNO4
[M+, 35Cl]: 317.04494, found 317.045352. 
Ethyl 2-chloro-2-(7-chloro-9-oxo-9H-xanthen-3-
yl)acetate (51b): Starting with 6-chloro-3-
cyanochromone 51b (205 mg, 1 mmol), Me3SiOTf 
(288 mg, 0.23 mL, 1.3 mmol), 38 (400 mg, 
1.3 mmol), CH2Cl2 (9 mL), EtOH (10 mL), and triethylamine (202 mg, 0.28 mL, 
2 mmol), 51b was isolated as a yellow solid (210 mg, 60%), mp. = 89-92 °C. 1H NMR 
(250 MHz, CDCl3): δ = 1.27 (t, 3 H, J= 7.2 Hz, CH3), 4.21 (q, 2 H, J = 7.1 Hz, OCH2), 
5.53 (s, 1H, CH), 7.53 (d, 1H, J = 8.8 Hz, ArH), 7.68-7.76 (m, 2H, ArH), 8.22 (d, 1 H, 
J = 2.6 Hz, ArH), 8.72 (d, 1H, J = 8.2 Hz, ArH). 13C NMR (75.47 MHz, CDCl3): δ = 14.0 
(CH3), 58.8 (CH), 63.1 (OCH2), 116.1 (C), 120.1 (CH), 122.5 (C), 126.1 (CH), 130.8 (C), 
135.8, 138.9 (CH), 154.0, 159.2, 160.2 (C), 166.6, 175.9 (C=O). IR (ATR, cm−1): 
~ν  = 3076 (w), 2982 (w), 2929 (w), 1728 (s), 1662 (s), 1600 (s), 1466 (m), 1432 (s), 1392 
(s), 1186 (s), 1019 (m), 752 (s). MS (EI, 70 eV): m/z (%): 353 (M+, 37Cl, 35Cl, 7), 351 
(M+, 2 × 35Cl, 32), 317 (33), 279 (47), 245 (100), 216 (20), 69 (16); HRMS (EI) calcd for 
C16H11Cl2NO4 [M+, 35Cl]: 351.00596, found 351.006048. 
O N
O
OEt
O
Cl
O N
O
OEt
O
Cl
Cl
109
Ethyl 2-chloro-2-(7-fluoro-9-oxo-9H-xanthen-3-
yl)acetate (51c): Starting with 6-fluoro-3-
cyanochromone 49c (189 mg, 1 mmol), Me3SiOTf 
(288 mg, 0.23 mL, 1.3 mmol), 38 (400 mg, 
1.3 mmol), CH2Cl2 (9 mL), EtOH (10 mL), and triethylamine (202 mg, 0.28 mL, 
2 mmol), 51c was isolated as a yellow solid (200 mg, 60%), mp. = 113-116 °C. 1H NMR 
(250 MHz, CDCl3): δ = 1.28 (t, 3 H, J= 7.2 Hz, CH3), 4.23 (q, 2 H, J = 7.0 Hz, OCH2), 
5.54 (s, 1H, CH), 7.46-7.63 (m, 2H, ArH), 7.74 (d, 1 H, J = 7.6 Hz, ArH), 8.34 (dd, 1 H, 
J = 6.9 Hz, J = 1.8 Hz, ArH), 8.72 (d, 1H, J = 7.5 Hz, ArH). 13C NMR (75.47 MHz, 
CDCl3): δ = 13.9 (CH3), 58.9 (CH), 63.2 (OCH2), 111.4 (CH), 115.6 (C), 119.9, 120.5 
(CH) 122.5 (C), 123.7, 138.8 (CH), 151.7, 157.4, 159.1, 160.0 (C), 166.4, 176.3 (C=O). 
IR (ATR, cm−1): ~ν  = 3053 (w), 2982 (w), 2943 (w), 1729 (s), 1663 (s), 1604 (m), 1486 
(s), 1448 (s), 1299 (s), 1190 (s), 1021 (m), 832 (s). MS (EI, 70 eV): m/z (%): 337 (M+, 
37Cl, 7), 335 (M+, 35Cl, 11), 301 (34), 263 (40), 229 (100), 200 (21), 69 (36); HRMS (EI) 
calcd for C16H11ClNFO4 [M+, 35Cl]: 335.03552, found 335.035168. 
Ethyl 2-chloro-2-(5,7-dichloro-9-oxo-9H-
xanthen-3-yl)acetate (51d): Starting with 6,8-
dichloro-3-cyanochromone (49d) (240 mg, 1 
mmol), Me3SiOTf (288 mg, 0.23 mL, 1.3 mmol), 
38 (400 mg, 1.3 mmol), CH2Cl2 (9 mL), EtOH (10 mL), and triethylamine (202 mg, 
0.28 mL, 2 mmol), 51d was isolated as a yellow solid (149 mg, 39%), mp. = 103-106 °C. 
1H NMR (250 MHz, CDCl3): δ = 1.28 (t, 3 H, J= 7.2 Hz, CH3), 4.23 (q, 2 H, J = 7.1 Hz, 
OCH2), 5.57 (s, 1H, CH), 7.79-7.82 (m, 2H, ArH), 8.12 (d, 1 H, J = 1.8 Hz, ArH), 8.71 
(d, 1H, J = 7.5 Hz, ArH). 13C NMR (75.47 MHz, CDCl3): δ = 13.9 (CH3), 58.7 (CH), 
63.2 (OCH2), 115.7 (C), 120.7 (CH) 123.5 (C), 124.7 (CH), 130.5 (C), 135.7, 138.9 
(CH), 150.1, 158.7, 160.7, (C), 166.6, 175.5 (C=O). IR (ATR, cm−1): ~ν  = 3076 (w), 2979 
(w), 2914 (w), 1722 (s), 1662 (s), 1607 (s), 1558 (m), 1386 (s), 1301 (m), 1180 (s), 1019 
(m), 727 (s). MS (EI, 70 eV): m/z (%): 387 (M+, 37Cl, 5), 385 (M+, 35Cl, 5), 353 (21), 313 
(20), 279 (100), 250 (12), 97 (18); HRMS (EI) calcd for C16H10Cl3NO4 [M+, 35Cl]: 
384.96699, found 384.966901. 
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Dimethyl 4-chloro-3,5-dihydroxyphthalate (52): Starting with 
38 (463mg, 1.5 mmol and DMAD (319mg, 0.27 mL, 2.25 
mmol) 52 was isolated as crystalline solid (460, 54 %), mp. = 
127-129 °C. 1H NMR (250 MHz, CDCl3): δ = 3.82 (s, 3 H, 
OCH3), 3.85 (s, 3 H, OCH3), 6.57 (s, 1H, OH), 6.57 (s, 1H, ArH), 11.55 (s, 1H, OH). 
13C NMR (62.90 MHz, CDCl3): δ = 52.8 (OCH3), 53.0 (OCH3), 103.5 (C), 107.5 (CH), 
109.3, 135.0 (C), 156.6, 158.7 (C-OH), 168.6, 169.0 (C=O). IR (ATR, cm−1): ~ν  = 2984 
(w), 2954 (w), 2905 (w), 2847 (w), 1792 (w), 1722 (s), 1668 (m), 1435 (m), 1328 (m), 
1243 (s), 1067 (s), 844 (m). MS (EI, 70 eV): m/z (%): 262 (M+, 37Cl, 9), 260 (M+, 35Cl, 
15), 228 (53), 198 (23), 170 (100), 153 (23), 89 (25); Anal.: calcd (%) for C10H9ClO6: C 
46.08, H 3.48; found: C 46.21, H 3.31. 
Ethyl-3-chloro-2-hydroxy-5-(2-
hydroxybenzoyl)benzoate (57a): Starting with 3-
formylchromone 56a (261 mg, 1.5 mmol), 1,3-
bis(silyl enol ether) 55b (602 mg, 1.95 mmol), and 
Me3SiOTf (0.08 mL, 0.45 mmol), 57a was isolated as a colourless crystalline solid (200 
mg, 42%), mp. = 117-118 °C; 1H NMR (300 MHz, CDCl3): δ = 1.33 (t, J = 7.1 Hz, 3 H, 
CH3), 4.36 (q, 2 H, J = 7.0 Hz, 14.2 Hz, OCH2), 6.83 (m, 1 H, ArH), 6.96 (d, 1 H, J = 8.3 
Hz, ArH), 7.40-7.47 (m, 2 H, ArH), 7.82 (d, 1 H, J = 2.25 Hz, ArH), 7.68 (d, J = 2.3 Hz, 
1 H, ArH), 8.08 (d, J = 2.43 Hz, 1 H, ArH), 11.60 (s, 1 H, OH), 11.80 (s, 1 H, OH); 13C 
NMR (62.9 MHz, CDCl3): δ = 14.0 (CH3), 62.6 (OCH2), 113.4, 118.6 (C), 118.6, 118.9 
(CH), 122.7, 129.0 (C), 130.2, 132.7, 136.2, 136.5(CH), 160.3, 163.0 (C-OH), 169.3, 
197.8 (C=O); IR (neat): ν~ = 3086 (w), 2991(m), 2962 (w), 1720 (w), 1680 (s), 1622 (s), 
1567 (m), 1444 (m), 1374 (m), 1337 (s), 1239 (s), 1014 (m) cm−1; MS (GC, 70 eV): m/z
(%): 322 (M+, 37Cl, 26), 320 (M+, 75), 274 (34), 181 (21), 154 (39), 121 (100); HRMS 
(EI) calcd for C16H13ClO5 [M+, 35Cl]: 320.04460, found 320.044647. 
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Ethyl-3-chloro-2-hydroxy-5-(2-hydroxy-5-
methylbenzoyl)benzoate (57b): Starting with 6-
methyl-3-formylchromone 56b (282 mg, 1.5 mmol), 
1,3-bis(silyl enol ether) 55b (602 mg, 1.95 mmol), 
and Me3SiOTf (0.08 mL, 0.45 mmol), 57b was isolated as a colourless crystalline solid 
(201 mg, 40 %), mp. = 142-144 °C; 1H NMR (250 MHz, CDCl3): δ = 1.35 (t, J = 7.1 Hz, 
3 H, CH3), 2.21 (s, 3 H, CH3), 4.36 (q, 2 H, J = 7.0 Hz, 14.2 Hz, OCH2), 6.89 (d, 1 H, J = 
8.3 Hz, ArH), 6.96 (d, 1 H, J = 8.3 Hz, ArH), 7.24-7.29 (m, 2 H, ArH), 7.85 (d, 1 H, J = 
2.1 Hz, ArH), 8.10 (d, J = 2.1 Hz, 1 H, ArH), 11.43 (s, 1 H, OH), 11.81 (s, 1 H, OH); 13C 
NMR (62 MHz, CDCl3): δ = 14.0 (CH3), 20.5 (CH3), 62.6 (OCH2), 113.4, 118.0 (C), 
118.4 (CH), 122.7, 128.0, 129.2 (C), 130.2, 132.3, 136.1, 137.5 (CH), 160.2, 160.9 (C-
OH), 169.3, 197.7 (C=O); IR (neat): ν~ = 3065 (w), 2993 (w), 2856 (w), 1679 (s), 1627 
(s), 1581 (s), 1482 (m), 1375 (m), 1338 (s), 1288 (s), 1210 (s), 786 (s) cm−1; MS (GC, 70 
eV): m/z (%): 336 (M+, 37Cl, 13), 334 (M+, 37), 288 (11), 181 (9), 134 (100), 77 (11); 
HRMS (EI) calcd for C17H15ClO5 [M+, 35Cl]: 334.06025, found 334.060293.     
Ethyl-3-chloro-2-hydroxy-5-(2-hydroxy-5-
nitrobenzoyl)benzoate (57c): Starting with 6-nitro-
3-formylchromone 56c (219 mg, 1 mmol), 1,3-
bis(silyl enol ether) 55b (401 mg, 1.3 mmol), and 
Me3SiOTf (0.05 mL, 0.3 mmol), 57c was isolated as a  yellowish solid (141 mg, 39 %), 
mp. = 159-161 °C; 1H NMR (250 MHz, CDCl3): δ = 1.34 (t, J = 7.1 Hz, 3 H, CH3), 4.36 
(q, 2 H, J = 7.2 Hz, 14.2 Hz, OCH2), 7.12 (d, 1 H, J = 9.3 Hz, ArH), 7.93 (d, 1 H, J = 
2.62 Hz, ArH), 8.14 (d, 1 H, J = 2.35 Hz, ArH), 8.32 (dd, 1 H, J = 3.0, 9.3 Hz, ArH), 8.50 
(d, 1 H, J = 2.5 Hz, ArH), 11.99 (s, 1 H, OH), 12.29 (s, 1 H, OH); 13C NMR (62 MHz, 
CDCl3): δ = 14.0 (CH3), 62.9 (OCH2), 113.6, 117.5 (C), 119.7 (CH),  123.8, 127.4 (C), 
128.7, 130.5, 131.0, 136.0 (CH), 139.5 (C), 161.3, 167.7 (C-OH), 169.1, 196.6 (C=O); IR 
(neat, cm−1): ν~ = 2919 (m), 2850 (w), 1682 (m), 1632 (m), 1460 (m), 1336 (s); MS (GC, 
70 eV): m/z (%): 367 (M+, 37Cl, 21), 365 (M+, 77), 329 (7), 319 (100), 283 (16), 154 (58); 
HRMS (EI) calcd for C16H12NClO7 [M+, 35Cl]: 365.02919, found 365.029150.       
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Ethyl-5-(5-bromo-2-hydroxybenzoyl)-3-chloro-2-
hydroxybenzoate (57d): Starting with 6-bromo-3-
formylchromone 56d (253 mg, 1 mmol), 1,3-bis(silyl 
enol ether) 55b (401 mg, 1.3 mmol), and Me3SiOTf 
(0.05 mL, 0.3 mmol), 57d was isolated as a yellowish solid (140 mg, 36 %), mp. = 133-
135 °C; 1H NMR (250 MHz, CDCl3): δ = 1.36 (t, J = 7.2 Hz, 3 H, CH3), 4.37 (q, 2 H, J = 
7.2 Hz, 14.2 Hz, OCH2), 6.90 (d, 1 H, J = 8.8 Hz, ArH), 7.51-7.60 (m, 2 H, ArH), 7.8 (d, 
1 H, J = 2.1 Hz, ArH), 8.09 (d, 1 H, J = 2.1 Hz, ArH), 11.50 (s, 1 H, OH), 11.88 (s, 1 H, 
OH); 13C NMR (62 MHz, CDCl3): δ = 14.0 (CH3), 62.7 (OCH2), 110.4, 113.5, 119.8, (C), 
120.7 (CH), 123.2, 128.3 (C), 130.4, 134.5, 136.0, 139.1 (CH), 160.8, 161.9 (C-OH), 
169.2, 196.6 (C=O);  IR (neat, cm−1): ν~ = 3068 (w), 2917 (w), 1686 (s), 1625 (s), 1595 
(s), 1567 (s), 1343 (s), 1164 (s), 681 (s); MS (GC, 70 eV): m/z (%): 401 (M+, 37Cl, 12), 
399 (M+, 77), 354 (33), 200 (100), 198 (75), 154 (67); HRMS (EI) calcd for 
C16H12BrClO5 [M+, 35Cl, 81Br]: 399.95307, found 399.952332.   
3-chloro-2-(2-oxobutyl)-5H-chromeno[2,3-b]pyridin-
5-one (60a): Starting with 3-cyanochromone (58a) 
(256 mg, 1.5 mmol), Me3SiOTf (433 mg, 0.35 mL, 
1.95 mmol), 55b (602 mg, 1.95 mmol), CH2Cl2
(13.5 mL), EtOH (15 mL), and triethylamine (303 mg, 0.42 mL, 3 mmol), 60a was 
isolated as a yellow solid (276 mg, 58 %), mp. = 110-114 °C. 1H NMR (250 MHz, 
CDCl3): δ = 1.40 (t, 3 H, J= 7.0 Hz, CH3), 4.40 (q, J = 7.6 Hz, 2 H, OCH2), 5.14 (s, 2 H, 
CH2), 7.38-7.45 (m, 1 H, ArH), 7.56-7.50 (m, 1 H, ArH), 8.34 (dd, 1 H, J = 7.6 Hz, J = 
1.4 Hz, ArH), 9.22 (s, 1 H, ArH). 13C NMR (75.47 MHz, CDCl3): δ = 14.2 (CH3), 44.6 
(CH2), 62.2 (OCH2), 115.7 (C), 118.6 (CH), 121.6, 123.0 (C), 125.4, 126.9, 141.6, (CH), 
155.5, 162.4 (C), 164.0, 176.5 (C=O). IR (neat, cm−1): ~ν  = 2979 (w), 1715 (m), 1673 
(m), 1596 (s), 1425 (m), 1308 (w), 1262 (s), 1213 (m), 1067 (m), 763 (m). MS (GC, 70 
eV): m/z (%): 319 (M+, 37Cl, 34), 317 (M+, 100), 289 (49), 283 (14), 274 (25), 272 (58), 
254 (89); HRMS (EI) calcd for C16H12ClNO4 [M+, 35Cl]: 317.04579, found 317.045442.      
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3-chloro-7,8-dimethyl-2-(2-oxobutyl)-5H-
chromeno[2,3-b]pyridin-5-one (60b): Starting 
with 6,7-dimethyl-3-cyanochromone (58b) 
(290 mg, 1.5 mmol), Me3SiOTf (433 mg, 
0.350 mL, 1.95 mmol), 55b (602 mg, 1.95 mmol), CH2Cl2 (13.5 mL), EtOH (15 mL), 
and triethylamine (303 mg, 0.42 mL, 3 mmol), 60b was isolated as a yellow solid 
(170 mg, 34 %), mp. = 148 °C. 1H NMR (250 MHz, CDCl3): δ = 1.20 (t, 3 H, J= 7.1 Hz, 
CH3), 2.31 (s, 3 H, CH3), 2.36 (s, 3 H, CH3),  4.09 (s, 2 H, CH2), 4.14 (q, 2 H, J = 7.1 Hz, 
OCH2), 7.28 (s, 1 H, ArH), 7.94 (s, 1 H, ArH), 8.97 (s, 1 H, ArH). 13C NMR (75.47 MHz, 
CDCl3): δ = 14.1 (CH3), 19.2 (CH3), 20.6 (CH3), 42.2 (CH2), 61.5 (OCH2), 116.5, 117.5 
(C), 117.5 (CH), 123.4, 125.3 (C), 126.3 (CH), 134.3 (C), 137.1 (CH), 146.9, 154.2, 
157.5 (C), 168.5, 176.7 (C=O). IR (neat, cm−1): ~ν  = 2979 (w), 1715 (m), 1673 (m), 1596 
(s), 1425 (m), 1308 (w), 1262 (s), 1213 (m), 1067 (m), 763 (m). MS (GC, 70 eV): m/z
(%): 347 (M+, 37Cl, 25), 345 (M+, 74), 311 (16), 301 (11), 273 (100), 244 (26); HRMS 
(EI) calcd for C18H16ClNO4 [M+, 35Cl]: 345.07624, found 345.076341.      
3-chloro-7-fluoro-2-(2-oxobutyl)-5H-
chromeno[2,3-b]pyridin-5-one (60c): Starting with 
6-floro-3-cyanochromone (58c) (280 mg, 
1.5 mmol), Me3SiOTf (433 mg, 0..35 mL, 
1.95 mmol), 55b (602 mg, 1.95 mmol), CH2Cl2 (13.5 mL), EtOH (15 mL), and 
triethylamine (303 mg, 0.42 mL, 3 mmol), 60c was isolated as a yellow solid (.180 mg, 
37 %), mp. = 126-130 °C. 1H NMR (250 MHz, CDCl3): δ = 1.20 (t, 3 H, J= 7.4 Hz, 
CH3), 4.06 (s, 2 H, CH2), 4.14 (q, 2 H, J = 7.4 Hz, OCH2), 7.41-7.49 (m, 1 H, ArH), 7.52-
7.57 (m, 1 H, ArH), 7.83 (dd, 1 H, J= 7.8 Hz, J= 2.9 Hz, ArH), 8.57 (s, 1 H, ArH). 
13C NMR (75.47 MHz, CDCl3): δ = 14.1 (CH3), 42.2 (CH2), 61.6 (OCH2), 111.4 (CH), 
115.6 (C), 120.5 (CH), 122.1 (C), 123.8 (CH), 128.8 (C), 137.1, 141.6 (CH), 151.7, 
157.2, 158.1 (C), 166.1, 175.9 (C=O). IR (neat, cm−1): ~ν  = 3056 (w), 2981 (w), 2925 
(w), 1727 (s), 1658 (s), 1593 (w), 1480 (s), 1397 (s), 1259 (s), 1193 (s), 791 (s). MS (GC, 
70 eV): m/z (%): 337 (M+, 37Cl, 19), 335 (M+, 68), 300 (27), 290 (14), 272 (18), 263 
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(100), 234 (17); HRMS (EI) calcd for C16H11ClFNO4 [M+, 35Cl]: 335.03522, found 
335.035008.      
3,7-dichloro-2-(2-oxobutyl)-5H-chromeno[2,3-
b]pyridin-5-one (60d): Starting with 6-chloro-3-
cyanochromone (60d) (300 mg, 1.5 mmol), 
Me3SiOTf (433 mg, 0.35 mL, 1.95 mmol), 55b
(602 mg, 1.95 mmol), CH2Cl2 (13.5 mL), EtOH (15 mL), and triethylamine (303 mg, 
0.42 mL, 3 mmol), 60d was isolated as a yellow solid (199 mg, 39 %), mp. = 154-157 °C. 
1H NMR (250 MHz, CDCl3): δ = 1.21 (t, 3 H, J= 7.0 Hz, CH3), 4.06 (s, 2 H, CH2), 4.12 
(q, 2 H, J = 7.0 Hz, OCH2), 7.48 (d, 1 H, J= 8.4 Hz, ArH), 8.34 (dd, 1 H, J = 9.22 Hz, J = 
2.3 Hz, ArH), 8.19 (d, 1 H, J= 2.3 Hz, ArH), 8.58 (s, 1 H, ArH). 13C NMR (75.47 MHz, 
CDCl3): δ = 14.1 (CH3), 42.5 (CH2), 61.6 (OCH2), 116.1 (C), 120.2 (CH), 122.1 (C), 
126.0 (CH), 128.9, 130.9 (C), 136.0, 137.2 (CH), 153.9, 157.5, 158.1 (C), 168.1, 175.5 
(C=O). IR (neat, cm−1): ~ν  = 2979 (w), 1715 (m), 1673 (m), 1596 (s), 1425 (m), 1308 (w), 
1262 (s), 1213 (m), 1067 (m), 763 (m). MS (GC, 70 eV): m/z (%): 353 (M+, 37Cl, 26), 
351 (M+, 41), 316 (28), 288 (21), 279 (100), 250 (17), 139 (11); HRMS (EI) calcd for 
C16H11Cl2NO4 [M+, 35Cl]: 351.00596, found 351.006388. 
Methyl 4-chloro-3-hydroxy-5-methylbiphenyl-2-carboxylate 
(62a): Starting with monosilylenolether 60a (234 mg, 1mmol), 
1,3-bis(silyl enol ether) 55a (324 mg, 1.1 mmol), and TiCl4
(208mg, 0.12mL, 0.58 mmol), 62a was isolated as a white solid 
(119 mg, 42 %), mp. = 94-96 °C. 1H NMR (250 MHz, CDCl3): δ
= 2.43 (s, 3H, CH3), 3.49 (s, 3H, OCH3), 6.75 (s, 1H, ArH), 7.18-7.21 (m, 2H, ArH), 
7.31-7.37 (m, 3H, ArH), 11.32 (s, 1 H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 20.7 
(CH3), 51.9 (OCH3), 110.8, 121.4 (C), 124.2, 127.0 (CH), 127.4, 128.0 (2C, CH), 142.0, 
142.38, 142.47, 157.0 (C), 171.1 (C=O).  IR (neat): ν~ = 3369 (w), 2951 (w), 2918 (w), 
1664 (s), 1596 (w), 1435 (s), 1347 (m), 1050 (m), 771 (s); MS (GC, 70 eV): m/z (%): 278 
(M+, 37Cl, 7), 276 (M+, 20), 244 (100), 216 (9), 181 (9), 152 (24); HRMS (EI) calcd for 
C15H13ClO3 [M+, 35Cl]: 276.05477, found 276.054965 . 
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Ethyl 4-chloro-3-hydroxy-5-methylbiphenyl-2-carboxylate 
(62b):   Starting with monosilylenolether 61b (234 mg, 1mmol), 
1,3-bis(silyl enol ether) 55b (330 mg, 1.1 mmol), and TiCl4
(208mg, 0.12mL, 0.58 mmol), 62b was isolated as a crystalline 
solid (112 mg, 41%), mp. = 94-96 °C.1H NMR (300MHz, 
CDCl3): δ = 0.74 (t, 3H, J = 7.4 Hz, CH3), 2.42 (s, 3H, CH3), 3.95 (q, 2 H, J = 7.4 Hz, 
OCH2), 6.71 (s, 1H, ArH), 7.17-7.20 (m, 2H, ArH), 7.31-7.36 (m, 3H, ArH), 11.53 (s, 1 
H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 12.9 (CH3), 20.7 (CH3), 61.3 (OCH2), 110.8, 
121.4 (C), 124.1, 126.8 (CH), 127.6, 128.0 (2C, CH), 142.32, 142.36, 142.5, 157.2 (C), 
170.7 (C=O). IR (neat): ν~ = 3063 (s), 2988 (m), 2921 (m), 2881 (w), 1651 (m), 1599 (m), 
1440 (m), 1375 (s), 1266 (s), 1216 (s); MS (GC, 70 eV): m/z (%): 292 (M+, 37Cl, 7), 290 
(M+, 37Cl, 18), 244 (100), 216 (7), 181 (9), 152 (21); HRMS (EI) calcd for C16H15ClO3
[M+, 35Cl]: 290.07042, found 290.070573. 
Ethyl 4-chloro-4'-fluoro-3-hydroxy-5-methyl[1,1'-
biphenyl]-2-carboxylate (62c): Starting with 
monosilylenolether 61c (101 mg, 0.4 mmol), 1,3-bis(silyl 
enol ether) 55b (135 mg, 0.44 mmol), and TiCl4 (0.05 mL, 
0.44 mmol), 62c was isolated as a crystalline solid (59 mg, 48 
%), mp. = 140-142 °C. 1H NMR (250 MHz, CDCl3): δ = 0.75 (t, 3H, J = 7.1 Hz, CH3), 
2.35 (s, 3H, CH3), 3.94 (q, 2 H, J = 7.0 Hz, OCH2), 6.60 (s, 1H, ArH), 6.94-7.01 (m, 2H, 
ArH), 7.06-7.12 (m, 2H, ArH), 11.53 (s, 1 H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 
13.06 (CH3), 20.6 (CH3), 61.4 (OCH2), 110.7 (C), 114.2, 114.6 (CH), 121.7 (C), 124.2, 
129.6, 129.7 (CH), 138.3, 141.3, 142.4, 157.4, 160.1 (C), 170.5 (C=O). IR (neat): ν~ = 
3076 (w), 2917 (s), 2837 (m), 1656 (m), 1602 (s), 1504 (m), 1453 (m), 1375 (s), 1221 
(m), 1155 (s), 777 (m); MS (GC, 70 eV): m/z (%): 310 (M+, 37Cl, 6), 308 (M+, 19), 262 
(100), 234 (9), 199 (9), 170 (22); HRMS (EI) calcd for C16H14ClFO3 [M+, 35Cl]: 
308.06100, found 308.060716. 
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Ethyl 2',4-dichloro-3-hydroxy-5-methyl[1,1'-biphenyl]-2-
carboxylate (62d): Starting with monosilylenolether 61d (140 
mg, 0.53 mmol), 1,3-bis(silyl enol ether) 55b (179 mg, 0.58 
mmol), and TiCl4 (0.06 mL, 0.58 mmol), 62d was isolated as a 
crystalline solid (85 mg, 49 %), mp. = 85-88 °C. 1H NMR (250 
MHz, CDCl3): δ = 0.69 (t, 3H, J = 7.4 Hz, CH3), 2.35 (s, 3H, CH3), 3.92 (q, 2 H, J = 7.4 
Hz, OCH2), 6.54 (s, 1H, ArH), 7.07-7.11 (m, 1H, ArH), 7.18-7.20 (m, 2H, ArH), 7.21-
7.32 (m, 1H, ArH), 11.90 (s, 1 H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 12.8 (CH3), 
20.7 (CH3), 61.5 (OCH2), 110.8, 112.2 (C), 123.8, 126.2,128.3, 128.6, 129.6 (CH), 132.3, 
139.1, 141.3, 142.9, 157.7 (C), 170.3 (C=O). IR (neat): ν~ = 3305 (br), 2986 (m), 2855 
(w), 1731 (w), 1651 (s), 1435 (w), 1374 (s), 1214 (s), 1011 (m), 753 (s); MS (GC, 70 
eV): m/z (%): 326 (M+, 37Cl, 2), 324 (M+, 4), 289 (98), 280 (65), 278 (100), 261 (67); 
HRMS (EI) calcd for C16H14Cl2O3 [M+, 35Cl]: 324.03145, found 324.030996. 
Ethyl 4-chloro-3-hydroxy-2',5-dimethyl[1,1'-biphenyl]-2-
carboxylate (62e): Starting with monosilylenolether 61e (248 
mg, 1 mmol), 1,3-bis(silyl enol ether) 55b (339 mg, 1.1 mmol), 
and TiCl4 (0.12 mL, 1.1 mmol), 62e was isolated as a crystalline 
solid (120 mg, 40 %), mp. = 77-79 °C. 1H NMR (250 MHz, 
CDCl3): δ = 0.69 (t, 3H, J = 7.4 Hz, CH3), 1.95 (s, 3H, CH3), 2.34 (s, 3H, CH3), 3.87 (q, 2 
H, J = 7.4 Hz, OCH2), 6.53 (s, 1H, ArH), 6.90-6.94 (m, 1H, ArH), 7.07-7.10 (m, 2H, 
ArH), 7.15-7.21 (m, 1H, ArH), 11.85 (s, 1 H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 
12.8 (CH3), 19.9 (CH3), 20.7 (CH3), 61.3 (OCH2), 110.7, 121.3 (C), 123.7, 125.0, 127.0, 
128.4, 129.1 (CH), 134.9, 141.9, 142.2, 142.8, 157.7 (C), 170.7 (C=O). IR (neat): ν~ = 
2985 (w), 2922 (m), 2853 (w), 1650 (s), 1600 (m), 1373 (s), 1294 (s), 1213 (m), 727 (s); 
MS (GC, 70 eV): m/z (%): 306 (M+, 37Cl, 4), 304 (M+, 13), 260 (35), 258 (100), 195 (21), 
165 (24); HRMS (EI) calcd for C17H17ClO3 [M+, 35Cl]: 304.08607, found 304.0086736. 
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Ethyl 4-chloro-2'-fluoro-3-hydroxy-5-methyl[1,1'-biphenyl]-2-
carboxylate (62f): Starting with monosilylenolether 61f (720 mg, 
2.85 mmol), 1,3-bis(silyl enol ether) 55b (970 mg, 3.14 mmol), 
and TiCl4 (0.34 mL, 3.14 mmol), 61f was isolated as a crystalline 
solid (390 mg, 45 %), mp. = 76-79 °C. 1H NMR (250 MHz, 
CDCl3): δ = 0.75 (t, 3H, J = 6.5 Hz, CH3), 2.34 (s, 3H, CH3), 3.96 (q, 2 H, J = 7.0 Hz, 
OCH2), 6.60 (s, 1H, ArH), 6.91-6.98 (m, 1H, ArH), 7.06-7.11 (m, 2H, ArH), 7.22 (m, 1H, 
ArH), 11.53 (s, 1 H, OH); 13C NMR (62.9 MHz, CDCl3): δ = 13.0 (CH3), 20.7 (CH3), 
61.5 (OCH2), 111.0 (C), 114.4, 114.8 (CH), 122.3 (C), 123.7, 124.4, 129.0 (CH), 135.4, 
142.9, 142.4, 157.7, 161.0 (C), 170.5 (C=O). IR (neat): ν~ = 3040 (w), 2979 (m), 1657 
(m), 1604 (m), 1495 (m), 1440 (m), 1374 (s), 1260 (s), 1215 (s), 759 (s); MS (GC, 70 
eV): m/z (%): 310 (M+, 37Cl, 8), 308 (M+, 24), 262 (100), 234 (12), 199 (11), 170 (24); 
HRMS (EI) calcd for C16H14ClFO3 [M+, 35Cl]: 308.06100, found 308.060555. 
4-Chloro-3-oxo-2-[3-oxo-3H-isobenzofuran-(1E)-ylidene]-
butyric acid ethyl ester (64): A CH2Cl2 solution (10ml) of the 
1,3-bis(silyl enol ether) 55b  (1.85g, 6mmol) was added 
phthaloyl dichloride 63 (0.81g, 4mmol) at -78 °C under argon 
atmosphere. The solution was allowed to warm to 20 °C within 6 
h and was stirred at this temperature for 6-8 hrs. To the solution was added a sat. aq 
solution of NaHCO3 (50ml), the organic and aqueous layers were separated and the latter 
was extracted with CH2Cl2 (3 × 50ml). The combined organic layers were purified by 
chromatography (silica gel, heptane/EtOAc 9: 1) to give the 64 as crystaline solid (360 
mg, 36 %), m.p = 111-113 °C. 1H NMR (250 MHz, CDCl3): δ = 1.30 (t, 3 H, J = 7.1 Hz, 
CH3), 4.32(q, 2 H, J = 7.1 Hz, 14.3 Hz, OCH2), 4.56 (s, 2 H, CH2), 7.67-7.80 (m, 2 H, 
ArH), 7.94 (d, 1 H, J = 7.3 Hz, ArH), 7.97 (d, 1 H, ArH); 13C NMR (62 MHz, CDCl3): δ
= 14.0 (CH3), 49.2 (CH2), 62.5 (OCH2), 113.4, 125.4 (C), 126.2, 127.0, 133.4, 135.7 
(CH), 137.3, 154.3 (C), 163.1, 163.4, 189.9 (C=O); IR (neat, cm−1): ν~ = 2919 (m), 2850 
(w), 1682 (m), 1632 (m), 1460 (m), 1336 (s); MS (GC, 70 eV): m/z (%): 296 (M+, 37Cl, 
1), 294 (M+, 1), 245 (88), 173 (100), 104 (14), 76 (19); HRMS (EI) calcd for C14H11ClO5
[M+, 35Cl]: 294.02895, found 294.028548.  
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Ethyl 8-chloro-7-oxo-7H-benzo[a]cycloheptene-6-carboxylate 
(66): A CH2Cl2 solution (140 mL) of phthalic dialdehyde 65 (2.0 
m.mol, 268 mg) and molecular sieves (4 Å, 1.0 g) was stirred for 
15 min at -78 °C. A CH2Cl2 solution (5ml) each of 1,3-bis(silyl 
enol ether) 55b (1.1 m.mol, 339 mg) and of TiCl4 (2.2 m.mol, 0.417 g, 0.24 ml) was 
added at -78 °C. The temperature of reaction mixture was allowed to rise to 20 C during 
12 h. After the mixture was stirred for 2h at 20 °C, an aqueous solution of hydrochloric 
acid (100ml, 10%) was added. The organic layer was separated, and aqueous layer was 
extracted three times with dichloromethane (100ml). The combined organic layers were 
extracted with brine, dried with (Na2SO4), and filtered. The filtrate was removed in 
vacuo. The residue was purified by column chromatography (silica gel, Heptane/EtOAc 
9:1) to give 66 as crystalline solid (257 mg, 51%) m.p. = 102-106 °C. 1H NMR (300 
MHz, CDCl3): δ = 1.32 (t, 3 H, J = 7.0 Hz, CH3), 4.32(q, 2 H, J = 7.2 Hz, 14.3 Hz, 
OCH2), 7.58-7.64 (brs, 3 H, ArH), 7.69 (m, 1 H, ArH), 7.88 (s, 1H, C=CH), 8.01 (s, 1H, 
C=CH); 13C NMR (62 MHz, CDCl3): δ = 14.2 (CH3), 62.2 (OCH2), 130.8, 132.1 (C), 
133.1, 133.4 (C), 133.6, 134.9 (CH), 135.2 (C), 139.4 (CH), 139.9 (C), 141.4 (CH), 
167.4, 177.5 (C=O); IR (neat, cm−1): ν~ = 2919 (m), 2850 (w), 1682 (m), 1632 (m), 1460 
(m), 1336 (s); MS (GC, 70 eV): m/z (%): 264 (M+, 37Cl, 6), 262 (M+, 17), 234 (45), 219 
(12), 217 (24), 189 (100), 161 (36), 126 (64); HRMS (EI) calcd for C14H11ClO3 [M+, 
35Cl]: 262.03912, found 262.038666.     
4-Allylcyclohexane-1,3-dione (71a). To a THF solution (98 ml) 
of 1,3-cyclohexanedione 67a (5.0 g, 44.6 mmol) and of 
anhydrous HMPA (20 ml) was added a THF solution of LDA 
which was prepared from nBuLi (2.5 M solution in hexane, 40 
ml, 98.2 mmol) and diisopropylamine at –78 °C. After stirring for 1 h, the reaction 
mixture was allowed to warm to -40 °C and 2-methylallyl bromide (4.1 ml, 44.6 mmol) 
was added rapidly. The mixture was slowly warmed to room temperature and stirred for 
additional 10 h at 20 °C. The reaction mixture was concentrated, diluted with 
hydrochloric acid (5%), and extracted with diethyl ether (3 x 100 ml). The organic layer 
was washed with hydrochloric acid (3%) and with brine, dried (MgSO4), filtered and 
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concentrated in vacuo. The crude product was purified by flash column chromatography 
(silica gel, heptanes/EtOAc = 1:1) to give 71a as a pale yellow oil (5.90 g, 87%). 1H-
NMR (300 MHz, CDCl3):   = 5.77 (m, 1H, C=CH), 5.45 (s, 1H, CH), 5.03 (m, 2H, 
C=CH2), 2.67 (m, 3H, CH, CH2), 2.43 (m, 2H, CH2), 2.23 (m, 2H, CH2), 1.7 (m, 1H, 
CH2). 13C-NMR (75 MHz, CDCl3):  = 196.7 (C=O), 189.5 (C=COH), 136.2 (C=CH), 
117.9 (C=CH2), 104.3 (CH), 41.9 (CH), 34.8 (CH2), 30.2 (CH2), 25.7 (CH2). IR (neat, 
cm–1): ~ν  = 3076 (m), 2934 (w), 2664 (w), 1598 (s, br), 1413 (m). MS (GC, 70 eV): m/z
(%) 152 [M]+ (13), 124 (16), 123 (27), 110 (46), 109 (24), 96 (26), 95 (52), 92 (10), 83 
(42), 82 (62), 81 (33), 79 (15), 69 (22), 68 (56), 67 (100). HRMS (EI, 70 eV): calcd. for 
C9H12O2 [M+]: m/z = 152.083669; found: 152.08318. 
12-Allyl-1,4,8,11-tetraoxadispiro[4.1.4.3]tetradecane (72a). A 
mixture of 71a (6.08 g, 40.0 mmol), ethylene glycol (5.0 ml, 85.0 
mmol) and p-toluenesulfonic acid monohydrate (50 mg, 2.6 
mmol) in toluene (300 ml) was stirred under reflux for 4 h using 
Dean-Stark conditions. Approximately 1.6 ml of water was collected in the Dean-Stark 
trap. The toluene solution was washed with a saturated aqueous solution of NaHCO3 (40 
ml) and with brine (60 ml). The solution was dried (MgSO4), filtered and the solvent of 
the filtrate was removed in vacuo. The residue was purified by chromatography (silica 
gel) to give 6a (3.65 g, 18.6 mmol, 90%) as a colourless oil. 1H-NMR (CDCl3, 300 
MHz):  = 5.92 (m, 1H, CH), 5.15 (m, 2H, CH2), 4.06 (m, 8H, OCH2), 2.58 (m, 1H, CH), 
2.18 - 1.86 (m, 6H, CH2), 1.69 (m, 2H, CH2). 13C-NMR: (CDCl3, 75.4 MHz): C = 137.8 
(C=CH), 116.1 (C=CH2), 110.5 (C), 109.3 (C), 65.6 (OCH2), 65.0 (OCH2), 64.9 (OCH2), 
64.2 (OCH2), 43.8 (CH), 43.1 (CH2), 33.5 (CH2), 32.7 (CH2), 24.9 (CH2). MS (GC, 70 
eV): m/z (%) = 240 ([M+1]+, 1), 157 (35), 154 (22), 139 (15), 138 (10), 126 (26), 125 
(14), 113 (5), 99 (35), 87 (12), 86 (100), 55 (11), 42 (10). HRMS (EI, 70 eV): calcd. for 
C13H20O4 [M+1]+: m/z = 240.13561; found: 240.13589. 
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 2-(1,4,8,11-Tetraoxadispiro[4.1.4.3]tetradec-12-yl)acetic 
acid (73a). To a stirred water solution (250 ml) of NaIO4 
(15.00 g, 196.0 mmol) and KMnO4 (0.63 g, 3.9 mmol) was 
added an acetone solution (39 ml) of 72a (2.30 g, 11.7 mmol). 
The solution was stirred at room temperature until a colour change from violet to red was 
observed. The solution was then extracted with EtOAc (3 x 100 ml) and the combined 
organic layers were dried (MgSO4). The solution was filtered and the filtrate was 
concentrated in vacuo to give 72a (1.61 g, 65%) as a light brown gummy substance 
which required no further purification. 1H-NMR (300 MHz, CDCl3): 10.09 (brs, 1H, 
COOH), 3.86 (m, 8H, OCH2), 2.51 (dd, J = 15.0, 4.5 Hz, 1H), 2.21 (m, 1H), 2.05 (dd, J = 
14.7, 8.1 Hz, 1H), 1.90 (dd, J = 12.5, 1.8 Hz, 2H), 1.69 (m, 2H), 1.50 (brd, d, J = 8.7, 
2H). 13C-NMR (75 MHz, CDCl3): 178.7 (C=O), 109.7 (C), 109.0 (C), 65.5 (OCH2), 65.4 
(OCH2), 64.9 (OCH2), 64.1 (OCH2), 42.6 (CH2), 40.9 (CH), 33.8 (CH2), 33.5 (CH2), 26.0 
(CH2). MS (EI, 70 eV): m/z (%) 258 [M]+ (2), 215 (8), 172 (18), 157 (87), 152 (6), 144 
(32), 128 (8), 113 (32), 100 (9), 99 (93), 87 (20), 86 (100), 85 (15), 83 (22). HRMS (EI, 
70 eV): calcd. for C12H18O6 [M]+: m/z = 258.10979; found: 258.109219. 
Typical procedure for the synthesis of amides 76: To a CH2Cl2 solution (20 mL) of 
73a (1 equiv.) was added N-hydroxysuccinimide (1.1 equiv.) and 
dicyclohexylcarbodiimide (1.1 equiv.) at 0 °C and the mixture was stirred for 1 h at the 
same temperature. After stirring for 12 h, the mixture was filtered, amine (1equiv.) was 
added to the filtrate and the mixture was stirred for 2 h. The mixture was filtered and 
washed for several times with water (50 mL for each washing). The organic layer was 
dried (NaSO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by column chromatography (silica gel, heptanes/EtOAc) to give 77.   
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2-(1,4,8,11-Tetraoxadispiro[4.1.4.3]tetradec-12-
yl)acetamide (76a). Starting with CH2Cl2 (40 mL), 73a (340 
mg, 1.3 mmol), N-hydroxysuccinimide (178.4 mg, 1.6 mmol), 
dicyclohexylcarbodiimide (328.8 mg, 1.6 mmol) and ammonia 
(25% aqueous solution, 0.12 ml, 1.6 mmol), 76a (210 mg, 62%) was isolated as a white 
solid, mp. = 149 - 152 °C. 1H-NMR (CDCl3, 250 MHz):  = 5.81 (brs, 1H, NH), 5.69 
(brs, 1H, NH), 3.89 (m, 8H, OCH2), 2.46 (dd, J = 14.5, 4.5 Hz, 1H, CH2), 2.16 (m, 1H, 
CH), 1.98 (dd, J = 8.5, 2.5 Hz, 1H, CH2), 1.92 (dd, J = 7.5, 5.3 Hz, 1H, CH2), 1.77 (m, 
2H, CH2), 1.70 (br, J = 13.8 Hz, 1H, CH2), 1.53, (dd, J = 11.0, 2.0 Hz, 1H, CH2), 1.49 
(dd, J = 11.2, 2.7 Hz, 1H, CH2). 13C-NMR (CDCl3, 62.9 MHz): C = 175.4 (NC=O), 
109.7 (C), 108.6 (C), 65.0 (OCH2), 64.7 (OCH2), 64.6 (OCH2), 63.9 (OCH2), 42.3 (CH2), 
40.6 (CH), 35.0 (CH2), 33.2 (CH2), 25.8 (CH2). IR (neat, cm–1): ~ν  = 3411 (w), 3175 (w), 
2946 (w), 2966 (w), 2946 (w), 2880 (w), 1669 (s, br), 1625 (m). MS (GC, 70 eV): m/z 
(%) 257 ([M]+, 2), 214 (5), 212 (5), 199 (9), 171 (19), 157 (69), 143 (16), 127 (6), 113 
(13), 99 (67), 87 (14), 86 (100). HRMS (EI, 70 eV): calcd. for C12H19O5 [M]+: m/z = 
257.125885; found: 257.12577. 
N-Heptyl-2-(1,4,8,11-tetraoxadispiro 
[4.1.4.3]tetradec-12-yl)acetamide (76b). Starting with 
CH2Cl2 (20 mL), 73a (200 mg, 0.8 mmol), N-
hydroxysuccinimide (97 mg, 0.9 mmol), 
dicyclohexylcarbodiimide (175 mg, 0.9 mmol) and n-
heptylamine (0.1 ml, 0.8 mmol), 76b (153 mg, 57%) was isolated as a white solid. 1H 
NMR (CDCl3, 250 MHz): δ = 5.68 (s, 1H, NH), 3.80-3.96 (m, 8H, CH2), 3.11 (q, 2H, J = 
1.9, J = 5.6 Hz, CH2), 2.38 (dd, 1H, J = 4.4, J = 14.3 Hz, CH2), 2.13-2.23 (m, 1H, CH2), 
1.67-1.97 (m, 6H, CH2), 1.38-1.97 (m, 1H, CH2), 1.20 (br, 10H, CH2), 0.80 (t, J = 6.9 Hz, 
3H, CH3). 13C NMR (CDCl3, 62.9 MHz): δ = 172.2 (C=O), 109.8 (C-O), 108.7 (C-O), 
65.0 (CH2), 64.6 (2C, CH2), 63.8 (CH2), 42.3 (CH2), 40.7 (CH), 39.5 (CH2), 35.8 (CH2), 
31.6 (CH2), 29.6 (CH2), 28.8 (CH2), 26.8 (CH2), 25.6 (CH2), 24.9 (CH2), 22.5 (CH2), 14.0 
(CH3). IR (neat, cm-1): ~ν  =  3268 (m), 2924 (s), 1626 (br), 1549 (br) 947 (s). MS (GC, 70 
eV): m/z (%) = 355 (M+, 3), 310 (17), 296 (9), 199 (10), 157 (100), 113 (19), 99 (58), 86 
NH2
O
O
O
OO
NH
O
O
O
OO
C6H13
122
(116), 55 (21). HRMS (EI, 70 eV): calcd. for C19H33O5N [M+]: m/z = 355.23532; found: 
355.23558. 
N-Isobutyl-2-(1,4,8,11-tetraoxadispiro[4.1.4.3]tetradec-
12-yl)acetamide (76c). Starting with CH2Cl2 (20 mL), 
73a (200 mg, 0.8 mmol), N-hydroxysuccinimide (97.0 
mg, 0.9 mmol), dicyclohexylcarbodiimide (175.0 mg, 0.9 
mmol) and isopropylamine (0.08 ml, 0.8 mmol), 76c (170 
mg, 76%) was isolated as a white solid. Although a small 
amount of impurity could not be removed, the product was used for the next reaction.  
N-Cyclopropyl-2-(1,4,8,11-tetraoxadispiro 
[4.1.4.3]tetradec-12-yl)acetamide (76d). Starting with 
CH2Cl2 (20 mL), 73a (200 mg, 0.8 mmol), N-
hydroxysuccinimide (106 mg, 0.9 mmol), 
dicyclohexylcarbodiimide (195 mg, 0.9 mmol) and cyclopropylamine (0.1 ml, 0.9 mmol), 
76d (150 mg, 65%) was isolated as a white solid. 1H-NMR (CDCl3, 250 MHz):  = 6.08 
(br, 1H, NH), 3.92 (m, 8H, OCH2), 3.64 (br, 2H, CH2), 2.63 (m, 1H, CH), 2.39 (dd, J = 
14.3, 4.8 Hz, 1H, CH2), 2.13 (m, 1H, CH), 1.95 (dd, J = 14.0, 2.0 Hz, 1H, CH2), 1.83 (dd, 
J = 14.5, 8.8, 1H, CH2), 1.70 (m, 1H, CH2), 1.66 (d, J = 14.0, 1H, CH2), 1.50 (m, 2H, 
CH2), 0.67 (ddd, J = 12.3, 5.1, 1.9, 2H, CH2), 0.40 (m, 1H, CH2). 13C-NMR (CDCl3, 62.9 
MHz): C = 174.2 (C=O), 109.7 (C), 108.6 (C), 64.9 (OCH2), 64.6 (OCH2), 63.8 (OCH2), 
63.7 (OCH2), 42.2 (NCH2), 40.6 (CH), 35.4 (CH2), 33.0 (CH2), 25.6 (CH2), 25.3 (CH2), 
22.5 (CH), 6.51 (CH2), 6.44 (CH2). IR (neat, cm–1): ~ν  = 3338 (w), 2944 (w), 2925 (w), 
2892 (w), 1720 (s), 1640 (s, br), 11517 (s, br). MS (EI, 70 eV): m/z (%) 297 (M+, 5), 252 
(14), 241 (35), 213 (54), 211 (14), 199 (9), 195 (11), 157 (85), 151 (17) 127 (9), 113 (99), 
99 (100), 97 (11), 87 (28), 86 (91), 83 (15). HRMS (EI, 70 eV): calcd. for C15H23NO5
[M+]: m/z = 297.157256; found: 297.15707.  
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N-Cyclopentyl-2-(7-oxo-1,4-dioxaspiro[4.5]dec-8-yl) 
acetamide (mono-76e). Starting with CH2Cl2 (20 mL), 
mono-73a (monoacetal, 200 mg, 0.8 mmol), N-
hydroxysuccinimide (97 mg, 0.9 mmol), 
dicyclohexylcarbodiimide (175 mg, 0.9 mmol) and cyclopentylamine (0.1 ml, 0.8 mmol), 
mono-76e (180 mg, 86%) was isolated as a white solid. 1H NMR (CDCl3, 250 MHz): δ
5.52 (d, 1H, J = 5.8 Hz, NH), 4.13 (q, 1H, J = 6.9, J = 13.7 Hz, CH), 3.83-3.97 (m, 4H, 
CH2), 2.43-2.60 (m, 2H, CH2), 2.28-2.34 (m, 1H, CH), 1.83-2.00 (m, 6H, CH2), 1.52-1.63 
(m, 6H, CH2), 1.18-1.35 (m, 2H, CH2). 13C NMR (CDCl3, 62.9 MHz): δ 207.1 (C=O), 
171.2 (C=O), 110.6 (C), 65.2 (CH2), 64.7 (CH2), 51.2 (C), 50.6 (CH2), 40.6 (CH), 39.7 
(CH2), 35.4 (CH2), 33.1 (2C, CH2), 26.0 (CH2), 23.6 (2C, CH2). IR (neat, cm-1): ~ν  = 3260 
(m), 2930 (s), 1620 (br), 1552 (br) 942 (s). MS (GC, 70 eV): m/z (%) = 281 (M+, 3), 236 
(19), 224 (16), 169 (18), 128 (100), 113 (24), 99 (16), 86 (35), 55 (31). HRMS (EI, 70 
eV): calcd. for C15H23O4N [M+]: m/z = 281.16216; found: 281.162100. 
N-Cyclohexyl-2-(1,4,8,11-tetraoxadispiro[4.1.4.3] 
tetradec-12-yl)acetamide (76f). Starting with CH2Cl2
(20 mL), 73a (200 mg, 0.8 mmol), N-
hydroxysuccinimide (106 mg, 0.9 mmol), 
dicyclohexylcarbodiimide (195 mg, 0.9 mmol) and cyclohexylamine (0.1 ml, 0.9 mmol), 
76f (120 mg, 46%) was isolated as a white solid. 1H-NMR (CDCl3, 250 MHz):  = 5.45 
(d, J = 5.5 Hz, 1H, NH), 3.92 (m, 8H, OCH2), 3.87 (m, 1H, NCH), 3.71 (dd, J = 14.3, 4.5 
Hz, 1H, CH2), 2.38 (m, 1H, CH), 2.18 (dd, J = 14.0, 2.5, 1H, CH2), 1.88 - 1.05 (m, 16H, 
CH2). 13C-NMR (CDCl3, 62.9 MHz): C = 171.3 (C=O), 109.8 (C), 108.7 (C), 65.0 
(OCH2), 64.6 (OCH2), 64.6 (OCH2), 63.9 (OCH2), 48.0 (NCH), 42.3 (CH2), 40.7 (CH), 
36.0 (CH2), 33.2 (CH2), 33.1 (CH2), 25.7 (CH2), 25.5 (CH2), 24.8 (CH2).  IR (neat, cm–1): 
~ν  = 3325 (w), 2930 (w), 2861 (w), 1731 (w), 1636 (s, br), 1531 (s). MS (EI, 70 eV): m/z 
(%) = 339 (M+, 9), 294 (44), 256 (12), 253 (14), 213 (21), 199 (16), 195 (14), 158 (11), 
157 (100) 153 (10), 141 (25), 128 (10), 127 (14), 125 (10), 113 (52), 112 (10), 111 (14), 
102 (11), 99 (87), 86 (97). HRMS (EI, 70 eV): calcd. for C18H29NO5 [M+]: m/z = 
339.204629; found: 339.20402. 
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N-(4-Chlorobenzyl)-2-(1,4,8,11-
tetraoxadispiro[4.1.4.3]tetradec-12-yl)acetamide (76i). 
Starting with CH2Cl2 (20 mL), 73a (200 mg, 0.8 mmol), N-
hydroxysuccinimide (97 mg, 0.9 mmol), 
dicyclohexylcarbodiimide (175 mg, 0.9 mmol) and 4-
chlorobenzylamine (0.1 ml, 0.8 mmol), 76i (170 mg, 79%) was 
isolated as a white solid. 1H NMR (CDCl3, 250 MHz): δ = 7.20 
(d, 2H, J = 8.5 Hz, ArH), 8.67 (d, 2H, J = 8.6 Hz, ArH), 6.03 (s, 1H, NH), 4.31 (q, 2H, J
= 1.9, J = 5.6 Hz, CH2), 3.70-3.90 (m, 8H, CH2), 3.66 (s, 2H, CH2), 2.44-2.62 (m, 2H, 
CH2), 2.10-2.27 (m, 1H, CH2), 1.89-2.01 (m, 4H, CH2), 1.67-1.76 (m, 2H, CH2), 1.42-
1.55 (m, 2H, CH2), 1.21 (t, J = 7.2 Hz, 2H, CH2). 13C NMR (CDCl3, 62.9 MHz): δ = 
172.6 (C=O), 133.2 (C), 129.1 (2CH), 128.7 (2CH), 109.7 (C), 108.69 (C), 65.0 (CH2), 
64.6 (CH2), 64.5 (CH2), 64.5 (CH2), 63.9 (CH2), 42.9 (CH2), 42.2 (CH2), 40.6 (CH), 35.8 
(CH2), 33.1 (CH2), 25.9 (CH2). IR (neat, cm-1): ~ν  = 3268 (m), 2924 (s), 1626 (br), 1549 
(br) 947 (s). MS (EI, 70 eV): m/z (%) = 383 (M+, 37Cl, 15) 381 (M+, 35Cl, 51), 336 (25), 
295 (13), 267 (15), 213 (45), 157 (100), 125 (72), 86 (99). HRMS (EI, 70 eV): calcd. for 
C19H34O5NCl [M+]: m/z = 381.13460; found: 381.134472. 
General procedure for the synthesis of 77: An acetone solution of amide 76 and of a 
catalytic amount of p-toluenesulfonic acid (PTSA) was heated under reflux for 6 h. The 
solution was cooled to 20 °C and concentrated in vacuo to give a solid residue which was 
purified by column chromatography (silica gel, heptanes/EtOAc). 
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3,3a,4,5-Tetrahydro-1H-indole-2,6-dione (77a). Starting with 76a (70 
mg, 0.27 mmol), PTSA (5 mg, 0.02 mmol) and dry acetone (40 mL), 
77a was isolated (31 mg, 90%) as a white solid. 1H-NMR (CDCl3, 250 
MHz):  = 9.05 (br, 1H, NH), 5.51 (d, J = 2.0 Hz, 1H, CH), 3.14 (m, 
1H, CH), 2.66 (dd, J = 17.3, 8.8 Hz, 1H, CH2), 2.49 (ddd, J = 17.3, 6.8, 2.3 Hz, 1H, 
CH2), 2.38 (dd, J = 13.3, 4.8 Hz, 1H, CH2), 2.26 (dd, J = 17.3, 8.8 Hz, 1H, CH2), 2.24 (m, 
1H, CH2), 1.77 (ddd, J = 27.3, 14.8, 6.3 Hz, 1H, CH2). 13C-NMR (CDCl3, 62.9 MHz): C
= 197.8 (C=O), 177.0 (NC=O), 165.3 (NC=C), 103.1 (CH), 37.4 (CH2), 36.2 (CH), 35.4 
(CH2), 27.9 (CH2). IR (neat, cm–1): ~ν  = 3098 (w), 2991 (w), 2950 (w), 2799 (w), 1746 (s, 
br), 1574 (a, br). MS (GC, 70 eV): m/z (%) = 151 ([M]+, 51), 124 (7), 123 (100), 122 (7), 
95 (35), 68 (16), 67 (21). HRMS (EI, 70 eV): calcd. for C8H9O2 [M]+: m/z = 151.063012; 
found: 151.06278. 
1-Heptyl-3,3a,4,5-tetrahydro-1H-indole-2,6-dione (77b). Starting 
with 76b (150 mg, 0.4 mmol), PTSA (5 mg, 0.02 mmol) and dry 
acetone (40 mL), 77b was isolated (67 mg, 64%) as a white solid. 
1H NMR (CDCl3, 250 MHz): δ = 5.41 (d, 1H, J = 1.7 Hz, C=CH), 
3.25-3.63 (m, 2H, CH2), 2.94-3.09 (m, 1H, CH), 2.10-2.76 (m, 6H, CH2), 1.21 (m, 10H, 
CH2), 0.80 (t, J = 6.9 Hz, 3H, CH3). 13C NMR (CDCl3, 62.9 MHz): δ = 197.0 (C=O), 
175.3 (C=O), 166.2 (C), 101.9 (CH), 40.4 (CH2), 37.5 (CH2), 34.9(CH2), 34.7 (CH), 31.6 
(CH2), 28.7 (CH2), 28.0 (CH2), 26.7 (2CH2), 22.4 (CH2), 14.0 (CH3). IR (neat, cm-1): ~ν  = 
2926 (m), 1739 (m), 1608 (br). MS (GC, 70 eV): m/z (%) = 249 (M+, 72), 220 (43), 206 
(18), 192 (79), 178 (32), 165 (100), 150 (56), 137 (53), 108 (36). HRMS (EI, 70 eV): 
calcd. for C15H23O2N [M+]: m/z = 249.17233; found: 249.172014. 
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1-Isobutyl-3,3a,4,5-tetrahydro-1H-indole-2,6-dione (77c). Starting 
with 76c (150 mg, 0.5 mmol), PTSA (5 mg, 0.02 mmol) and dry 
acetone (40 mL), 77c was isolated (80 mg, 81%) as a highly viscous 
yellow oil. 1H NMR (CDCl3, 250 MHz): δ = 5.43 (d, 1H, J = 1.7 Hz, 
C=CH), 3.34-3.43 (dd, 1H, J = 8.3, 13.7 Hz, CH2), 2.96-3.17 (m, 2H, 
CH2), 2.68 (dd, 1H, J = 8.5, J = 13.8 Hz, CH2), 2.34-2.43 (m, 2H, CH2), 
2.18-2.29 (m, 2H, CH2), 1.89-2.02 (m, 2H, CH2), 0.83 (t, J = 6.6 Hz, 6H, CH3). 13C NMR 
(CDCl3, 62.9 MHz): δ = 197.2 (C=O), 175.6 (C=O), 166.6 (C), 102.2 (CH), 47.6 (CH2), 
37.4 (CH2), 34.9 (CH2), 34.7 (CH), 28.0 (CH2), 26.4 (CH) 20.1 (2CH3). IR (neat, cm-1): 
~ν   = 2957 (m), 1735 (m), 1597 (br). MS (GC, 70 eV): m/z (%) = 207 (M+, 37), 179 (22), 
152 (100), 136 (47), 123 (30), 108 (35). HRMS (EI, 70 eV): calcd. for C12H17O2N [M+]: 
m/z = 207.12538; found: 207.125713. 
1-Cyclopropyl-3,3a,4,5-tetrahydro-1H-indole-2,6-dione (77d). 
Starting with 76d (120 mg, 0.3 mmol), PTSA (5 mg, 0.02 mmol) and 
dry acetone (40 mL), 77d was isolated (40 mg, 51%) as a white solid. 
1H-NMR (CDCl3, 250 MHz):  = 5.72 (d, 1H), 2.95 (m, 1H), 2.74 (dd, 
1H), 2.57 (ddd, 1H), 2.39 (dd, 1H), 2.35 (dd, 1H), 2.23 (dd, 1H), 2.20 
(m, 1H), 1.75 (ddd, 1H), 1.02 (m, 1H), 0.86 (m, 2H), 0.59 (m, 1H). 13C-NMR (CDCl3, 
62.9 MHz): C = 198.2 (C=O), 175 9 (NC=O), 168.1 (NC=C), 103.2 (CH), 37.2 (CH2), 
35.5 (CH2), 34.1 (CH), 28.1 (CH2), 22.5 (NCH), 6.9 (CH2), 5.1 (CH2). IR (neat, cm–1): ~ν
= 2945 (m), 2862 (s), 1702 (br), 1589 (br), 1413 (m), 1196 (br). MS (GC, 70 eV): m/z 
(%) 191 (M+, 78), 163 (28), 162 (7), 149 (12), 136 (10), 135 (100), 134 (74), 121 (31), 
120 (40), 108 (23), 107 (84), 106 (65), 81 (11), 80 (19). HRMS (EI, 70 eV): calcd. for 
C11H13NO2 [M+]: m/z = 191.093697; found: 191.09408. 
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Synthesis of 1-cyclopentyl-3,3a,4,5-tetrahydro-1H-indole-2,6-dione 
(77e). Starting with mono-76e (150 mg, 0.5 mmol), PTSA (5 mg, 0.02 
mmol) and dry acetone (40 mL), 77e was isolated (100 mg, 91%) as 
white crystals. 1H NMR (CDCl3, 250 MHz): δ = 5.47 (d, 1H, J = 1.7 
Hz, C=CH), 4.46 (q, 1H, J = 8.3 Hz, CH2), 2.89-3.03 (m, 1H, CH), 2.63 
(d, 1H, J = 8.82, 17.2 Hz, CH2), 2.48-2.57 (m, 1H, CH2), 2.31-2.39 (m, 1H, CH2), 2.15-
2.26 (m, 2H, CH2), 2.01 (s, 1H, CH2), 1.70-1.89 (m, 6H, CH2), 1.54-1.59 (m, 2H, CH2). 
13C NMR (CDCl3, 62.9 MHz): δ = 197.3 (C=O), 175.5 (C), 165.3 (C=O), 103.4 (CH), 
53.0 (CH), 37.1 (CH2), 35.3 (CH2), 34.6 (CH), 27.9 (CH2), 27.7 (CH2), 27.1 (CH2), 25.1 
(CH2), 25.0 (CH2). IR (neat, cm-1): ~ν  = 2953 (m), 1731 (m), 1638 (m), 1595 (br). MS 
(GC, 70 eV): m/z (%)= 219 (M+, 20), 191 (6), 152 (100), 123 (5). HRMS (EI, 70 eV): 
calcd. for C13H17O2N [M+]: m/z = 219.12538; found: 219.125710.  
1-Cyclohexyl-3,3a,4,5-tetrahydro-1H-indole-2,6-dione (77f). 
Starting with 76f (100 mg, 0.3 mmol), PTSA (5 mg, 0.02 mmol) and 
dry acetone (40 mL), 77f was isolated (50 mg, 73%) as a white solid. 
1H-NMR (CDCl3, 250 MHz):  = 5.59 (d, J = 1.8 Hz, 1H, CH), 3.83 (tt, 
J = 12.5, 4.0 Hz, 1H, NCH), 2.94 (m, 1H, CH), 2.68 (dd, J = 17.0, 8.8 
Hz, 1H, CH2), 2.52 (ddd, J = 17.3, 6.5, 2.0 Hz, 1H, CH2), 2.33 (dd, J = 
13.5, 5.0 Hz, 1H, CH2), 2.21 (dd, J = 17.0, 8.8 Hz, 1H, CH2), 2.19 (m, 1H, CH2), 1.99 (m, 
2H, CH2), 1.80 (m, 2H, CH2), 1.59 (m, 3H, CH2), 1.28 - 1.17 (m, 4H, CH2). 13C-NMR 
(CDCl3, 62.9 MHz): C = 197.3 (C=O), 175 3 (NC=O), 165.8 (NC=C), 103.5 (CH), 53.4 
(CH), 37.1 (CH2), 35.4 (CH2), 34.8 (CH), 29.0 (CH2), 27.9 (CH2), 25.9 (CH2), 25.7 
(CH2), 25.0 (CH2). IR (neat, cm–1): ~ν  = 2921 (w), 2850 (w), 1730 (s), 1586 (s, br), 1387 
(m). MS (GC, 70 eV): m/z (%) = 233 (M+, 19), 205 (9), 177 (12), 176 (17), 152 (100), 
123 (41), 98 (9), 95 (8). HRMS (EI, 70 eV): calcd. for C14H19NO2 [M+]: m/z = 
233.140814; found: 233.14103. 
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1-(4-Chlorobenzyl)-3,3a,4,5-tetrahydro-1H-indole-2,6-dione (77i).
Starting with 76i (200 mg, 0.5 mmol), PTSA (5 mg, 0.02 mmol) and 
dry acetone (40 mL), 77i was isolated (102 mg, 71%) as highly viscous 
brownish oil. 1H NMR (CDCl3, 250 MHz): δ = 7.19 (d, 2H, J = 8.5 Hz, 
ArH), 7.08 (d, 2H, J = 8.6 Hz, ArH), 5.43 (d, 1H, J = 1.7 Hz, C=CH), 
4.42-4.7 (m, 2H, CH2), 2.96-3.10 (m, 1H, CH), 2.46-2.82 (m, 2H, CH2), 
2.17-2.36 (m, 2H, CH2), 1.65-1.98 (m, 2H, CH2). 13C NMR (CDCl3, 
62.9 MHz): δ = 197.0 (C=O), 175.3 (C=O), 165.4 (C), 133.9 (C), 133.6 (C), 129.1 
(4CH), 102.7 (CH), 43.3(CH2), 37.5 (CH2), 34.8 (CH2), 34.8 (CH), 27.9 (CH2). IR (neat, 
cm-1): ~ν  = 2934 (m), 2908 (m), 1731 (m), 1606 (br). MS (GC, 70 eV): m/z (%) = 277 
(M+, 37Cl, 17), 275 (M+, 35Cl, 50), 247 (37), 218 (11), 125 (100), 89 (16). HRMS (EI, 70 
eV): calcd. for C15H14O2NCl [M+, 35Cl]: m/z = 275.07076; found: 275.070624. 
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(103) W. Zhang, G. Pugh, Tetrahedron 2003, 59, 4237. 
(104) CCDC 716534, CCDC 670738, and CCDC 716346 contain the supplementary 
crystallographic data for this paper. These data can be obtained free of charge 
from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
(105) We have prepared 7c by oxidation of 2-allylcyclohexanone (5c) which is readily 
available from cyclohexanone (see below). This approach to 7c has, to the best of 
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our knowledge, not yet been reported. For a different synthesis of 7c, see for 
example: S. M. Allin, S. L. James, M. R. Elsegood, W. P. Martin, J. Org. Chem. 
2002, 67, 9464. 
O
7c (75%)
O
O
HO
O
i ii
5c (79%)
Conditions: i, 1) LDA, HMPTA, THF, −78 °C, 1 h, 2) allylbromide, −40 → 20 
°C, 12 h; ii, NaIO4, KMnO4, acetone
(106) The following reaction has been reported by Padwa and Wang (ref. 6): 
ON
O
N
MeO
MeO
MeO
MeO
TfOH
CO2Me
OTBDS
ref. 6 OH
(107) For related heterocycles, such as 5,8,9,10-tetrahydro-6H-indolo[2,1-a]isoquinolin-
11-ones, see: a) H. Meyer, Liebigs Ann. Chem. 1981, 1534; b) Z. Vincze, P. 
Nemes, ´B. Balazs, G. Toth, P. Scheiber, Synlett 2004, 1023; c) M. Menes-Arzate, 
R. Martinez, R. Cruz-Almanza, J. M. Muchowski, Y. M. Osornio, L. D. Miranda, 
J. Org. Chem. 2004, 69, 4001. 
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                    Data of Crystals from X-ray Measurements: 
Crystal data and structure refinement for 5e (Fig 1). 
Identification code  av_ma242 
Empirical formula  C18 H15 N O8
Formula weight  373.31 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.1158(14)Å = 81.23(3)°. 
b = 9.5538(19)Å = 80.71(3)°. 
c = 12.574(3)Å  = 82.26(3)°. 
Volume 828.4(3) Å3
Z 2 
Density (calculated) 1.497 Mg/m3
Absorption coefficient 0.120 mm-1
F(000) 388 
Crystal size 0.38 x  0.13 x  0.11 mm3
Θ range for data collection 4.72°  to  30.00°. 
Index ranges -10h9, -13k12, -17l17 
Reflections collected 16899 
Independent reflections 3964 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 97.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9869 and  0.9559 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4791 / 0 / 254 
Goodness-of-fit on F2 1.026 
Final R indices [I>2σ(I)] R1 = 0.0515, wR2 = 0.1246 
R indices (all data) R1 = 0.0407, wR2 = 0.1183 
Largest diff. peak and hole 0.408 and  -0.255e.Å-3
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Crystal data and structure refinement for 5h (Fig 2) 
Identification code  ma248 
Empirical formula  C18 H15 Cl O6
Formula weight  362.75 
Temperature  98(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  1P   
Space group (Hall)  -P 1 
Unit cell dimensions a = 5.6086(5) Å = 79.276(6)°. 
b = 11.6290(9) Å = 86.269(6)°. 
c = 12.5307(10) Å  = 82.285(6)°. 
Volume 795.07(11) Å3
Z 2 
Density (calculated) 1.515 Mg/m3
Absorption coefficient 0.274 mm-1
F(000) 376 
Crystal size 0.60 x 0.30 x 0.02 mm3
Θ range for data collection 2.21 to 29.82°. 
Index ranges -7h7, -16k16, -17l17 
Reflections collected 15882 
Independent reflections 4405 [R(int) = 0.0908] 
Completeness to Θ = 29.82° 96.6 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9945 and 0.8528 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 4405 / 0 / 230 
Goodness-of-fit on F2 1.005 
Final R indices [I>2σ(I)] R1 = 0.0771, wR2 = 0.1802 
R indices (all data) R1 = 0.1786, wR2 = 0.2482 
Largest diff. peak and hole 1.084 and -1.697 e.Å-3
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Crystal data and structure refinement for 5j (Fig 3) 
Identification code  ma239 
Empirical formula  C18 H15 F O6 
Formula weight  346.30 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P-1    
Space group (Hall)  -P 1 
Unit cell dimensions a = 5.5132(6) Å = 77.479(6)°. 
b = 11.6841(14) Å = 87.431(6)°. 
c = 12.5530(16) Å  = 79.203(6)°. 
Volume 775.41(16) Å3
Z 2 
Density (calculated) 1.483 Mg/m3
Absorption coefficient 0.119 mm-1
F(000) 360 
Crystal size 0.45 x 0.08 x 0.03 mm3
Θ range for data collection 2.71 to 26.70°. 
Index ranges -6h6, -14k14, -15l15 
Reflections collected 14035 
Independent reflections 3223 [R(int) = 0.0405] 
Completeness to Θ = 26.70° 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9964 and 0.9482 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3223 / 0 / 233 
Goodness-of-fit on F2 1.043 
Final R indices [I>2σ(I)] R1 = 0.0528, wR2 = 0.0968 
R indices (all data) R1 = 0.0890, wR2 = 0.1112 
Largest diff. peak and hole 0.257 and -0.240 e.Å-3
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Crystal data and structure refinement for 11b (Fig. 4):  
Identification code  av_ma89 
Empirical formula  C15 H14 O4' 
Formula weight  258.26 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic  
Space group (H.-M.)   'P n a 21' 
Space group (Hall)  'P 2c -2n' 
Unit cell dimensions a = 26.312(5)Å = 90.00°. 
b = 3.8740(8)Å = 90.00°. 
c = 11.824(2)Å  = 90.00°. 
Volume 1205.3(4) Å3
Z 4 
Density (calculated) 1.423 Mg/m3
Absorption coefficient 0.103 mm-1
F(000) 544 
Crystal size 0.52 x  0.51 x  0.05 mm3
Θ range for data collection 3.10  to  29.99°. 
Index ranges -37h37, -4k5, -14l14 
Reflections collected 14947 
Independent reflections 3964 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 97.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9949 and  0.9482 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2943 / 1 / 178 
Goodness-of-fit on F2 1.026 
Final R indices [I>2σ(I)] R1 = 0.0426, wR2 = 0.0870 
R indices (all data) R1 = 0.0346, wR2 = 0.0839 
Largest diff. peak and hole 0.251 and -0.178e.Å-3
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Crystal data and structure refinement for 13e (Fig 5). 
Identification code  av_ma75 
Empirical formula  C17H17ClO4
Formula weight  320.76 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  1P   
Space group (Hall)  -P 1 
Unit cell dimensions a = 6.534(4) Å = 97.420(15)°. 
b = 9.574(6) Å = 100.56(2)°. 
c = 12.694(8) Å  = 96.042(14)°. 
Volume 767.3(8) Å3
Z 2 
Density (calculated) 1.388 Mg/m3
Absorption coefficient 0.264 mm-1
F(000) 336 
Crystal size 0.55 x 0.27 x 0.01 mm3
Θ range for data collection 4.40 to 29.00°. 
Index ranges -8h8, -13k13, -17l17 
Reflections collected 14947 
Independent reflections 3964 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 97.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8683 and 0.9974 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3091 / 0 / 207 
Goodness-of-fit on F2 1.093 
Final R indices [I>2σ(I)] R1 = 0.0403, wR2 = 0.1170 
R indices (all data) R1 = 0.0563, wR2 = 0.1247 
Largest diff. peak and hole 0.308 and -0.230 e.Å-3
145
Crystal data and structure refinement for 13i (Fig 8). 
Identification code  ma93 
Empirical formula  C16 H14 Cl2 O3 
Formula weight  325.17 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21    
Space group (Hall)  P 2yb 
Unit cell dimensions a = 4.0956(5) Å = 90°. 
b = 13.3066(17) Å = 92.711(7)°. 
c = 13.3656(16) Å  = 90°. 
Volume 727.59(16) Å3
Z 2 
Density (calculated) 1.484 Mg/m3
Absorption coefficient 0.453 mm-1
F(000) 336 
Crystal size 0.65 x 0.50 x 0.06 mm3
Θ range for data collection 3.05 to 29.88°. 
Index ranges -5h5, -18k15, -17l18 
Reflections collected 9311 
Independent reflections 3754 [R(int) = 0.0217] 
Completeness to Θ = 29.88° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9734 and 0.7575 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3754 / 1 / 197 
Goodness-of-fit on F2 1.041 
Final R indices [I>2σ(I)] R1 = 0.0302, wR2 = 0.0700 
R indices (all data) R1 = 0.0385, wR2 = 0.0742 
Absolute structure parameter 0.05(5) 
Largest diff. peak and hole 0.324 and -0.179 e.Å-3
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Crystal data and structure refinement for 23j (Fig 9).  
Identification code  ma10 
Empirical formula  C15H13ClO3
Formula weight  276.70 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  Pna21
Space group (Hall)  P 2c -2n 
Unit cell dimensions a = 15.1424(4) Å = 90°. 
b = 8.2046(3) Å = 90°. 
c = 21.5336(6) Å  = 90°. 
Volume 2675.28(14) Å3
Z 8 
Density (calculated) 1.374 Mg/m3
Absorption coefficient 0.286 mm-1
F(000) 1152 
Crystal size 0.90 x 0.56 x 0.12 mm3
Θ range for data collection 2.66 to 30.00°. 
Index ranges -21h19, -11k11, -30l30 
Reflections collected 33153 
Independent reflections 7807 [R(int) = 0.0296] 
Completeness to Θ = 30.00° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9665 and 0.7829 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 7807 / 1 / 355 
Goodness-of-fit on F2 1.013 
Final R indices [I>2σ(I)] R1 = 0.0381, wR2 = 0.0952 
R indices (all data) R1 = 0.0462, wR2 = 0.1011 
Absolute structure parameter 0.06(4) 
Largest diff. peak and hole 0.320 and -0.219 e.Å-3
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Crystal data and structure refinement for 24ab (Fig 10). 
Identification code  ma32 
Empirical formula  C14H9ClO2 
Formula weight  244.66 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.) P21    
Space group (Hall) P 2yb 
Unit cell dimensions a = 9.7610(2) Å = 90°. 
b = 5.02930(10) Å = 96.0950(10)°. 
c = 11.3448(2) Å  = 90°. 
Volume 553.779(19) Å3
Z 2 
Density (calculated) 1.467 Mg/m3
Absorption coefficient 0.329 mm-1
F(000) 252 
Crystal size 0.67 x 0.10 x 0.08 mm3
Θ range for data collection 2.62 to 29.99°. 
Index ranges -13h13, -7k7, -13l15 
Reflections collected 8643 
Independent reflections 3164 [R(int) = 0.0346] 
Completeness to Θ = 29.99° 98.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9742 and 0.8099 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3164 / 1 / 158 
Goodness-of-fit on F2 1.026 
Final R indices [I>2σ(I)] R1 = 0.0398, wR2 = 0.0840 
R indices (all data) R1 = 0.0558, wR2 = 0.0911 
Absolute structure parameter 0.02(6) 
Largest diff. peak and hole 0.320 and -0.208 e.Å-3
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Crystal data and structure refinement for 35e (Fig 12). 
Identification code  ma233 
Empirical formula  C16 H11 F2 N O4
Formula weight  319.26 
Temperature  103(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P212121  
Space group (Hall)  P 2ac 2ab 
Unit cell dimensions a = 4.7205(3) Å = 90°. 
b = 11.9607(7) Å = 90°. 
c = 24.1144(12) Å = 90°. 
Volume 1361.51(14) Å3
Z 4 
Density (calculated) 1.558 Mg/m3
Absorption coefficient 0.130 mm-1
F(000) 656 
Crystal size 0.58 x 0.18 x 0.06 mm3
Θ range for data collection 2.40 to 30.00°. 
Index ranges -6h6, -16k15, -33l30 
Reflections collected 13914 
Independent reflections 2302 [R(int) = 0.0941] 
Completeness to Θ = 30.00° 98.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9922 and 0.9283 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2302 / 0 / 209 
Goodness-of-fit on F2 1.046 
Final R indices [I>2σ(I)] R1 = 0.0654, wR2 = 0.1044 
R indices (all data) R1 = 0.1035, wR2 = 0.1132 
Absolute structure parameter 0(10) 
Largest diff. peak and hole 0.341 and -0.330 e.Å-3
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Crystal data and structure refinement for 52 (Fig 13). 
Identification code  av_ma254 
Empirical formula  'C10 H9 Cl O6' 
Formula weight  260.62 
Temperature  103(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  'P b c a' 
Space group (Hall)  '-P 2ac 2ab' 
Unit cell dimensions a = 8.326(3) Å = 90°. 
b = 14.430(6) Å = 90°. 
c = 17.680(7)Å  = 90°. 
Volume 2124.1(15) Å3
Z 8 
Density (calculated) 1.630 Mg/m3
Absorption coefficient 0.374 mm-1
F(000) 1072 
Crystal size 0.63 x 0.38 x 0.33 mm3
Θ range for data collection 4.47 to 30.00°. 
Index ranges -7h11, -19k20, -24l24 
Reflections collected 13973 
Independent reflections 2741 [R(int) = 0.0941] 
Completeness to Θ = 30.00° 99.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8865 and 0.7984 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3079 / 0 / 164 
Goodness-of-fit on F2 1.079 
Final R indices [I>2σ(I)] R1 = 0.0324, wR2 = 0.0823 
R indices (all data) R1 = 0.0282, wR2 = 0.0795 
Largest diff. peak and hole 0.458 and -0.274 e.Å-3
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Crystal data and structure refinement for 57a (Fig 14). 
Identification code  av_ma208 
Empirical formula  C16 H13 Cl O5
Formula weight  320.71 
Temperature  100(2)K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)  P 21/n 
Space group (Hall)  -P 2yn 
Unit cell dimensions a = 10.977(8)Å = 90.00°. 
b = 10.528(8)Å = 100.081(15)°. 
c = 12.486(10)Å  = 90.00°. 
Volume 1420.6(19)Å3
Z 4 
Density (calculated) 1.499 Mg/m3
Absorption coefficient 0.291 mm-1
F(000) 664 
Crystal size 0.31 x  0.29 x  0.21 mm3
Θ range for data collection 4.30°  to  32.50°. 
Index ranges -16h16, -15k13, -18l14 
Reflections collected 22084  
Independent reflections 4510 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 99.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9153 and  0.9415 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5106 / 0 / 208 
Goodness-of-fit on F2 1.074 
Final R indices [I>2σ(I)] R1 = 0.0367, wR2 = 0.0949 
R indices (all data) R1 = 0.0313, wR2 = 0.0919 
Largest diff. peak and hole 0.505 and -0.238e.Å-3
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Crystal data and structure refinement for 60c (Fig 15). 
Identification code  av_ma211 
Empirical formula  C16 H11 Cl F N O4
Formula weight  335.71 
Temperature  173(2)K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 4.833(3)Å = 97.74(4)°. 
b = 10.824(6)Å = 91.31(4)°. 
c = 14.809(9)Å  = 92.29(3)°. 
Volume 766.6(7)Å3
Z 2 
Density (calculated) 1.454 Mg/m3
Absorption coefficient 0.279 mm-1
F(000) 344 
Crystal size 0.83 x  0.14 x  0.05 mm3
Θ range for data collection 4.17°  to  27.50°. 
Index ranges -3h6, -14k14, -19l19 
Reflections collected 9597  
Independent reflections 1845 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 92.7%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9862 and  0.8014 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3275 / 0 / 238 
Goodness-of-fit on F2 1.074 
Final R indices [I>2σ(I)] R1 = 0.1195, wR2 = 0.1569 
R indices (all data) R1 = 0.0539, wR2 = 0.1371 
Largest diff. peak and hole 0.560 and -0.355e.Å-3
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Crystal data and structure refinement for 62b (Fig 16). 
Identification code  av_ma258B 
Empirical formula  C16 H15 Cl O3
Formula weight  290.73 
Temperature  173(2)K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.243(2)Å = 75.67(2)°. 
b = 9.084(3)Å = 68.683(16)°. 
c = 10.418(3)Å  = 86.17(2)°. 
Volume 703.9(4)Å3
Z 2 
Density (calculated) 1.372 Mg/m3
Absorption coefficient 0.275 mm-1
F(000) 304 
Crystal size 0.19 x  0.16 x  0.10 mm3
Θ range for data collection 4.30°  to  27.50°. 
Index ranges -10h10, -11k11, -13l13 
Reflections collected 11010  
Independent reflections 2339 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 98.5%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9730 and  0.9496 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3187 / 0 / 187 
Goodness-of-fit on F2 1.054 
Final R indices [I>2σ(I)] R1 = 0.0616, wR2 = 0.1206 
R indices (all data) R1 = 0.0407, wR2 = 0.1119 
Largest diff. peak and hole 0.393 and -0.258e.Å-3
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Crystal data and structure refinement for 62c (Fig 17). 
Identification code  ma223 
Empirical formula  C16H14ClFO3
Formula weight  308.72 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P21/m   
Space group (Hall)  -P 2yb 
Unit cell dimensions a = 8.1793(2) Å = 90°. 
b = 6.9958(2) Å = 105.7850(10)°. 
c = 13.4427(3) Å  = 90°. 
Volume 740.19(3) Å3
Z 2 
Density (calculated) 1.385 Mg/m3
Absorption coefficient 0.276 mm-1
F(000) 320 
Crystal size 0.53 x 0.21 x 0.12 mm3
Θ range for data collection 2.59 to 28.62°. 
Index ranges -11h11, -9k9, -18l16 
Reflections collected 15329 
Independent reflections 2029 [R(int) = 0.0273] 
Completeness to Θ = 28.62° 98.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9677 and 0.8677 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2029 / 0 / 127 
Goodness-of-fit on F2 1.018 
Final R indices [I>2σ(I)] R1 = 0.0381, wR2 = 0.1068 
R indices (all data) R1 = 0.0533, wR2 = 0.1184 
Extinction coefficient 0.018(4) 
Largest diff. peak and hole 0.157 and -0.226 e.Å-3
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Crystal data and structure refinement for 62d (Fig 18). 
Identification code  ma221 
Empirical formula  C16 H14 Cl2 O3
Formula weight  325.17 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1  
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.237(2) Å = 78.700(16)°. 
b = 14.226(5) Å = 85.993(18)°. 
c = 19.964(6) Å  = 80.558(18)°. 
Volume 2261.3(12) Å3
Z 6 
Density (calculated) 1.433 Mg/m3
Absorption coefficient 0.437 mm-1
F(000) 1008 
Crystal size 0.52 x 0.12 x 0.04 mm3
Θ range for data collection 2.51 to 29.96°. 
Index ranges -10h10, -19k18, -27l27 
Reflections collected 22611 
Independent reflections 9718 [R(int) = 0.0608] 
Completeness to Θ = 29.96° 73.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9827 and 0.8047 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 9718 / 0 / 577 
Goodness-of-fit on F2 0.961 
Final R indices [I>2σ(I)] R1 = 0.0588, wR2 = 0.0909 
R indices (all data) R1 = 0.1763, wR2 = 0.1286 
Largest diff. peak and hole 0.354 and -0.353 e.Å-3
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Crystal data and structure refinement for 62f.(Fig 19). 
Identification code  av_ma210 
Empirical formula  C16 H14 Cl F O3
Formula weight  308.72 
Temperature  173(2)K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.212(4)Å = 71.18(3)°. 
b = 9.780(3)Å = 76.41(2)°. 
c = 10.156(3)Å  = 71.34(2)°. 
Volume 723.5(5)Å3
Z 2 
Density (calculated) 1.417 Mg/m3
Absorption coefficient 0.282 mm-1
F(000) 320 
Crystal size 0.31 x  0.18 x  0.08 mm3
Θ range for data collection 4.57°  to  29.00°. 
Index ranges -11h11, -10k13, -13l13 
Reflections collected 12813  
Independent reflections 2902 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 98.2%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9177 and  0.9778 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3773 / 0 / 195 
Goodness-of-fit on F2 1.067 
Final R indices [I>2σ(I)] R1 = 0.0647, wR2 = 0.1393 
R indices (all data) R1 = 0.0472, wR2 = 0.1318 
Largest diff. peak and hole 0.869 and  -0.243e.Å-3
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Crystal data and structure refinement for ma64 (Fig 20). 
Identification code  ma192 
Empirical formula  C14H11ClO5
Formula weight  294.68 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P1    
Space group (Hall)  -P 1 
Unit cell dimensions a = 8.3207(3) Å = 69.638(2)°. 
b = 8.3976(3) Å = 79.963(2)°. 
c = 11.2648(4) Å  = 61.383(2)°. 
Volume 647.76(4) Å3
Z 2 
Density (calculated) 1.511 Mg/m3
Absorption coefficient 0.311 mm-1
F(000) 304 
Crystal size 0.81 x 0.57 x 0.22 mm3
Θ range for data collection 2.79 to 30.00°. 
Index ranges -11h11, -11k11, -15l15 
Reflections collected 15827 
Independent reflections 3732 [R(int) = 0.0428] 
Completeness to Θ= 30.00° 99.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9347 and 0.7866 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3732 / 0 / 182 
Goodness-of-fit on F2 1.054 
Final R indices [I>2σ(I)] R1 = 0.0339, wR2 = 0.0912 
R indices (all data) R1 = 0.0383, wR2 = 0.0949 
Largest diff. peak and hole 0.379 and -0.637 e.Å-3
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Crystal data and structure refinement for 66 (Fig 21). 
Identification code  av_ma194 
Empirical formula  C14 H11 Cl O3
Formula weight  262.68 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group (H.-M.)  P -1 
Space group (Hall)  -P 1 
Unit cell dimensions a = 7.964(5)Å = 102.460(10)°. 
b = 9.959(6)Å = 94.583(16)°. 
c = 15.587(9)Å  = 96.925(14)°. 
Volume 1191.2(13)Å3
Z 4 
Density (calculated) 1.465 Mg/m3
Absorption coefficient 0.317 mm-1
F(000) 544 
Crystal size 0.39 x  0.18 x  0.14 mm3
Θ range for data collection 2.23°  to  32.57°. 
Index ranges -11h12, -15k15, -23l23 
Reflections collected 29864 
Independent reflections 7110 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 96.9%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9974 and  0.8683 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 8388 / 0 / 327 
Goodness-of-fit on F2 1.031 
Final R indices [I>2σ(I)] R1 = 0.0420, wR2 = 0.0910 
R indices (all data) R1 = 0.0330, wR2 = 0.0855 
Largest diff. peak and hole 0.518 and  -0.230e.Å-3
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Crystal data and structure refinement for 77e (Fig 24). 
Identification code  av_ma139 
Empirical formula  C13 H17 N O2
Formula weight  219.28 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group (H.-M.)  P 21/c 
Space group (Hall)  -P 2ybc 
Unit cell dimensions a = 8.6600(17)Å = 90.00°. 
b = 9.800(2)Å = 116.74(2)°. 
c = 14.801(5) Å  = 90.00°. 
Volume 1121.8(5)Å3
Z 4 
Density (calculated) 1.388 Mg/m3
Absorption coefficient 0.264 mm-1
F(000) 336 
Crystal size 0.55 x 0.27 x 0.01 mm3
Θ range for data collection 4.40 to 29.00°. 
Index ranges -8h8, -13k13, -17l17 
Reflections collected 12323 
Independent reflections 3964 [R(int) = 0.0239] 
Completeness to Θ = 29.82° 97.6%  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9726 and 0.9931 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2517 / 0 / 176 
Goodness-of-fit on F2 1.057 
Final R indices [I>2σ(I)] R1 = 0.0567, wR2 = 0.1081 
R indices (all data) R1 = 0.0413, wR2 = 0.1026 
Largest diff. peak and hole 0.219 and -0.174e.Å-3
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